activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1442933	CHEMBL828168	In vitro inhibitory concentration against human casein kinase 1 delta (CK1 delta) by using [gamma-33P]-ATP] as radioligand	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	1352.0	CHEMBL2828	Homo sapiens	IC50	nM	1352.0
	1442933	CHEMBL828168	In vitro inhibitory concentration against human casein kinase 1 delta (CK1 delta) by using [gamma-33P]-ATP] as radioligand	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	1352.0	CHEMBL2828	Homo sapiens	IC50	nM	1352.0
	1443232	CHEMBL828168	In vitro inhibitory concentration against human casein kinase 1 delta (CK1 delta) by using [gamma-33P]-ATP] as radioligand	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	35.0	CHEMBL2828	Homo sapiens	IC50	nM	35.0
Not Determined	1443239	CHEMBL832320	In vitro inhibitory concentration against human casein kinase 1 delta (CK1 delta) by using [gamma-33P]-ATP] as radioligand; NA is value not available	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465		IC50	nM		CHEMBL2828	Homo sapiens	IC50	nM	
	1512981	CHEMBL833068	Inhibition of human casein kinase 1 delta at 100 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	124.0	CHEMBL2828	Homo sapiens	IC50	nM	124.0
	1723122	CHEMBL860204	Inhibition of CK1delta	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1723150	CHEMBL860204	Inhibition of CK1delta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1723151	CHEMBL860204	Inhibition of CK1delta	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1723152	CHEMBL860204	Inhibition of CK1delta	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1723153	CHEMBL860204	Inhibition of CK1delta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1723154	CHEMBL860204	Inhibition of CK1delta	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	1744499	CHEMBL867299	Inhibition of CK1delta	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	uM	7.8
	1824522	CHEMBL913846	Inhibition of Ck1 delta	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2828	Homo sapiens	Ki	uM	10.0
	1824708	CHEMBL913846	Inhibition of Ck1 delta	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2828	Homo sapiens	Ki	uM	10.0
	1824780	CHEMBL913846	Inhibition of Ck1 delta	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2828	Homo sapiens	Ki	uM	10.0
	1917475	CHEMBL895141	Inhibition of CK1delta at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	Inhibition	%	16.0
	1917498	CHEMBL895141	Inhibition of CK1delta at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	100.0	CHEMBL2828	Homo sapiens	Inhibition	%	100.0
	1989400	CHEMBL899111	Inhibition of CK1delta	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	IC50	nM	6340.0	CHEMBL2828	Homo sapiens	IC50	uM	6.34
	2025131	CHEMBL886958	Inhibition of CK1delta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	111.0	CHEMBL2828	Homo sapiens	Inhibition	%	111.0
	2025285	CHEMBL886958	Inhibition of CK1delta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	107.0	CHEMBL2828	Homo sapiens	Inhibition	%	107.0
	2025286	CHEMBL886958	Inhibition of CK1delta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	109.0	CHEMBL2828	Homo sapiens	Inhibition	%	109.0
	2025287	CHEMBL886958	Inhibition of CK1delta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	112.0	CHEMBL2828	Homo sapiens	Inhibition	%	112.0
	2051611	CHEMBL941749	Inhibition of CK1delta	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	7826.0	CHEMBL2828	Homo sapiens	Ki	uM	7.826
	2077625	CHEMBL944999	Inhibition of CK1delta	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Inhibition	%	6.0	CHEMBL2828	Homo sapiens	Inhibition	%	6.0
	2136855	CHEMBL940173	Inhibition of CK1delta	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	300.0	CHEMBL2828	Homo sapiens	IC50	nM	300.0
	2137007	CHEMBL940173	Inhibition of CK1delta	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	IC50	nM	700.0	CHEMBL2828	Homo sapiens	IC50	nM	700.0
	2147222	CHEMBL929101	Activity of human CK1delta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	129.0	CHEMBL2828	Homo sapiens	Activity	%	129.0
	2197910	CHEMBL1004016	Inhibition of human CKIdelta	B	CNc1nccc(-c2nc(C3CCNCC3)[nH]c2-c2cccc(C(F)(F)F)c2)n1		CHEMBL489344	=	IC50	nM	1400.0	CHEMBL2828	Homo sapiens	IC50	uM	1.4
	2197918	CHEMBL1004016	Inhibition of human CKIdelta	B	CC1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1		CHEMBL523938	=	IC50	nM	400.0	CHEMBL2828	Homo sapiens	IC50	uM	0.4
	2248195	CHEMBL1012678	Inhibition of CK1delta at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	2248225	CHEMBL1012678	Inhibition of CK1delta at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	2356988	CHEMBL958284	Inhibition of CK1delta at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	2470137	CHEMBL1033257	Inhibition of CSNK1D at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	2476681	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	7.7	CHEMBL2828	Homo sapiens	Activity	%	7.7
Not Evaluated	2476884	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2828	Homo sapiens	Activity		
Not Evaluated	2478723	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2828	Homo sapiens	Activity		
	2479556	CHEMBL988948	Binding affinity to human CK1delta	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Kd	nM	58.0	CHEMBL2828	Homo sapiens	Kd	nM	58.0
	2479781	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	16.3	CHEMBL2828	Homo sapiens	Activity	%	16.3
Active	2480578	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2828	Homo sapiens	Activity		
Not Evaluated	2480780	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2828	Homo sapiens	Activity		
	2482680	CHEMBL987141	Inhibition of CK1delta	B	Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O		CHEMBL86771	=	IC50	nM	330.0	CHEMBL2828	Homo sapiens	IC50	uM	0.33
	2482683	CHEMBL987141	Inhibition of CK1delta	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	IC50	nM	2570.0	CHEMBL2828	Homo sapiens	IC50	uM	2.57
	2482684	CHEMBL987141	Inhibition of CK1delta	B	O=C1c2ccccc2C(=O)c2c(O)ccc(O)c21		CHEMBL17594	>	IC50	nM	40000.0	CHEMBL2828	Homo sapiens	IC50	uM	40.0
	2482685	CHEMBL987141	Inhibition of CK1delta	B	Nc1ccc(O)c2c1C(=O)c1ccccc1C2=O		CHEMBL88326	=	IC50	nM	660.0	CHEMBL2828	Homo sapiens	IC50	uM	0.66
	2512014	CHEMBL970581	Inhibition of CK1delta at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	2567229	CHEMBL973712	Inhibition of human CK1delta kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
Active	2577402	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2828	Homo sapiens	Activity		
Not Evaluated	2593607	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2828	Homo sapiens	Activity		
Active	2593810	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2828	Homo sapiens	Activity		
	2593873	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	19.6	CHEMBL2828	Homo sapiens	Activity	%	19.6
Active	2594076	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2828	Homo sapiens	Activity		
Not Evaluated	2595019	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2828	Homo sapiens	Activity		
Not Evaluated	2595288	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2828	Homo sapiens	Activity		
	2595814	CHEMBL1017882	Inhibition of CSNK1D assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL459769	=	Activity	%	0.0	CHEMBL2828	Homo sapiens	Activity	%	0.0
Not Evaluated	2596216	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2828	Homo sapiens	Activity		
	2596419	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	9.1	CHEMBL2828	Homo sapiens	Activity	%	9.1
	2597688	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	19.0	CHEMBL2828	Homo sapiens	Activity	%	19.0
Active	2597891	CHEMBL1025753	Binding affinity to human CK1d at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2828	Homo sapiens	Activity		
	2613497	CHEMBL1031539	Inhibition of CK1delta expressed in Escherichia coli	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	2626909	CHEMBL999793	Binding affinity to human CSNK1D at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	48.0	CHEMBL2828	Homo sapiens	Activity	%	48.0
	2626936	CHEMBL999793	Binding affinity to human CSNK1D at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	77.0	CHEMBL2828	Homo sapiens	Activity	%	77.0
	2721742	CHEMBL1059117	Inhibition of CK1d at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	2892309	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892310	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892311	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2500.0	CHEMBL2828	Homo sapiens	Kd	nM	2500.0
	2892312	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892313	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892314	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1800.0	CHEMBL2828	Homo sapiens	Kd	nM	1800.0
	2892315	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892316	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892317	CHEMBL1050829	Binding constant for full-length CSNK1D	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892318	CHEMBL1050829	Binding constant for full-length CSNK1D	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892319	CHEMBL1050829	Binding constant for full-length CSNK1D	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892320	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892321	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1100.0	CHEMBL2828	Homo sapiens	Kd	nM	1100.0
	2892322	CHEMBL1050829	Binding constant for full-length CSNK1D	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3500.0	CHEMBL2828	Homo sapiens	Kd	nM	3500.0
	2892323	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892324	CHEMBL1050829	Binding constant for full-length CSNK1D	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892325	CHEMBL1050829	Binding constant for full-length CSNK1D	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892326	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892327	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892328	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892329	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892330	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892331	CHEMBL1050829	Binding constant for full-length CSNK1D	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892332	CHEMBL1050829	Binding constant for full-length CSNK1D	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892333	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892334	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892335	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892336	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	260.0	CHEMBL2828	Homo sapiens	Kd	nM	260.0
	2892337	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	59.0	CHEMBL2828	Homo sapiens	Kd	nM	59.0
	2892338	CHEMBL1050829	Binding constant for full-length CSNK1D	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	37.0	CHEMBL2828	Homo sapiens	Kd	nM	37.0
	2892339	CHEMBL1050829	Binding constant for full-length CSNK1D	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	=	Kd	nM	170.0	CHEMBL2828	Homo sapiens	Kd	nM	170.0
	2892340	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892341	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2400.0	CHEMBL2828	Homo sapiens	Kd	nM	2400.0
	2892342	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	260.0	CHEMBL2828	Homo sapiens	Kd	nM	260.0
	2892343	CHEMBL1050829	Binding constant for full-length CSNK1D	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	15.0	CHEMBL2828	Homo sapiens	Kd	nM	15.0
	2892344	CHEMBL1050829	Binding constant for full-length CSNK1D	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892345	CHEMBL1050829	Binding constant for full-length CSNK1D	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	2892346	CHEMBL1050829	Binding constant for full-length CSNK1D	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
Antagonist	2897281	CHEMBL1051359	Inhibition of CK1delta in the presence of 100uM ATP	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	300.0	CHEMBL2828	Homo sapiens	IC50	uM	0.3
Antagonist	2897282	CHEMBL1061194	Inhibition of CK1delta in the presence of 20uM ATP	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	510.0	CHEMBL2828	Homo sapiens	IC50	uM	0.51
Antagonist	2897283	CHEMBL1061194	Inhibition of CK1delta in the presence of 20uM ATP	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	1500.0	CHEMBL2828	Homo sapiens	IC50	uM	1.5
Antagonist	2897284	CHEMBL1061194	Inhibition of CK1delta in the presence of 20uM ATP	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	150.0	CHEMBL2828	Homo sapiens	IC50	uM	0.15
Antagonist	2897285	CHEMBL1061194	Inhibition of CK1delta in the presence of 20uM ATP	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	41.0	CHEMBL2828	Homo sapiens	IC50	uM	0.041
Antagonist	2897286	CHEMBL1061194	Inhibition of CK1delta in the presence of 20uM ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	170.0	CHEMBL2828	Homo sapiens	IC50	uM	0.17
	2899781	CHEMBL1052083	Percentage CK1delta activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	79.0	CHEMBL2828	Homo sapiens	Activity	%	79.0
	2899782	CHEMBL1052083	Percentage CK1delta activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
	2899783	CHEMBL1052083	Percentage CK1delta activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
	2899784	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	81.0	CHEMBL2828	Homo sapiens	Activity	%	81.0
	2899785	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
	2899786	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	74.0	CHEMBL2828	Homo sapiens	Activity	%	74.0
	2899787	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	103.0	CHEMBL2828	Homo sapiens	Activity	%	103.0
	2899788	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
	2899789	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	88.0	CHEMBL2828	Homo sapiens	Activity	%	88.0
	2899790	CHEMBL1061953	Percentage CK1delta activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	2899791	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	2899792	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	103.0	CHEMBL2828	Homo sapiens	Activity	%	103.0
	2899793	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	2899794	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
Antagonist	2899795	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	4.0	CHEMBL2828	Homo sapiens	Activity	%	4.0
	2899796	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	55.0	CHEMBL2828	Homo sapiens	Activity	%	55.0
	2899797	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	57.0	CHEMBL2828	Homo sapiens	Activity	%	57.0
	2899798	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	51.0	CHEMBL2828	Homo sapiens	Activity	%	51.0
	2899799	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	2899800	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	2899801	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	68.0	CHEMBL2828	Homo sapiens	Activity	%	68.0
	2899802	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	83.0	CHEMBL2828	Homo sapiens	Activity	%	83.0
	2899803	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	2899804	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	2899805	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
Antagonist	2899806	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	4.0	CHEMBL2828	Homo sapiens	Activity	%	4.0
Antagonist	2900659	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	14.0	CHEMBL2828	Homo sapiens	Activity	%	14.0
	2900660	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	90.0	CHEMBL2828	Homo sapiens	Activity	%	90.0
	2900661	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	99.0	CHEMBL2828	Homo sapiens	Activity	%	99.0
	2900662	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	88.0	CHEMBL2828	Homo sapiens	Activity	%	88.0
	2900663	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	92.0	CHEMBL2828	Homo sapiens	Activity	%	92.0
	2900664	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	106.0	CHEMBL2828	Homo sapiens	Activity	%	106.0
	2900665	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	90.0	CHEMBL2828	Homo sapiens	Activity	%	90.0
	2900666	CHEMBL1061203	Percentage CK1delta activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	111.0	CHEMBL2828	Homo sapiens	Activity	%	111.0
	2900667	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	97.0	CHEMBL2828	Homo sapiens	Activity	%	97.0
	2900668	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	85.0	CHEMBL2828	Homo sapiens	Activity	%	85.0
	2900669	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	2900670	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	2900671	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	104.0	CHEMBL2828	Homo sapiens	Activity	%	104.0
	2900672	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	57.0	CHEMBL2828	Homo sapiens	Activity	%	57.0
Antagonist	2900673	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	30.0	CHEMBL2828	Homo sapiens	Activity	%	30.0
Antagonist	2900674	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	8.0	CHEMBL2828	Homo sapiens	Activity	%	8.0
Antagonist	2900675	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	21.0	CHEMBL2828	Homo sapiens	Activity	%	21.0
	2900676	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	2900677	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	76.0	CHEMBL2828	Homo sapiens	Activity	%	76.0
	2900678	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	98.0	CHEMBL2828	Homo sapiens	Activity	%	98.0
	2900679	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	98.0	CHEMBL2828	Homo sapiens	Activity	%	98.0
	2900680	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	68.0	CHEMBL2828	Homo sapiens	Activity	%	68.0
Antagonist	2900681	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	15.0	CHEMBL2828	Homo sapiens	Activity	%	15.0
	2900682	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	71.0	CHEMBL2828	Homo sapiens	Activity	%	71.0
	2900683	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	60.0	CHEMBL2828	Homo sapiens	Activity	%	60.0
	2900684	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	2900685	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	99.0	CHEMBL2828	Homo sapiens	Activity	%	99.0
	2900686	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	65.0	CHEMBL2828	Homo sapiens	Activity	%	65.0
	2900687	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	93.0	CHEMBL2828	Homo sapiens	Activity	%	93.0
	2900688	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
	2900689	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
Antagonist	2900690	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	43.0	CHEMBL2828	Homo sapiens	Activity	%	43.0
Antagonist	2900691	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	30.0	CHEMBL2828	Homo sapiens	Activity	%	30.0
Antagonist	2900692	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	7.0	CHEMBL2828	Homo sapiens	Activity	%	7.0
	2900693	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	56.0	CHEMBL2828	Homo sapiens	Activity	%	56.0
	2900694	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	88.0	CHEMBL2828	Homo sapiens	Activity	%	88.0
	2900695	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	104.0	CHEMBL2828	Homo sapiens	Activity	%	104.0
	2900696	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	93.0	CHEMBL2828	Homo sapiens	Activity	%	93.0
	2900697	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	101.0	CHEMBL2828	Homo sapiens	Activity	%	101.0
	2900698	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	105.0	CHEMBL2828	Homo sapiens	Activity	%	105.0
Antagonist	2900699	CHEMBL1062001	Percentage CK1delta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	20.0	CHEMBL2828	Homo sapiens	Activity	%	20.0
Antagonist	2900700	CHEMBL1062901	Percentage CK1delta activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	9.0	CHEMBL2828	Homo sapiens	Activity	%	9.0
Antagonist	2900701	CHEMBL1062901	Percentage CK1delta activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	12.0	CHEMBL2828	Homo sapiens	Activity	%	12.0
	2900702	CHEMBL1063738	Percentage CK1delta activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	78.0	CHEMBL2828	Homo sapiens	Activity	%	78.0
	2900703	CHEMBL1063739	Percentage CK1delta activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	63.0	CHEMBL2828	Homo sapiens	Activity	%	63.0
	2921391	CHEMBL1052901	Inhibition of CSNK1D assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	99.0	CHEMBL2828	Homo sapiens	Activity	%	99.0
	2924048	CHEMBL1041534	Inhibition of N-terminal FLAG-tagged CK1delta by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	2924049	CHEMBL1041534	Inhibition of N-terminal FLAG-tagged CK1delta by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	2938624	CHEMBL1041494	Inhibition of CK1delta	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	microM	10.0
	2946003	CHEMBL1054424	Inhibition of CK1delta at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	2995387	CHEMBL1039037	Binding affinity to CSNK1D assessed as dissociation constant	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Kd	nM	150.0	CHEMBL2828	Homo sapiens	Kd	nM	150.0
	2999025	CHEMBL1043728	Inhibition of CK1delta assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	6.0	CHEMBL2828	Homo sapiens	Activity	%	6.0
	2999815	CHEMBL1043728	Inhibition of CK1delta assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	55.0	CHEMBL2828	Homo sapiens	Activity	%	55.0
	2999888	CHEMBL1049890	Inhibition of CK1delta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
	2999964	CHEMBL1049890	Inhibition of CK1delta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	18.0	CHEMBL2828	Homo sapiens	Activity	%	18.0
	3000000	CHEMBL1045450	Inhibition of CK1delta at 10 uM by Cherenkov counting in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Inhibition	%	90.0	CHEMBL2828	Homo sapiens	INH	%	90.0
	3000001	CHEMBL1045450	Inhibition of CK1delta at 10 uM by Cherenkov counting in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	3000002	CHEMBL1045449	Inhibition of CK1delta by Cherenkov counting in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	IC50	nM	230.0	CHEMBL2828	Homo sapiens	IC50	uM	0.23
	3000007	CHEMBL1045449	Inhibition of CK1delta by Cherenkov counting in presence of 20 uM ATP	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	IC50	nM	120.0	CHEMBL2828	Homo sapiens	IC50	uM	0.12
	3000009	CHEMBL1045457	Inhibition of GST-fused human full length CK1delta expressed in Escherichia coli at 1 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	92.0	CHEMBL2828	Homo sapiens	INH	%	92.0
	3000011	CHEMBL1045457	Inhibition of GST-fused human full length CK1delta expressed in Escherichia coli at 1 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	79.0	CHEMBL2828	Homo sapiens	INH	%	79.0
	3000013	CHEMBL1045460	Inhibition of human CK1delta	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	uM	1.0
	3000017	CHEMBL1045459	Inhibition of GST-fused human full length CK1delta expressed in Escherichia coli at 25 uM	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Inhibition	%	88.0	CHEMBL2828	Homo sapiens	INH	%	88.0
	3000029	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCOCC2)c1		CHEMBL569552	=	IC50	nM	2500.0	CHEMBL2828	Homo sapiens	IC50	uM	2.5
	3000030	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(N[C@@H](C)c2ccccc2)c1		CHEMBL571357	=	IC50	nM	1600.0	CHEMBL2828	Homo sapiens	IC50	uM	1.6
	3000031	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)noc2C(C)C)ccn1		CHEMBL585533	=	IC50	nM	700.0	CHEMBL2828	Homo sapiens	IC50	uM	0.7
	3000032	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccnc(NC(=O)Cc2ccc(F)cc2)c1		CHEMBL569151	=	IC50	nM	110.0	CHEMBL2828	Homo sapiens	IC50	uM	0.11
	3000033	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	CC(Oc1ccccc1)C(=O)Nc1cc(-c2c(-c3ccc(F)cc3)noc2C(C)C)ccn1		CHEMBL566058	=	IC50	nM	820.0	CHEMBL2828	Homo sapiens	IC50	uM	0.82
	3000034	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3c(-c4ccc(F)cc4)noc3C(C)C)ccn2)c(OC)c1		CHEMBL571142	=	IC50	nM	33.0	CHEMBL2828	Homo sapiens	IC50	uM	0.033
	3000044	CHEMBL1045469	Inhibition of recombinant CK1delta kinase domain at 5 nM by ATP competitive binding assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Inhibition	%	18.0	CHEMBL2828	Homo sapiens	INH	%	18.0
	3000045	CHEMBL1045469	Inhibition of recombinant CK1delta kinase domain at 5 nM by ATP competitive binding assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	3000046	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	IC50	nM	4.0	CHEMBL2828	Homo sapiens	IC50	uM	0.004
	3000050	CHEMBL1045455	Inhibition of recombinant CK1delta kinase domain by Cherenkov counting	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	IC50	nM	5.0	CHEMBL2828	Homo sapiens	IC50	uM	0.005
	3000064	CHEMBL1045470	Inhibition of recombinant CK1delta kinase domain at 10 nM by ATP competitive binding assay	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	3021778	CHEMBL1048143	Inhibition of CK1delta at 10 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NC(C)=O)C3)cn2)cc1		CHEMBL576502	=	Inhibition	%	39.0	CHEMBL2828	Homo sapiens	INH	%	39.0
	3021779	CHEMBL1048144	Inhibition of CK1delta at 1 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NC(C)=O)C3)cn2)cc1		CHEMBL576502	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	3052565	CHEMBL1037106	Residual activity of CK1delta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	102.0	CHEMBL2828	Homo sapiens	Residual activity	%	102.0
	3053874	CHEMBL1044274	Residual activity of CK1delta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	149.0	CHEMBL2828	Homo sapiens	Residual activity	%	149.0
	3054126	CHEMBL1066644	Residual activity of CK1delta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	94.0	CHEMBL2828	Homo sapiens	Residual activity	%	94.0
	3055413	CHEMBL1037106	Residual activity of CK1delta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL2828	Homo sapiens	Residual activity	%	96.0
	3055665	CHEMBL1044274	Residual activity of CK1delta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	156.0	CHEMBL2828	Homo sapiens	Residual activity	%	156.0
	3056970	CHEMBL1066644	Residual activity of CK1delta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL2828	Homo sapiens	Residual activity	%	95.0
	3058290	CHEMBL1037106	Residual activity of CK1delta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL2828	Homo sapiens	Residual activity	%	100.0
	3058542	CHEMBL1044274	Residual activity of CK1delta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	133.0	CHEMBL2828	Homo sapiens	Residual activity	%	133.0
	3062455	CHEMBL1048648	Binding affinity to human CSNK1D at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	3063590	CHEMBL1039787	Binding affinity to human CSNK1D at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	3063680	CHEMBL1038891	Binding affinity to human CSNK1D at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	3065860	CHEMBL1069292	Inhibition of CSNK1D at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	3066926	CHEMBL1069292	Inhibition of CSNK1D at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	3072888	CHEMBL1066644	Residual activity of CK1delta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL2828	Homo sapiens	Residual activity	%	98.0
	3084393	CHEMBL1072672	Inhibition of Ck1delta	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	530.0	CHEMBL2828	Homo sapiens	IC50	uM	0.53
	3094800	CHEMBL1069037	Inhibition of CK1delta at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	18.0	CHEMBL2828	Homo sapiens	INH	%	18.0
	3094821	CHEMBL1069037	Inhibition of CK1delta at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	37.0	CHEMBL2828	Homo sapiens	INH	%	37.0
	3094828	CHEMBL1069037	Inhibition of CK1delta at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	64.0	CHEMBL2828	Homo sapiens	INH	%	64.0
	3094830	CHEMBL1069037	Inhibition of CK1delta at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	70.0	CHEMBL2828	Homo sapiens	INH	%	70.0
	3213902	CHEMBL1114858	Inhibition of CK1delta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	3224787	CHEMBL1102781	Inhibition of CSNK1D at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3225037	CHEMBL1102781	Inhibition of CSNK1D at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3240797	CHEMBL1109660	Inhibition of CK1delta	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	740.0	CHEMBL2828	Homo sapiens	IC50	uM	0.74
	3271649	CHEMBL1112876	Inhibition of casein kinase delta at 10 uM	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Inhibition	%	19.0	CHEMBL2828	Homo sapiens	INH	%	19.0
	3271650	CHEMBL1112876	Inhibition of casein kinase delta at 10 uM	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796	=	Inhibition	%	99.0	CHEMBL2828	Homo sapiens	INH	%	99.0
	3271651	CHEMBL1112876	Inhibition of casein kinase delta at 10 uM	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	=	Inhibition	%	87.0	CHEMBL2828	Homo sapiens	INH	%	87.0
	3271697	CHEMBL1112892	Inhibition of human CK1delta expressed in simian genome expressing mouse 3T3 cells	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	IC50	nM	2570.0	CHEMBL2828	Homo sapiens	IC50	uM	2.57
Not Active	3271832	CHEMBL1112906	Inhibition of CK1delta	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271833	CHEMBL1112906	Inhibition of CK1delta	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271834	CHEMBL1112906	Inhibition of CK1delta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271835	CHEMBL1112906	Inhibition of CK1delta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271836	CHEMBL1112906	Inhibition of CK1delta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271837	CHEMBL1112906	Inhibition of CK1delta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271838	CHEMBL1112906	Inhibition of CK1delta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271839	CHEMBL1112906	Inhibition of CK1delta	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271840	CHEMBL1112906	Inhibition of CK1delta	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	3271841	CHEMBL1112906	Inhibition of CK1delta	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	3271842	CHEMBL1112906	Inhibition of CK1delta	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
Not Active	3271843	CHEMBL1112906	Inhibition of CK1delta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	3331880	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3333295	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3334700	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3336120	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3337487	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3337735	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3339067	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3340369	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3340648	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3342064	CHEMBL1168839	Inhibition of CSNK1D at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	3354249	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	53.0	CHEMBL2828	Homo sapiens	INH	%	53.0
	3354340	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	3354341	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	3354342	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	8.0	CHEMBL2828	Homo sapiens	INH	%	8.0
	3354343	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	3354344	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	3354345	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	75.0	CHEMBL2828	Homo sapiens	INH	%	75.0
	3354346	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	12.0	CHEMBL2828	Homo sapiens	INH	%	12.0
	3354347	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	68.0	CHEMBL2828	Homo sapiens	INH	%	68.0
	3354348	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	62.0	CHEMBL2828	Homo sapiens	INH	%	62.0
	3354349	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	3354350	CHEMBL1173983	Inhibition of CK1d at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	38.0	CHEMBL2828	Homo sapiens	INH	%	38.0
	3358513	CHEMBL1174185	Inhibition of CSNK1D at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	29.0	CHEMBL2828	Homo sapiens	INH	%	29.0
	3358955	CHEMBL1174185	Inhibition of CSNK1D at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	22.0	CHEMBL2828	Homo sapiens	INH	%	22.0
	3443366	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	72.0	CHEMBL2828	Homo sapiens	INH	%	72.0
	3443583	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	80.0	CHEMBL2828	Homo sapiens	INH	%	80.0
	3444738	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	87.0	CHEMBL2828	Homo sapiens	INH	%	87.0
	3445362	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	3445579	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	3445791	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	58.0	CHEMBL2828	Homo sapiens	INH	%	58.0
	3445981	CHEMBL1244399	Inhibition of CK1delta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	64.0	CHEMBL2828	Homo sapiens	INH	%	64.0
	3448385	CHEMBL1244777	Binding affinity to CSNK1D	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3448720	CHEMBL1244777	Binding affinity to CSNK1D	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3449139	CHEMBL1244777	Binding affinity to CSNK1D	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	15.0	CHEMBL2828	Homo sapiens	Kd	nM	15.0
	3449612	CHEMBL1244777	Binding affinity to CSNK1D	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3449917	CHEMBL1244777	Binding affinity to CSNK1D	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3450034	CHEMBL1244777	Binding affinity to CSNK1D	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3450953	CHEMBL1244777	Binding affinity to CSNK1D	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	uM	10.0
	3463199	CHEMBL1252287	Inhibition of CSNK1D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	3463418	CHEMBL1252287	Inhibition of CSNK1D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	-4.0	CHEMBL2828	Homo sapiens	INH	%	-4.0
	3463962	CHEMBL1252287	Inhibition of CSNK1D at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	-2.0	CHEMBL2828	Homo sapiens	INH	%	-2.0
	3521254	CHEMBL1272512	Inhibition of CSNK1d	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	>	IC50	nM	10.0	CHEMBL2828	Homo sapiens	IC50	nM	10.0
	5120292	CHEMBL1648369	Inhibition of human CK1d at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	96.0	CHEMBL2828	Homo sapiens	INH	%	96.0
	5120824	CHEMBL1646808	Inhibition of CSNK1D at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	5140522	CHEMBL1646072	Inhibition of CSNK1D at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	5143839	CHEMBL1656197	Inhibition of CSNK1D	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	>	IC50	nM	100.0	CHEMBL2828	Homo sapiens	IC50	nM	100.0
	5143856	CHEMBL1656197	Inhibition of CSNK1D	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	>	IC50	nM	100.0	CHEMBL2828	Homo sapiens	IC50	nM	100.0
	5143873	CHEMBL1656197	Inhibition of CSNK1D	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	>	IC50	nM	100.0	CHEMBL2828	Homo sapiens	IC50	nM	100.0
	5199834	CHEMBL1671067	Inhibition of CK1delta at 1 uM	B	O/N=C1\CCc2cc(Nc3c(-c4ncccn4)oc4cnccc34)ccc21		CHEMBL1668922	=	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	6157556	CHEMBL1763569	Inhibition of CK1delta at 1 uM relative to control	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	IC50	nM	40000.0	CHEMBL2828	Homo sapiens	IC50	uM	40.0
	6157557	CHEMBL1763570	Inhibition of DCAMKL3 at 1 uM relative to control	B	N#CCNc1ncnc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1615182	=	IC50	nM	16000.0	CHEMBL2828	Homo sapiens	IC50	uM	16.0
	6157563	CHEMBL1763569	Inhibition of CK1delta at 1 uM relative to control	B	Cc1nc(NCC#N)nc(-n2c(Nc3cccc(O)c3)nc3ccccc32)n1		CHEMBL1762782	=	Inhibition	%	90.0	CHEMBL2828	Homo sapiens	INH	%	90.0
	6218827	CHEMBL1786918	Binding affinity to human CSNK1D at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	26.0	CHEMBL2828	Homo sapiens	Activity	%	26.0
Not Determined	6218853	CHEMBL1787157	Binding affinity to human CSNK1D incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL2828	Homo sapiens	Kd		
	6218872	CHEMBL1787535	Inhibition of human CSNK1D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	90.0	CHEMBL2828	Homo sapiens	Activity	%	90.0
Not Determined	6218884	CHEMBL1787682	Inhibition of human CSNK1D using gamma-33P-ATP as substrate by scintillation counting	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		IC50			CHEMBL2828	Homo sapiens	IC50		
	6219031	CHEMBL1786918	Binding affinity to human CSNK1D at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	23.0	CHEMBL2828	Homo sapiens	Activity	%	23.0
	6219050	CHEMBL1787535	Inhibition of human CSNK1D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	6220380	CHEMBL1786918	Binding affinity to human CSNK1D at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	22.0	CHEMBL2828	Homo sapiens	Activity	%	22.0
	6220399	CHEMBL1787535	Inhibition of human CSNK1D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	74.0	CHEMBL2828	Homo sapiens	Activity	%	74.0
	6268160	CHEMBL1805339	Inhibition of CSNK1d	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	=	IC50	nM	1900.0	CHEMBL2828	Homo sapiens	IC50	nM	1900.0
	6315219	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	34.0	CHEMBL2828	Homo sapiens	INH	%	34.0
	6315220	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	6315221	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	80.0	CHEMBL2828	Homo sapiens	INH	%	80.0
	6315222	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	61.0	CHEMBL2828	Homo sapiens	INH	%	61.0
	6315223	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	43.0	CHEMBL2828	Homo sapiens	INH	%	43.0
	6315224	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	46.0	CHEMBL2828	Homo sapiens	INH	%	46.0
	6315225	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	49.0	CHEMBL2828	Homo sapiens	INH	%	49.0
	6315226	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	57.0	CHEMBL2828	Homo sapiens	INH	%	57.0
	6315227	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	14.0	CHEMBL2828	Homo sapiens	INH	%	14.0
	6315228	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	6315229	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	36.0	CHEMBL2828	Homo sapiens	INH	%	36.0
	6315230	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	6315231	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	93.0	CHEMBL2828	Homo sapiens	INH	%	93.0
	6315232	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	98.0	CHEMBL2828	Homo sapiens	INH	%	98.0
	6315233	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	28.0	CHEMBL2828	Homo sapiens	INH	%	28.0
	6315234	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	43.0	CHEMBL2828	Homo sapiens	INH	%	43.0
	6315235	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	82.0	CHEMBL2828	Homo sapiens	INH	%	82.0
	6315236	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	43.0	CHEMBL2828	Homo sapiens	INH	%	43.0
	6315237	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	43.0	CHEMBL2828	Homo sapiens	INH	%	43.0
	6315238	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	52.0	CHEMBL2828	Homo sapiens	INH	%	52.0
	6315239	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	17.0	CHEMBL2828	Homo sapiens	INH	%	17.0
	6315240	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	36.0	CHEMBL2828	Homo sapiens	INH	%	36.0
	6315241	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	6315242	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	17.0	CHEMBL2828	Homo sapiens	INH	%	17.0
	6315243	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	6315244	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	6315245	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	6315246	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	79.0	CHEMBL2828	Homo sapiens	INH	%	79.0
	6315247	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	56.0	CHEMBL2828	Homo sapiens	INH	%	56.0
	6315248	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	6315249	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	6315250	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	51.0	CHEMBL2828	Homo sapiens	INH	%	51.0
	6315251	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	6315252	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	38.0	CHEMBL2828	Homo sapiens	INH	%	38.0
	6315253	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	17.0	CHEMBL2828	Homo sapiens	INH	%	17.0
	6315254	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	27.0	CHEMBL2828	Homo sapiens	INH	%	27.0
	6315255	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	-1.0	CHEMBL2828	Homo sapiens	INH	%	-1.0
	6315256	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	6315257	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	6315258	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	6315259	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	6315260	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	6315261	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	15.0	CHEMBL2828	Homo sapiens	INH	%	15.0
	6315262	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	37.0	CHEMBL2828	Homo sapiens	INH	%	37.0
	6315263	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	72.0	CHEMBL2828	Homo sapiens	INH	%	72.0
	6315264	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	52.0	CHEMBL2828	Homo sapiens	INH	%	52.0
	6315265	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	6315266	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	54.0	CHEMBL2828	Homo sapiens	INH	%	54.0
	6315267	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	18.0	CHEMBL2828	Homo sapiens	INH	%	18.0
	6315268	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	6315269	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	6315270	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	26.0	CHEMBL2828	Homo sapiens	INH	%	26.0
	6315271	CHEMBL1815696	Inhibition of CK1d at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	6318845	CHEMBL1815743	Inhibition of CK1delta by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	39000.0	CHEMBL2828	Homo sapiens	IC50	uM	39.0
	6341035	CHEMBL1828204	Activity of CSNK1D kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	6352198	CHEMBL1825735	Inhibition of CK1delta assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	27.0	CHEMBL2828	Homo sapiens	Activity	%	27.0
	7567121	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7567580	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7568051	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7568519	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7568951	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	260.0	CHEMBL2828	Homo sapiens	Kd	nM	260.0
	7569094	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7569554	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7570026	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7570489	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	4200.0	CHEMBL2828	Homo sapiens	Kd	nM	4200.0
	7570916	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	15.0	CHEMBL2828	Homo sapiens	Kd	nM	15.0
	7571070	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7571527	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7572003	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7573051	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1500.0	CHEMBL2828	Homo sapiens	Kd	nM	1500.0
	7573508	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7573984	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7574011	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7574419	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7575029	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1300.0	CHEMBL2828	Homo sapiens	Kd	nM	1300.0
	7575490	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3500.0	CHEMBL2828	Homo sapiens	Kd	nM	3500.0
	7575984	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7576392	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	1300.0	CHEMBL2828	Homo sapiens	Kd	nM	1300.0
	7577003	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7577498	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7577968	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7578373	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7579393	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7579867	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2300.0	CHEMBL2828	Homo sapiens	Kd	nM	2300.0
	7580336	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	320.0	CHEMBL2828	Homo sapiens	Kd	nM	320.0
	7580739	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7580927	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	210.0	CHEMBL2828	Homo sapiens	Kd	nM	210.0
	7581312	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7581757	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7582228	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7582692	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7583092	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7583273	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7583670	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7584115	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	1400.0	CHEMBL2828	Homo sapiens	Kd	nM	1400.0
	7584586	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7585048	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7585452	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7585603	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7586011	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1800.0	CHEMBL2828	Homo sapiens	Kd	nM	1800.0
	7586457	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	1200.0	CHEMBL2828	Homo sapiens	Kd	nM	1200.0
	7586928	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7587382	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7587564	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7587983	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7588436	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	3200.0	CHEMBL2828	Homo sapiens	Kd	nM	3200.0
	7588907	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7589529	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7589953	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7590420	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	3500.0	CHEMBL2828	Homo sapiens	Kd	nM	3500.0
	7590903	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	37.0	CHEMBL2828	Homo sapiens	Kd	nM	37.0
	7591502	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7591924	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7592427	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7592880	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7593469	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2500.0	CHEMBL2828	Homo sapiens	Kd	nM	2500.0
	7593904	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7593934	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7594407	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7594859	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	240.0	CHEMBL2828	Homo sapiens	Kd	nM	240.0
	7595437	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7595913	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7596384	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7596831	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7597420	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4600.0	CHEMBL2828	Homo sapiens	Kd	nM	4600.0
	7597893	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7598363	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2828	Homo sapiens	Kd	nM	10000.0
	7598805	CHEMBL1908413	Binding constant for CSNK1D kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2400.0	CHEMBL2828	Homo sapiens	Kd	nM	2400.0
	7939630	CHEMBL1919590	Inhibition of human CK1delta	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	7970420	CHEMBL1930197	Inhibition of Ckld at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	-5.0	CHEMBL2828	Homo sapiens	INH	%	-5.0
	7987132	CHEMBL1936136	Inhibition of CK1delta	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	7987154	CHEMBL1936136	Inhibition of CK1delta	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	=	IC50	nM	11000.0	CHEMBL2828	Homo sapiens	IC50	uM	11.0
	7987176	CHEMBL1936136	Inhibition of CK1delta	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	=	IC50	nM	6610.0	CHEMBL2828	Homo sapiens	IC50	uM	6.61
	7987208	CHEMBL1936136	Inhibition of CK1delta	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	=	IC50	nM	1730.0	CHEMBL2828	Homo sapiens	IC50	uM	1.73
	8011634	CHEMBL1944167	Inhibition of CK1delta	B	COc1cc(C)c2nc3[nH]nc(C)c3c(N3CCNCC3)c2c1		CHEMBL1939782	=	IC50	nM	320.0	CHEMBL2828	Homo sapiens	IC50	nM	320.0
	8037534	CHEMBL1954389	Inhibition of human recombinant CK1delta expressed in Escherichia coli using PLSRTLpSVASLPGL as substrate after 2 hrs by KinaseGlo assay	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	8.0	CHEMBL2828	Homo sapiens	IC50	nM	8.0
	8051008	CHEMBL1961070	Inhibition of recombinant CK1delta at 10 uM after 90 mins fluorescence assay	B	CCCC(=O)NCc1nc(-c2nc(C)cs2)c(-c2ccc3ncsc3c2)[nH]1		CHEMBL1957675	=	Inhibition	%	63.0	CHEMBL2828	Homo sapiens	INH	%	63.0
active	9584461	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9584462	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584463	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584464	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9584465	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584466	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9584467	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584468	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584469	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584470	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584471	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9584472	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9584473	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
active	9584474	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9584475	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584476	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9584477	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584478	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9584479	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584480	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584481	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9584482	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584483	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
inactive	9584484	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584485	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	=	Ki	nM	10.0	CHEMBL2828	Homo sapiens	pKi		8.0
active	9584486	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9584487	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584488	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	19.95	CHEMBL2828	Homo sapiens	pKi		7.7
inactive	9584489	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584490	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584491	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9584492	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9584493	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584494	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9584495	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9584496	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584497	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9584498	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584499	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584500	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584501	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584502	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9584503	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9584504	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9584505	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584506	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584507	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584508	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584509	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
active	9584510	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9584511	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9584512	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
inactive	9584513	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584514	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584515	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584516	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584517	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
inactive	9584518	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584519	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584520	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9584521	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	10.0	CHEMBL2828	Homo sapiens	pKi		8.0
inactive	9584522	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584523	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	=	Ki	nM	7.943	CHEMBL2828	Homo sapiens	pKi		8.1
inactive	9584524	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584525	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9584526	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584527	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584528	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
inactive	9584529	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584530	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9584531	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584532	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9584533	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9584534	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584535	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584536	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9584537	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584538	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9584539	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584540	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9584541	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584542	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584543	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584544	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
active	9584545	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9584546	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9584547	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584548	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
active	9584549	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
inactive	9584550	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584551	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584552	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584553	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584554	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
active	9584555	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	19.95	CHEMBL2828	Homo sapiens	pKi		7.7
inactive	9584556	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584557	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9584558	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584559	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584560	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584561	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	10.0	CHEMBL2828	Homo sapiens	pKi		8.0
inactive	9584562	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584563	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584564	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584565	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9584566	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
inactive	9584567	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584568	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584569	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584570	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584571	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9584572	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584573	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9584574	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584575	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9584576	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584577	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584578	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584579	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584580	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9584581	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9584582	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584583	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
active	9584584	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9584585	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584586	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584587	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9584588	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9584589	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584590	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9584591	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9584592	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584593	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9584594	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9584595	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584596	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584597	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9584598	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584599	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584600	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
inactive	9584601	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584602	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
inactive	9584603	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9584604	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9584605	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9584606	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588177	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9588178	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9588179	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588180	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588181	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588182	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588183	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588184	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9588185	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588186	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588187	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9588188	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
inactive	9588189	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588190	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9588191	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588192	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9588193	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588194	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588195	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588196	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588197	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9588198	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588199	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588200	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588201	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588202	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
active	9588203	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	=	Ki	nM	100.0	CHEMBL2828	Homo sapiens	pKi		7.0
inactive	9588204	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588205	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9588206	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(NC2CCC(N)CC2)nc2ccnn2c1Nc1ccc(F)c(Cl)c1		CHEMBL1980371	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9588207	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588208	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588209	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588210	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588211	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588212	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9588213	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
active	9588214	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9588215	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588216	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588217	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588218	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588219	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588220	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588221	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588222	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9588223	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588224	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9588225	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9588226	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588227	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
active	9588228	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9588229	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
active	9588230	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
inactive	9588231	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588232	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588233	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	=	Ki	nM	7.943	CHEMBL2828	Homo sapiens	pKi		8.1
inactive	9588234	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	<	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588235	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588236	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588237	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9588238	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588239	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9588240	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588241	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588242	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588243	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9588244	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588245	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	50.12	CHEMBL2828	Homo sapiens	pKi		7.3
active	9588246	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9588247	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588248	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588249	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9588250	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588251	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588252	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588253	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9588254	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588255	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588256	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588257	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9588258	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9588259	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588260	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588261	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9588262	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588263	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9588264	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588265	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1968340	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588266	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588267	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	=	Ki	nM	79.43	CHEMBL2828	Homo sapiens	pKi		7.1
inactive	9588268	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588269	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588270	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588271	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9588272	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9588273	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588274	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
inactive	9588275	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588276	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588277	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588278	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588279	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588280	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588281	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588282	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588283	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588284	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9588285	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588286	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	50.12	CHEMBL2828	Homo sapiens	pKi		7.3
active	9588287	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9588288	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
active	9588289	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9588290	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588291	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9588292	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9588293	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588294	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588295	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9588296	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588297	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588298	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588299	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588300	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588301	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9588302	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588303	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588304	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588305	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	50.12	CHEMBL2828	Homo sapiens	pKi		7.3
inactive	9588306	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9588307	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9588308	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9588309	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588310	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588311	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
active	9588312	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9588313	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9588314	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588315	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9588316	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9588317	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
inactive	9588318	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588319	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588320	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9588321	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588322	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588323	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588324	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588325	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
active	9588326	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9588327	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588328	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9588329	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588330	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588331	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588332	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588333	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588334	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9588335	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588336	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
active	9588337	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cncc(Nc2ncc(-c3ccncn3)c(-c3ccco3)n2)c1		CHEMBL375293	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9588338	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9588339	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9588340	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588341	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588342	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9588343	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588344	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588345	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588346	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9588347	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588348	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588349	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9588350	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9588351	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9588352	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
active	9588353	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9588354	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
active	9588355	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588356	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588357	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588358	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588359	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588360	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588361	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588362	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9588363	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9588364	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588365	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588366	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588367	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588368	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	12.59	CHEMBL2828	Homo sapiens	pKi		7.9
inactive	9588369	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588370	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
active	9588371	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9588372	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588373	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9588374	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	19.95	CHEMBL2828	Homo sapiens	pKi		7.7
inactive	9588375	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588376	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588377	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9588378	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588379	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588380	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588381	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588382	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588383	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588384	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588385	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588386	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
active	9588387	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9588388	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9588389	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL86066	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588390	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588391	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588392	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588393	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	100.0	CHEMBL2828	Homo sapiens	pKi		7.0
active	9588394	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9588395	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588396	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
inactive	9588397	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588398	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588399	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588400	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588401	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
inactive	9588402	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9588403	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
active	9588404	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9588405	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9588406	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588407	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588408	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588409	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588410	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9588411	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591983	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9591984	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	10.0	CHEMBL2828	Homo sapiens	pKi		8.0
inactive	9591985	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591986	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9591987	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9591988	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591989	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591990	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591991	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591992	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9591993	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
inactive	9591994	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9591995	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9591996	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9591997	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9591998	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9591999	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592000	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592001	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	63.1	CHEMBL2828	Homo sapiens	pKi		7.2
inactive	9592002	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592003	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592004	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592005	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592006	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592007	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592008	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592009	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592010	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9592011	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592012	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592013	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9592014	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592015	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592016	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592017	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592018	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592019	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
active	9592020	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9592021	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
active	9592022	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9592023	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9592024	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9592025	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9592026	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592027	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592028	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592029	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592030	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592031	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9592032	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9592033	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9592034	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592035	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592036	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	79.43	CHEMBL2828	Homo sapiens	pKi		7.1
active	9592037	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9592038	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592039	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	=	Ki	nM	50.12	CHEMBL2828	Homo sapiens	pKi		7.3
inactive	9592040	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592041	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592042	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	63.1	CHEMBL2828	Homo sapiens	pKi		7.2
inactive	9592043	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592044	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592045	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592046	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592047	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9592048	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
inactive	9592049	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592050	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
active	9592051	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9592052	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
active	9592053	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1(N2CCC(c3ccccc3)CC2)CCN(C(=O)CNc2ncnc3cc(Cl)c(Cl)cc23)C1		CHEMBL1964623	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9592054	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592055	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592056	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592057	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592058	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592059	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592060	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592061	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9592062	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592063	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
active	9592064	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9592065	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592066	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592067	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592068	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592069	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
inactive	9592070	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592071	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592072	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592073	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	=	Ki	nM	100.0	CHEMBL2828	Homo sapiens	pKi		7.0
active	9592074	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9592075	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592076	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592077	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
inactive	9592078	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592079	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592080	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9592081	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9592082	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9592083	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9592084	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	7.943	CHEMBL2828	Homo sapiens	pKi		8.1
inactive	9592085	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592086	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592087	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9592088	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9592089	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592090	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592091	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9592092	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592093	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9592094	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592095	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	39.81	CHEMBL2828	Homo sapiens	pKi		7.4
active	9592096	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9592097	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592098	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592099	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592100	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
active	9592101	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(=O)c4cccc(c24)O3)CC1		CHEMBL1972218	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9592102	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592103	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9592104	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592105	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9592106	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592107	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592108	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592109	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	31.62	CHEMBL2828	Homo sapiens	pKi		7.5
inactive	9592110	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592111	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
active	9592112	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
active	9592113	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592114	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592115	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592116	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9592117	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592118	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	7.943	CHEMBL2828	Homo sapiens	pKi		8.1
active	9592119	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9592120	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9592121	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592122	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592123	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592124	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9592125	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592126	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592127	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592128	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592129	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
inactive	9592130	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592131	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9592132	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	398.11	CHEMBL2828	Homo sapiens	pKi		6.4
inactive	9592133	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592134	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9592135	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592136	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592137	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592138	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592139	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592140	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
active	9592141	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9592142	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592143	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592144	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592145	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592146	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	5.012	CHEMBL2828	Homo sapiens	pKi		8.3
active	9592147	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9592148	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	63.1	CHEMBL2828	Homo sapiens	pKi		7.2
inactive	9592149	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592150	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9592151	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592152	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9592153	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9592154	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCOc1ccccc1CCc1cccc2nc(N)nc(N)c12		CHEMBL1983255	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
inactive	9592155	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592156	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9592157	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592158	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592159	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592160	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592161	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592162	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
inactive	9592163	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592164	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592165	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592166	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592167	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592168	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	=	Ki	nM	63.1	CHEMBL2828	Homo sapiens	pKi		7.2
inactive	9592169	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592170	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	=	Ki	nM	12.59	CHEMBL2828	Homo sapiens	pKi		7.9
inactive	9592171	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592172	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592173	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
active	9592174	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9592175	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592176	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592177	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9592178	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592179	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
inactive	9592180	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592181	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592182	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592183	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592184	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592185	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592186	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	158.49	CHEMBL2828	Homo sapiens	pKi		6.8
inactive	9592187	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592188	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592189	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592190	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9592191	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592192	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592193	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9592194	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592195	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592196	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592197	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9592198	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1000.0	CHEMBL2828	Homo sapiens	pKi		6.0
inactive	9592199	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592200	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592201	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9592202	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592203	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592204	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592205	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592206	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592207	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	501.19	CHEMBL2828	Homo sapiens	pKi		6.3
inactive	9592208	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592209	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592210	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1oc2ccccc2c2[nH]c(-c3ccccc3)nc12		CHEMBL1968646	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9592211	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592212	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592213	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	=	Ki	nM	10.0	CHEMBL2828	Homo sapiens	pKi		8.0
inactive	9592214	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9592215	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9592216	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9592217	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595782	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595783	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595784	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
inactive	9595785	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595786	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9595787	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595788	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595789	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595790	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	100.0	CHEMBL2828	Homo sapiens	pKi		7.0
active	9595791	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
inactive	9595792	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595793	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595794	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595795	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595796	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595797	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595798	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595799	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9595800	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595801	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
active	9595802	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	19.95	CHEMBL2828	Homo sapiens	pKi		7.7
inactive	9595803	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595804	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	=	Ki	nM	12.59	CHEMBL2828	Homo sapiens	pKi		7.9
inactive	9595805	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595806	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595807	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595808	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
inactive	9595809	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595810	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595811	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595812	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9595813	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595814	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	39.81	CHEMBL2828	Homo sapiens	pKi		7.4
inactive	9595815	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595816	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595817	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595818	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595819	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9595820	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
inactive	9595821	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595822	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595823	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595824	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9595825	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	630.96	CHEMBL2828	Homo sapiens	pKi		6.2
active	9595826	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9595827	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9595828	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9595829	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595830	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9595831	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	=	Ki	nM	125.89	CHEMBL2828	Homo sapiens	pKi		6.9
inactive	9595832	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595833	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
active	9595834	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9595835	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595836	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	316.23	CHEMBL2828	Homo sapiens	pKi		6.5
active	9595837	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9595838	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595839	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	3162.28	CHEMBL2828	Homo sapiens	pKi		5.5
active	9595840	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9595841	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595842	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595843	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	Ki	nM	19.95	CHEMBL2828	Homo sapiens	pKi		7.7
inactive	9595844	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9595845	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9595846	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595847	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595848	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9595849	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595850	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595851	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9595852	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595853	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595854	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
inactive	9595855	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595856	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	=	Ki	nM	15.85	CHEMBL2828	Homo sapiens	pKi		7.8
active	9595857	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	6309.57	CHEMBL2828	Homo sapiens	pKi		5.2
inactive	9595858	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595859	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9595860	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595861	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9595862	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595863	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	79.43	CHEMBL2828	Homo sapiens	pKi		7.1
active	9595864	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
active	9595865	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9595866	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595867	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	100.0	CHEMBL2828	Homo sapiens	pKi		7.0
inactive	9595868	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595869	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595870	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9595871	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595872	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595873	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9595874	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595875	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9595876	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595877	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595878	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595879	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595880	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595881	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	3981.07	CHEMBL2828	Homo sapiens	pKi		5.4
active	9595882	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9595883	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595884	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
inactive	9595885	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595886	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595887	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9595888	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
active	9595889	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	5011.87	CHEMBL2828	Homo sapiens	pKi		5.3
active	9595890	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
inactive	9595891	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595892	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	2511.89	CHEMBL2828	Homo sapiens	pKi		5.6
inactive	9595893	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595894	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
active	9595895	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	7.943	CHEMBL2828	Homo sapiens	pKi		8.1
active	9595896	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	199.53	CHEMBL2828	Homo sapiens	pKi		6.7
active	9595897	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	25.12	CHEMBL2828	Homo sapiens	pKi		7.6
active	9595898	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	1584.89	CHEMBL2828	Homo sapiens	pKi		5.8
inactive	9595899	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595900	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1258.93	CHEMBL2828	Homo sapiens	pKi		5.9
inactive	9595901	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595902	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595903	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595904	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595905	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	251.19	CHEMBL2828	Homo sapiens	pKi		6.6
inactive	9595906	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595907	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
active	9595908	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1995.26	CHEMBL2828	Homo sapiens	pKi		5.7
active	9595909	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	794.33	CHEMBL2828	Homo sapiens	pKi		6.1
inactive	9595910	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595911	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
inactive	9595912	CHEMBL1963783	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1D	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL2828	Homo sapiens	pKi		5.1
	10838680	CHEMBL2014906	Inhibition of CK1d at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	93.0	CHEMBL2828	Homo sapiens	INH	%	93.0
	10849709	CHEMBL2019668	Inhibition of CK1delta	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL2828	Homo sapiens	IC50	uM	40.0
	10850051	CHEMBL2019773	Inhibition of human CK1delta at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	10850640	CHEMBL2019918	Inhibition of human CSNK1D	B	O=C(Nc1ccc(N2CCNCC2)cc1)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL1938680	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	nM	30000.0
	10980248	CHEMBL2065113	Inhibition of CSNK1D at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	10980249	CHEMBL2065113	Inhibition of CSNK1D at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL2828	Homo sapiens	INH	%	15.0
	10980299	CHEMBL2065143	Inhibition of CSNK1D by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	10983952	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	N#Cc1ccc2nc(Nc3ccc(Oc4ncccc4C(F)(F)F)cc3)[nH]c2c1		CHEMBL2071607	=	IC50	nM	5770.0	CHEMBL2828	Homo sapiens	IC50	uM	5.77
	10983953	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	N#Cc1ccc2nc(Nc3ccc(Oc4ccccc4)cc3)[nH]c2c1		CHEMBL2071608	=	IC50	nM	3170.0	CHEMBL2828	Homo sapiens	IC50	uM	3.17
	10983954	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	N#Cc1ccc2nc(Nc3ccc(-c4ccccc4)cc3)[nH]c2c1		CHEMBL2071609	=	IC50	nM	2180.0	CHEMBL2828	Homo sapiens	IC50	uM	2.18
	10983955	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	N#Cc1ccc2nc(Nc3ccc(-c4cccnc4F)cc3)[nH]c2c1		CHEMBL2071610	=	IC50	nM	1630.0	CHEMBL2828	Homo sapiens	IC50	uM	1.63
	10983956	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	Cn1cc(-c2ccc(Nc3nc4ccc(C#N)cc4[nH]3)cc2)cn1		CHEMBL2071611	=	IC50	nM	1080.0	CHEMBL2828	Homo sapiens	IC50	uM	1.08
	10983957	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071612	=	IC50	nM	2620.0	CHEMBL2828	Homo sapiens	IC50	uM	2.62
	10983958	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	Cc1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071613	=	IC50	nM	3610.0	CHEMBL2828	Homo sapiens	IC50	uM	3.61
	10983959	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(O)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071614	=	IC50	nM	2320.0	CHEMBL2828	Homo sapiens	IC50	uM	2.32
	10983960	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)c(F)c1		CHEMBL2071615	=	IC50	nM	2180.0	CHEMBL2828	Homo sapiens	IC50	uM	2.18
	10983961	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	Cc1cc(C(C)(C)C)ccc1Nc1nc2ccc(C#N)cc2[nH]1		CHEMBL2071616	=	IC50	nM	4370.0	CHEMBL2828	Homo sapiens	IC50	uM	4.37
	10983962	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1		CHEMBL2071618	=	IC50	nM	2880.0	CHEMBL2828	Homo sapiens	IC50	uM	2.88
	10983963	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	Cc1cc2nc(Nc3ccc(C(C)(C)C)cc3)[nH]c2cc1C#N		CHEMBL2071622	=	IC50	nM	3970.0	CHEMBL2828	Homo sapiens	IC50	uM	3.97
	10983964	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3o2)cc1		CHEMBL2071623	=	IC50	nM	2370.0	CHEMBL2828	Homo sapiens	IC50	uM	2.37
	10983965	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3s2)cc1		CHEMBL2071624	=	IC50	nM	1660.0	CHEMBL2828	Homo sapiens	IC50	uM	1.66
	10983966	CHEMBL2072008	Inhibition of CK1delta by Lance assay	B	CC(C)(C)c1ccc(Nc2cn3cc(C#N)ccc3n2)cc1		CHEMBL2071625	=	IC50	nM	3170.0	CHEMBL2828	Homo sapiens	IC50	uM	3.17
	10984740	CHEMBL2072036	Inhibition of human CK1delta at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	11018504	CHEMBL2091533	Inhibition of CK1delta	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	80.0	CHEMBL2828	Homo sapiens	IC50	nM	80.0
	11018505	CHEMBL2091533	Inhibition of CK1delta	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	IC50	nM	711.0	CHEMBL2828	Homo sapiens	IC50	nM	711.0
	12046266	CHEMBL2156503	Inhibition of CK1delta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	12074673	CHEMBL2161235	Inhibition of CK1delta at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	12135277	CHEMBL2184765	Inhibition of CK1-delta at 10 uM	B	O=C(Nc1cc(Nc2ccc3c(c2)CCCCC3=O)ccc1F)c1ccccc1		CHEMBL2177219	>	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	12148473	CHEMBL2184565	Binding affinity to human CK1delta R69K mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	Delta Tm	degrees C	4.8	CHEMBL2828	Homo sapiens	deltaTm	degrees C	4.8
	12148474	CHEMBL2184566	Binding affinity to human CK1delta T67S mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	Delta Tm	degrees C	4.8	CHEMBL2828	Homo sapiens	deltaTm	degrees C	4.8
	12148475	CHEMBL2184568	Binding affinity to human CK1delta I55F mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	Delta Tm	degrees C	13.2	CHEMBL2828	Homo sapiens	deltaTm	degrees C	13.2
	12148476	CHEMBL2184567	Binding affinity to wild type human CK1delta (1-294 amino acids) assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	Delta Tm	degrees C	4.8	CHEMBL2828	Homo sapiens	deltaTm	degrees C	4.8
	12148478	CHEMBL2184570	Inhibition of Casein kinase 1 delta	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	IC50	nM	711.0	CHEMBL2828	Homo sapiens	IC50	nM	711.0
	12148484	CHEMBL2184565	Binding affinity to human CK1delta R69K mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	Delta Tm	degrees C	9.6	CHEMBL2828	Homo sapiens	deltaTm	degrees C	9.6
	12148485	CHEMBL2184566	Binding affinity to human CK1delta T67S mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	Delta Tm	degrees C	9.6	CHEMBL2828	Homo sapiens	deltaTm	degrees C	9.6
	12148486	CHEMBL2184568	Binding affinity to human CK1delta I55F mutant assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	Delta Tm	degrees C	9.6	CHEMBL2828	Homo sapiens	deltaTm	degrees C	9.6
	12148487	CHEMBL2184567	Binding affinity to wild type human CK1delta (1-294 amino acids) assessed as change in melting temperature by differential scanning fluorimetry	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	Delta Tm	degrees C	9.6	CHEMBL2828	Homo sapiens	deltaTm	degrees C	9.6
	12148488	CHEMBL2184570	Inhibition of Casein kinase 1 delta	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	13.0	CHEMBL2828	Homo sapiens	IC50	nM	13.0
	12166132	CHEMBL2211606	Binding affinity to CK1delta at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL2828	Homo sapiens	Activity	%	50.0
	12170829	CHEMBL2212696	Inhibition of CK1d assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	107.0	CHEMBL2828	Homo sapiens	Activity	%	107.0
	12172130	CHEMBL2213955	Inhibition of CK1d assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	12173677	CHEMBL2209313	Inhibition of CSNK1D assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	19.0	CHEMBL2828	Homo sapiens	Activity	%	19.0
	12175186	CHEMBL2210712	Inhibition of CK1delta	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	12180261	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2cc(F)c(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203565	=	IC50	nM	114.0	CHEMBL2828	Homo sapiens	IC50	uM	0.114
	12180262	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2ccc(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203564	=	IC50	nM	59.0	CHEMBL2828	Homo sapiens	IC50	uM	0.059
	12180263	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203563	=	IC50	nM	40.0	CHEMBL2828	Homo sapiens	IC50	uM	0.04
	12180264	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2ccc(F)cc2F)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203562	=	IC50	nM	36.0	CHEMBL2828	Homo sapiens	IC50	uM	0.036
	12180265	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203561	=	IC50	nM	21.0	CHEMBL2828	Homo sapiens	IC50	uM	0.021
	12180266	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(CCc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203560	=	IC50	nM	202.0	CHEMBL2828	Homo sapiens	IC50	uM	0.202
	12180267	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(COc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203559	=	IC50	nM	58.0	CHEMBL2828	Homo sapiens	IC50	uM	0.058
	12180268	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(Oc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203558	=	IC50	nM	4860.0	CHEMBL2828	Homo sapiens	IC50	uM	4.86
	12180269	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(OCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203557	=	IC50	nM	168.0	CHEMBL2828	Homo sapiens	IC50	uM	0.168
	12180270	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(Nc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203556	=	IC50	nM	22.0	CHEMBL2828	Homo sapiens	IC50	uM	0.022
	12180271	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(NCc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203555	=	IC50	nM	22.0	CHEMBL2828	Homo sapiens	IC50	uM	0.022
	12180272	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(CCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203554	=	IC50	nM	112.0	CHEMBL2828	Homo sapiens	IC50	uM	0.112
	12180273	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(/C=C/c2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203553	=	IC50	nM	15.0	CHEMBL2828	Homo sapiens	IC50	uM	0.015
	12180274	CHEMBL2211470	Inhibition of CK1-delta using biotin[long chain]-KKRRRAL{pS}VATLPGL substrate in presence of 11 uM ATP	B	COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203552	=	IC50	nM	68.0	CHEMBL2828	Homo sapiens	IC50	nM	68.0
	12183902	CHEMBL2211483	Inhibition of CSNK1D	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	pIC50		5.0
	12195478	CHEMBL2210927	Inhibition of recombinant CK1delta after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	>	Ki	nM	7800.0	CHEMBL2828	Homo sapiens	Ki	nM	7800.0
	12208024	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL2828	Homo sapiens	Residual Activity	%	99.0
	12208025	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	95.0	CHEMBL2828	Homo sapiens	Residual Activity	%	95.0
	12208026	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208027	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12208028	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	111.0	CHEMBL2828	Homo sapiens	Residual Activity	%	111.0
	12208029	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208030	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	93.0	CHEMBL2828	Homo sapiens	Residual Activity	%	93.0
	12208031	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12208032	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	95.0	CHEMBL2828	Homo sapiens	Residual Activity	%	95.0
	12208033	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12208034	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	93.0	CHEMBL2828	Homo sapiens	Residual Activity	%	93.0
	12208035	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	64.0	CHEMBL2828	Homo sapiens	Residual Activity	%	64.0
	12208036	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	97.0	CHEMBL2828	Homo sapiens	Residual Activity	%	97.0
	12208037	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	40.0	CHEMBL2828	Homo sapiens	Residual Activity	%	40.0
	12208038	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12208039	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12208040	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12208041	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12208042	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL2828	Homo sapiens	Residual Activity	%	89.0
	12208043	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12208044	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12208045	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208046	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	98.0	CHEMBL2828	Homo sapiens	Residual Activity	%	98.0
	12208047	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	101.0	CHEMBL2828	Homo sapiens	Residual Activity	%	101.0
	12208048	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12208049	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208050	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12208051	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12208052	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	78.0	CHEMBL2828	Homo sapiens	Residual Activity	%	78.0
	12208053	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL2828	Homo sapiens	Residual Activity	%	86.0
	12208054	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	25.0	CHEMBL2828	Homo sapiens	Residual Activity	%	25.0
	12208055	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208056	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208057	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL2828	Homo sapiens	Residual Activity	%	98.0
	12208058	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12208059	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL2828	Homo sapiens	Residual Activity	%	91.0
	12208060	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	76.0	CHEMBL2828	Homo sapiens	Residual Activity	%	76.0
	12208061	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208062	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	69.0	CHEMBL2828	Homo sapiens	Residual Activity	%	69.0
	12208063	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	86.0	CHEMBL2828	Homo sapiens	Residual Activity	%	86.0
	12208064	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	95.0	CHEMBL2828	Homo sapiens	Residual Activity	%	95.0
	12208065	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	89.0	CHEMBL2828	Homo sapiens	Residual Activity	%	89.0
	12208066	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	70.0	CHEMBL2828	Homo sapiens	Residual Activity	%	70.0
	12208067	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	73.0	CHEMBL2828	Homo sapiens	Residual Activity	%	73.0
	12208068	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208069	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208070	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	86.0	CHEMBL2828	Homo sapiens	Residual Activity	%	86.0
	12208071	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	13.0	CHEMBL2828	Homo sapiens	Residual Activity	%	13.0
	12208072	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208073	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12208074	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12208075	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	56.0	CHEMBL2828	Homo sapiens	Residual Activity	%	56.0
	12208076	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	23.0	CHEMBL2828	Homo sapiens	Residual Activity	%	23.0
	12208077	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12208078	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12208079	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	100.0	CHEMBL2828	Homo sapiens	Residual Activity	%	100.0
	12208080	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12208081	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12208082	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12208083	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208084	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12208085	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12208086	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12208087	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12208088	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	90.0	CHEMBL2828	Homo sapiens	Residual Activity	%	90.0
	12208089	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	56.0	CHEMBL2828	Homo sapiens	Residual Activity	%	56.0
	12208090	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	90.0	CHEMBL2828	Homo sapiens	Residual Activity	%	90.0
	12208091	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12208092	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12208093	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12208094	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12208095	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12208096	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	90.0	CHEMBL2828	Homo sapiens	Residual Activity	%	90.0
	12208097	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12208098	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12208099	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	69.0	CHEMBL2828	Homo sapiens	Residual Activity	%	69.0
	12208100	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12208101	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	23.0	CHEMBL2828	Homo sapiens	Residual Activity	%	23.0
	12208102	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	72.0	CHEMBL2828	Homo sapiens	Residual Activity	%	72.0
	12208103	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12208104	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL2828	Homo sapiens	Residual Activity	%	97.0
	12208105	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	100.0	CHEMBL2828	Homo sapiens	Residual Activity	%	100.0
	12208106	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12208107	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL2828	Homo sapiens	Residual Activity	%	103.0
	12208108	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12208109	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	98.0	CHEMBL2828	Homo sapiens	Residual Activity	%	98.0
	12208110	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	35.0	CHEMBL2828	Homo sapiens	Residual Activity	%	35.0
	12208111	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	11.0	CHEMBL2828	Homo sapiens	Residual Activity	%	11.0
	12208112	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12208113	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	14.0	CHEMBL2828	Homo sapiens	Residual Activity	%	14.0
	12208114	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL2828	Homo sapiens	Residual Activity	%	101.0
	12208115	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	60.0	CHEMBL2828	Homo sapiens	Residual Activity	%	60.0
	12208116	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12208117	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	104.0	CHEMBL2828	Homo sapiens	Residual Activity	%	104.0
	12208118	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	44.0	CHEMBL2828	Homo sapiens	Residual Activity	%	44.0
	12208119	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	94.0	CHEMBL2828	Homo sapiens	Residual Activity	%	94.0
	12208120	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	45.0	CHEMBL2828	Homo sapiens	Residual Activity	%	45.0
	12208121	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12208122	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12208123	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208124	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	15.0	CHEMBL2828	Homo sapiens	Residual Activity	%	15.0
	12208125	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12208126	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	102.0	CHEMBL2828	Homo sapiens	Residual Activity	%	102.0
	12208127	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12208128	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	93.0	CHEMBL2828	Homo sapiens	Residual Activity	%	93.0
	12208129	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	70.0	CHEMBL2828	Homo sapiens	Residual Activity	%	70.0
	12208130	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	29.0	CHEMBL2828	Homo sapiens	Residual Activity	%	29.0
	12208131	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12208132	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12208133	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12208134	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	1.0
	12208135	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	44.0	CHEMBL2828	Homo sapiens	Residual Activity	%	44.0
	12208136	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12208137	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12208138	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12208139	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12210975	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	71.0	CHEMBL2828	Homo sapiens	Residual Activity	%	71.0
	12210976	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12210977	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	-2.0	CHEMBL2828	Homo sapiens	Residual Activity	%	-2.0
	12210978	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	3.0	CHEMBL2828	Homo sapiens	Residual Activity	%	3.0
	12210979	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12210980	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	89.0	CHEMBL2828	Homo sapiens	Residual Activity	%	89.0
	12210981	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12210982	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12210983	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	35.0	CHEMBL2828	Homo sapiens	Residual Activity	%	35.0
	12210984	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12210985	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12210986	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12210987	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12210988	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	59.0	CHEMBL2828	Homo sapiens	Residual Activity	%	59.0
	12210989	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	40.0	CHEMBL2828	Homo sapiens	Residual Activity	%	40.0
	12210990	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12210991	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	5.0	CHEMBL2828	Homo sapiens	Residual Activity	%	5.0
	12210992	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL2828	Homo sapiens	Residual Activity	%	91.0
	12210993	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	86.0	CHEMBL2828	Homo sapiens	Residual Activity	%	86.0
	12210994	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12210995	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12210996	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	71.0	CHEMBL2828	Homo sapiens	Residual Activity	%	71.0
	12210997	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12210998	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	15.0	CHEMBL2828	Homo sapiens	Residual Activity	%	15.0
	12210999	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12211000	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	94.0	CHEMBL2828	Homo sapiens	Residual Activity	%	94.0
	12211001	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12211002	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	21.0	CHEMBL2828	Homo sapiens	Residual Activity	%	21.0
	12211003	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	17.0	CHEMBL2828	Homo sapiens	Residual Activity	%	17.0
	12211004	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211005	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	78.0	CHEMBL2828	Homo sapiens	Residual Activity	%	78.0
	12211006	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	52.0	CHEMBL2828	Homo sapiens	Residual Activity	%	52.0
	12211007	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	42.0	CHEMBL2828	Homo sapiens	Residual Activity	%	42.0
	12211008	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12211009	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12211010	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	56.0	CHEMBL2828	Homo sapiens	Residual Activity	%	56.0
	12211011	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12211012	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211013	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12211014	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12211015	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	7.0	CHEMBL2828	Homo sapiens	Residual Activity	%	7.0
	12211016	CHEMBL2218996	Millipore: Percentage of residual kinase activity of CSNK1D at 1uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211017	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	48.0	CHEMBL2828	Homo sapiens	Residual Activity	%	48.0
	12211018	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	56.0	CHEMBL2828	Homo sapiens	Residual Activity	%	56.0
	12211019	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	54.0	CHEMBL2828	Homo sapiens	Residual Activity	%	54.0
	12211020	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL2828	Homo sapiens	Residual Activity	%	108.0
	12211021	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL2828	Homo sapiens	Residual Activity	%	90.0
	12211022	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	36.0	CHEMBL2828	Homo sapiens	Residual Activity	%	36.0
	12211023	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	59.0	CHEMBL2828	Homo sapiens	Residual Activity	%	59.0
	12211024	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	62.0	CHEMBL2828	Homo sapiens	Residual Activity	%	62.0
	12211025	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	67.0	CHEMBL2828	Homo sapiens	Residual Activity	%	67.0
	12211026	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	64.0	CHEMBL2828	Homo sapiens	Residual Activity	%	64.0
	12211027	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	106.0	CHEMBL2828	Homo sapiens	Residual Activity	%	106.0
	12211028	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	62.0	CHEMBL2828	Homo sapiens	Residual Activity	%	62.0
	12211029	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	100.0	CHEMBL2828	Homo sapiens	Residual Activity	%	100.0
	12211030	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	3.0	CHEMBL2828	Homo sapiens	Residual Activity	%	3.0
	12211031	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	58.0	CHEMBL2828	Homo sapiens	Residual Activity	%	58.0
	12211032	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	62.0	CHEMBL2828	Homo sapiens	Residual Activity	%	62.0
	12211033	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL2828	Homo sapiens	Residual Activity	%	93.0
	12211034	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL2828	Homo sapiens	Residual Activity	%	103.0
	12211035	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12211036	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211037	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL2828	Homo sapiens	Residual Activity	%	101.0
	12211038	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	45.0	CHEMBL2828	Homo sapiens	Residual Activity	%	45.0
	12211039	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	113.0	CHEMBL2828	Homo sapiens	Residual Activity	%	113.0
	12211040	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL2828	Homo sapiens	Residual Activity	%	105.0
	12211041	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12211042	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12211043	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12211044	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	38.0	CHEMBL2828	Homo sapiens	Residual Activity	%	38.0
	12211045	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	89.0	CHEMBL2828	Homo sapiens	Residual Activity	%	89.0
	12211046	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12211047	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	2.0	CHEMBL2828	Homo sapiens	Residual Activity	%	2.0
	12211048	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	61.0	CHEMBL2828	Homo sapiens	Residual Activity	%	61.0
	12211049	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	53.0	CHEMBL2828	Homo sapiens	Residual Activity	%	53.0
	12211050	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	86.0	CHEMBL2828	Homo sapiens	Residual Activity	%	86.0
	12211051	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12211052	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12211053	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	39.0	CHEMBL2828	Homo sapiens	Residual Activity	%	39.0
	12211054	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	109.0	CHEMBL2828	Homo sapiens	Residual Activity	%	109.0
	12211055	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	33.0	CHEMBL2828	Homo sapiens	Residual Activity	%	33.0
	12211056	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12211057	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	96.0	CHEMBL2828	Homo sapiens	Residual Activity	%	96.0
	12211058	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	94.0	CHEMBL2828	Homo sapiens	Residual Activity	%	94.0
	12211059	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	48.0	CHEMBL2828	Homo sapiens	Residual Activity	%	48.0
	12211060	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	26.0	CHEMBL2828	Homo sapiens	Residual Activity	%	26.0
	12211061	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	62.0	CHEMBL2828	Homo sapiens	Residual Activity	%	62.0
	12211062	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12211063	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12211064	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	2.0	CHEMBL2828	Homo sapiens	Residual Activity	%	2.0
	12211065	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	98.0	CHEMBL2828	Homo sapiens	Residual Activity	%	98.0
	12211066	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	72.0	CHEMBL2828	Homo sapiens	Residual Activity	%	72.0
	12211067	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	76.0	CHEMBL2828	Homo sapiens	Residual Activity	%	76.0
	12211068	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	8.0	CHEMBL2828	Homo sapiens	Residual Activity	%	8.0
	12211069	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL2828	Homo sapiens	Residual Activity	%	4.0
	12211070	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL2828	Homo sapiens	Residual Activity	%	95.0
	12211071	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12211072	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL2828	Homo sapiens	Residual Activity	%	101.0
	12211073	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	69.0	CHEMBL2828	Homo sapiens	Residual Activity	%	69.0
	12211074	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	63.0	CHEMBL2828	Homo sapiens	Residual Activity	%	63.0
	12211075	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	33.0	CHEMBL2828	Homo sapiens	Residual Activity	%	33.0
	12211076	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12211077	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	35.0	CHEMBL2828	Homo sapiens	Residual Activity	%	35.0
	12211078	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	69.0	CHEMBL2828	Homo sapiens	Residual Activity	%	69.0
	12211079	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	54.0	CHEMBL2828	Homo sapiens	Residual Activity	%	54.0
	12211080	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12211081	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12211082	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	21.0	CHEMBL2828	Homo sapiens	Residual Activity	%	21.0
	12211083	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	81.0	CHEMBL2828	Homo sapiens	Residual Activity	%	81.0
	12211084	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12211085	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	46.0	CHEMBL2828	Homo sapiens	Residual Activity	%	46.0
	12211086	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	101.0	CHEMBL2828	Homo sapiens	Residual Activity	%	101.0
	12211087	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	55.0	CHEMBL2828	Homo sapiens	Residual Activity	%	55.0
	12211088	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	78.0	CHEMBL2828	Homo sapiens	Residual Activity	%	78.0
	12211089	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211090	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211091	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	54.0	CHEMBL2828	Homo sapiens	Residual Activity	%	54.0
	12211092	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	40.0	CHEMBL2828	Homo sapiens	Residual Activity	%	40.0
	12211093	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	65.0	CHEMBL2828	Homo sapiens	Residual Activity	%	65.0
	12211094	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	5.0	CHEMBL2828	Homo sapiens	Residual Activity	%	5.0
	12211095	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	39.0	CHEMBL2828	Homo sapiens	Residual Activity	%	39.0
	12211096	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	46.0	CHEMBL2828	Homo sapiens	Residual Activity	%	46.0
	12211097	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	80.0	CHEMBL2828	Homo sapiens	Residual Activity	%	80.0
	12211098	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	65.0	CHEMBL2828	Homo sapiens	Residual Activity	%	65.0
	12211099	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	90.0	CHEMBL2828	Homo sapiens	Residual Activity	%	90.0
	12211100	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	110.0	CHEMBL2828	Homo sapiens	Residual Activity	%	110.0
	12211101	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	71.0	CHEMBL2828	Homo sapiens	Residual Activity	%	71.0
	12211102	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	92.0	CHEMBL2828	Homo sapiens	Residual Activity	%	92.0
	12211103	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	9.0	CHEMBL2828	Homo sapiens	Residual Activity	%	9.0
	12211104	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	5.0	CHEMBL2828	Homo sapiens	Residual Activity	%	5.0
	12211105	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	44.0	CHEMBL2828	Homo sapiens	Residual Activity	%	44.0
	12211106	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	4.0	CHEMBL2828	Homo sapiens	Residual Activity	%	4.0
	12211107	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	74.0	CHEMBL2828	Homo sapiens	Residual Activity	%	74.0
	12211108	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	17.0	CHEMBL2828	Homo sapiens	Residual Activity	%	17.0
	12211109	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12211110	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211111	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	5.0	CHEMBL2828	Homo sapiens	Residual Activity	%	5.0
	12211112	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12211113	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	64.0	CHEMBL2828	Homo sapiens	Residual Activity	%	64.0
	12211114	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	89.0	CHEMBL2828	Homo sapiens	Residual Activity	%	89.0
	12211115	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	88.0	CHEMBL2828	Homo sapiens	Residual Activity	%	88.0
	12211116	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	54.0	CHEMBL2828	Homo sapiens	Residual Activity	%	54.0
	12211117	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	9.0	CHEMBL2828	Homo sapiens	Residual Activity	%	9.0
	12211118	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12211119	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	87.0	CHEMBL2828	Homo sapiens	Residual Activity	%	87.0
	12211120	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12211121	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	78.0	CHEMBL2828	Homo sapiens	Residual Activity	%	78.0
	12211122	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	22.0	CHEMBL2828	Homo sapiens	Residual Activity	%	22.0
	12211123	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	4.0	CHEMBL2828	Homo sapiens	Residual Activity	%	4.0
	12211124	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12211125	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	6.0	CHEMBL2828	Homo sapiens	Residual Activity	%	6.0
	12211126	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	68.0	CHEMBL2828	Homo sapiens	Residual Activity	%	68.0
	12211127	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	4.0	CHEMBL2828	Homo sapiens	Residual Activity	%	4.0
	12211128	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	8.0	CHEMBL2828	Homo sapiens	Residual Activity	%	8.0
	12211129	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12211130	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12211131	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	83.0	CHEMBL2828	Homo sapiens	Residual Activity	%	83.0
	12211132	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	84.0	CHEMBL2828	Homo sapiens	Residual Activity	%	84.0
	12211133	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	31.0	CHEMBL2828	Homo sapiens	Residual Activity	%	31.0
	12211134	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	66.0	CHEMBL2828	Homo sapiens	Residual Activity	%	66.0
	12211135	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	1.0
	12211136	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	1.0
	12211137	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	52.0	CHEMBL2828	Homo sapiens	Residual Activity	%	52.0
	12211138	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	51.0	CHEMBL2828	Homo sapiens	Residual Activity	%	51.0
	12211139	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	7.0	CHEMBL2828	Homo sapiens	Residual Activity	%	7.0
	12211140	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	75.0	CHEMBL2828	Homo sapiens	Residual Activity	%	75.0
	12211141	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	9.0	CHEMBL2828	Homo sapiens	Residual Activity	%	9.0
	12211142	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	78.0	CHEMBL2828	Homo sapiens	Residual Activity	%	78.0
	12211143	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	23.0	CHEMBL2828	Homo sapiens	Residual Activity	%	23.0
	12211144	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	72.0	CHEMBL2828	Homo sapiens	Residual Activity	%	72.0
	12211145	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	73.0	CHEMBL2828	Homo sapiens	Residual Activity	%	73.0
	12211146	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL2828	Homo sapiens	Residual Activity	%	16.0
	12211147	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	6.0	CHEMBL2828	Homo sapiens	Residual Activity	%	6.0
	12211148	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	73.0	CHEMBL2828	Homo sapiens	Residual Activity	%	73.0
	12211149	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	1.0
	12211150	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	85.0	CHEMBL2828	Homo sapiens	Residual Activity	%	85.0
	12211151	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	44.0	CHEMBL2828	Homo sapiens	Residual Activity	%	44.0
	12211152	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	26.0	CHEMBL2828	Homo sapiens	Residual Activity	%	26.0
	12211153	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	34.0	CHEMBL2828	Homo sapiens	Residual Activity	%	34.0
	12211154	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	34.0	CHEMBL2828	Homo sapiens	Residual Activity	%	34.0
	12211155	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	17.0	CHEMBL2828	Homo sapiens	Residual Activity	%	17.0
	12211156	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	1.0
	12211157	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL2828	Homo sapiens	Residual Activity	%	82.0
	12211158	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	73.0	CHEMBL2828	Homo sapiens	Residual Activity	%	73.0
	12211159	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	58.0	CHEMBL2828	Homo sapiens	Residual Activity	%	58.0
	12211160	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	3.0	CHEMBL2828	Homo sapiens	Residual Activity	%	3.0
	12211161	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	2.0	CHEMBL2828	Homo sapiens	Residual Activity	%	2.0
	12211162	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	53.0	CHEMBL2828	Homo sapiens	Residual Activity	%	53.0
	12211163	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	48.0	CHEMBL2828	Homo sapiens	Residual Activity	%	48.0
	12211164	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	8.0	CHEMBL2828	Homo sapiens	Residual Activity	%	8.0
	12211165	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	7.0	CHEMBL2828	Homo sapiens	Residual Activity	%	7.0
	12211166	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12211167	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	37.0	CHEMBL2828	Homo sapiens	Residual Activity	%	37.0
	12211168	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	12.0	CHEMBL2828	Homo sapiens	Residual Activity	%	12.0
	12211169	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	76.0	CHEMBL2828	Homo sapiens	Residual Activity	%	76.0
	12211170	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	79.0	CHEMBL2828	Homo sapiens	Residual Activity	%	79.0
	12211171	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	77.0	CHEMBL2828	Homo sapiens	Residual Activity	%	77.0
	12211172	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	53.0	CHEMBL2828	Homo sapiens	Residual Activity	%	53.0
	12211173	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	-1.0	CHEMBL2828	Homo sapiens	Residual Activity	%	-1.0
	12211174	CHEMBL2218997	Millipore: Percentage of residual kinase activity of CSNK1D at 10uM relative to control. Control inhibitor: Jnk Inhibitor II at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	62.0	CHEMBL2828	Homo sapiens	Residual Activity	%	62.0
	12629541	CHEMBL2319133	Inhibition of CK1delta (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	12629542	CHEMBL2319133	Inhibition of CK1delta (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	12629543	CHEMBL2319133	Inhibition of CK1delta (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	12629544	CHEMBL2319133	Inhibition of CK1delta (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	12631712	CHEMBL2317778	Inhibition of CK1-delta (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	110.0	CHEMBL2828	Homo sapiens	IC50	uM	0.11
	12631713	CHEMBL2317778	Inhibition of CK1-delta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	4500.0	CHEMBL2828	Homo sapiens	IC50	uM	4.5
Not Determined	12631714	CHEMBL2317778	Inhibition of CK1-delta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649		IC50			CHEMBL2828	Homo sapiens	IC50		
	12631715	CHEMBL2317778	Inhibition of CK1-delta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	2390.0	CHEMBL2828	Homo sapiens	IC50	uM	2.39
	12631716	CHEMBL2317778	Inhibition of CK1-delta (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	12647991	CHEMBL2329201	Inhibition of CK1D (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	-2.0	CHEMBL2828	Homo sapiens	INH	%	-2.0
	12647992	CHEMBL2329201	Inhibition of CK1D (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	37.0	CHEMBL2828	Homo sapiens	INH	%	37.0
	12647993	CHEMBL2329201	Inhibition of CK1D (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	-5.0	CHEMBL2828	Homo sapiens	INH	%	-5.0
	12647994	CHEMBL2329201	Inhibition of CK1D (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	-1.0	CHEMBL2828	Homo sapiens	INH	%	-1.0
	12649654	CHEMBL2329551	Inhibition of CK1D (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	93.0	CHEMBL2828	Homo sapiens	INH	%	93.0
	12649655	CHEMBL2329551	Inhibition of CK1D (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	12649656	CHEMBL2329551	Inhibition of CK1D (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	62.0	CHEMBL2828	Homo sapiens	INH	%	62.0
	12693245	CHEMBL2343931	Inhibition of CK1delta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	12728876	CHEMBL2349958	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
	12730018	CHEMBL2353892	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	12730266	CHEMBL2349958	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
	12730898	CHEMBL2349826	Inhibition of CK1d (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	13282390	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	1.0	CHEMBL2828	Homo sapiens	INH	%	1.0
	13282391	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	75.0	CHEMBL2828	Homo sapiens	INH	%	75.0
	13282392	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	14.0	CHEMBL2828	Homo sapiens	INH	%	14.0
	13282393	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	13282394	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	13282395	CHEMBL2378494	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	-3.0	CHEMBL2828	Homo sapiens	INH	%	-3.0
	13296922	CHEMBL2383897	Inhibition of human CSNK1D	B	NC(=O)c1cnc(N[C@H]2CC[C@H](N)CC2)c2nc(-c3ccc(Cl)cc3)cn12		CHEMBL2381601	=	IC50	nM	12000.0	CHEMBL2828	Homo sapiens	IC50	uM	12.0
	13311866	CHEMBL2384689	Inhibition of human CSNK1D	B	COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2		CHEMBL2381116	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	nM	30000.0
	13321303	CHEMBL2389959	Inhibition of CSNK1D (unknown origin)	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1		CHEMBL2385543	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	13342444	CHEMBL2394169	Competitive binding affinity to CSNK1D (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
	13371739	CHEMBL2405965	Inhibition of CK1-delta (unknown origin) at 1 uM relative to control	B	CCOC(=O)n1ccc2ccc(C(=O)Nc3cc(C(=O)NC4CC4)ccc3C)cc21		CHEMBL2402005	=	Inhibition	%	24.6	CHEMBL2828	Homo sapiens	INH	%	24.6
	13375905	CHEMBL2405314	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL2828	Homo sapiens	INH	%	1.0
	13415151	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	Cn1cc(-c2ccnc(C3COCCN3)c2)c(-c2ccc(F)cc2)n1		CHEMBL2420704	=	IC50	nM	90.0	CHEMBL2828	Homo sapiens	IC50	nM	90.0
	13415152	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	Cn1cc(-c2ccnc3c2OCCNC3)c(-c2ccc(F)cc2)n1		CHEMBL2420703	=	IC50	nM	42.1	CHEMBL2828	Homo sapiens	IC50	nM	42.1
	13415153	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	CNCc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1		CHEMBL2420702	=	IC50	nM	63.8	CHEMBL2828	Homo sapiens	IC50	nM	63.8
	13415154	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	Cn1cc(-c2ccnc(CO)c2)c(-c2ccc(F)cc2)n1		CHEMBL2420701	=	IC50	nM	237.0	CHEMBL2828	Homo sapiens	IC50	nM	237.0
	13415155	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)n1		CHEMBL2420700	=	IC50	nM	545.0	CHEMBL2828	Homo sapiens	IC50	nM	545.0
	13415156	CHEMBL2423572	Inhibition of human CK1 delta transfected in african green monkey cos7 cells after overnight incubation by whole cell assay	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	80.5	CHEMBL2828	Homo sapiens	IC50	nM	80.5
	13415163	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	Cn1cc(-c2ccnc(C3COCCN3)c2)c(-c2ccc(F)cc2)n1		CHEMBL2420704	=	IC50	nM	6.6	CHEMBL2828	Homo sapiens	IC50	nM	6.6
	13415164	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	Cn1cc(-c2ccnc3c2OCCNC3)c(-c2ccc(F)cc2)n1		CHEMBL2420703	=	IC50	nM	6.0	CHEMBL2828	Homo sapiens	IC50	nM	6.0
	13415165	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	CNCc1cc(-c2cn(C)nc2-c2ccc(F)cc2)ccn1		CHEMBL2420702	=	IC50	nM	12.9	CHEMBL2828	Homo sapiens	IC50	nM	12.9
	13415166	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	Cn1cc(-c2ccnc(CO)c2)c(-c2ccc(F)cc2)n1		CHEMBL2420701	=	IC50	nM	14.2	CHEMBL2828	Homo sapiens	IC50	nM	14.2
	13415167	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	Cn1cc(-c2ccncc2)c(-c2ccc(F)cc2)n1		CHEMBL2420700	=	IC50	nM	48.1	CHEMBL2828	Homo sapiens	IC50	nM	48.1
	13415168	CHEMBL2423574	Inhibition of CK1 delta (unknown origin) using PLSRTLpSVASLPGL as substrate after 60 mins by microplate reader analysis	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	7.8	CHEMBL2828	Homo sapiens	IC50	nM	7.8
	13419778	CHEMBL2424111	Inhibition of CK1delta (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	97000.0	CHEMBL2828	Homo sapiens	IC50	uM	97.0
	13419779	CHEMBL2424111	Inhibition of CK1delta (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1	Outside typical range	CHEMBL2420909	=	IC50	nM	238000.0	CHEMBL2828	Homo sapiens	IC50	uM	238.0
	13421047	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	54.0	CHEMBL2828	Homo sapiens	INH	%	54.0
	13421048	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	1.0	CHEMBL2828	Homo sapiens	INH	%	1.0
	13421049	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	13421050	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	6.0	CHEMBL2828	Homo sapiens	INH	%	6.0
	13421051	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	12.0	CHEMBL2828	Homo sapiens	INH	%	12.0
	13421052	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13421053	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	13421054	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	17.0	CHEMBL2828	Homo sapiens	INH	%	17.0
	13421055	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	17.0	CHEMBL2828	Homo sapiens	INH	%	17.0
	13421056	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	15.0	CHEMBL2828	Homo sapiens	INH	%	15.0
	13421057	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	13421058	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	13421059	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	13421060	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	13421061	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	15.0	CHEMBL2828	Homo sapiens	INH	%	15.0
	13421062	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	21.0	CHEMBL2828	Homo sapiens	INH	%	21.0
	13421063	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	13421064	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	13421065	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	13421066	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13421067	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	8.0	CHEMBL2828	Homo sapiens	INH	%	8.0
	13421068	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13421069	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	13421070	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	13421071	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	13421072	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	13421073	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	21.0	CHEMBL2828	Homo sapiens	INH	%	21.0
	13421074	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13421075	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	13421076	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	21.0	CHEMBL2828	Homo sapiens	INH	%	21.0
	13421077	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	23.0	CHEMBL2828	Homo sapiens	INH	%	23.0
	13421078	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	13421079	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	21.0	CHEMBL2828	Homo sapiens	INH	%	21.0
	13421080	CHEMBL2424135	Inhibition of CK1delta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	22.0	CHEMBL2828	Homo sapiens	INH	%	22.0
	13439877	CHEMBL2428167	Competitive binding affinity to CSNK1D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	91.0	CHEMBL2828	Homo sapiens	INH	%	91.0
	13445398	CHEMBL2428167	Competitive binding affinity to CSNK1D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL2828	Homo sapiens	INH	%	100.0
	13448442	CHEMBL2428167	Competitive binding affinity to CSNK1D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	96.0	CHEMBL2828	Homo sapiens	INH	%	96.0
	13451697	CHEMBL2428167	Competitive binding affinity to CSNK1D (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL2828	Homo sapiens	INH	%	100.0
Not Active	13863518	CHEMBL3101992	Inhibition of CSNK1D (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N([C@H]2CC[C@H](c3cnc(N)c(-c4ncccn4)c3)CC2)[C@H]1c1ccccc1		CHEMBL3099716		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	13863519	CHEMBL3101992	Inhibition of CSNK1D (unknown origin) at 1 uM after 1 hr	B	CC1(C)OC(=O)N(c2ccc(-c3cnc(N)c(-c4ncccn4)c3)cc2)[C@H]1c1ccccc1		CHEMBL3099720		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	13872180	CHEMBL3101932	Inhibition of human CK1d assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	68.0	CHEMBL2828	Homo sapiens	Activity	%	68.0
	13948199	CHEMBL3132606	Inhibition of CK1delta (unknown origin) using CK1tide as substrate after 20 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nmol/L	10000.0
	13965692	CHEMBL3135777	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	46.0	CHEMBL2828	Homo sapiens	INH	%	46.0
	13966070	CHEMBL3136907	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	94.5	CHEMBL2828	Homo sapiens	INH	%	94.5
	13973972	CHEMBL3135745	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	9.5	CHEMBL2828	Homo sapiens	INH	%	9.5
	13974063	CHEMBL3134723	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	10.5	CHEMBL2828	Homo sapiens	INH	%	10.5
	13974154	CHEMBL3136368	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	39.5	CHEMBL2828	Homo sapiens	INH	%	39.5
	13974245	CHEMBL3135626	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	26.0	CHEMBL2828	Homo sapiens	INH	%	26.0
	13974983	CHEMBL3135149	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	81.5	CHEMBL2828	Homo sapiens	INH	%	81.5
	13975074	CHEMBL3136719	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13975165	CHEMBL3134948	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.5	CHEMBL2828	Homo sapiens	INH	%	0.5
	13975256	CHEMBL3136537	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	13975899	CHEMBL3136266	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	25.5	CHEMBL2828	Homo sapiens	INH	%	25.5
	13975992	CHEMBL3136301	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	8.5	CHEMBL2828	Homo sapiens	INH	%	8.5
	13976083	CHEMBL3136183	Inhibition of human CK1D catalytic domain expressed in Escherichia coli cell assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	77.5	CHEMBL2828	Homo sapiens	INH	%	77.5
	14577863	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(CNC(=O)c1ccccc1)Nc1nc2ccccc2s1		CHEMBL3235178	=	IC50	nM	7290.0	CHEMBL2828	Homo sapiens	IC50	uM	7.29
	14577864	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOC(=O)c1sc(NC(=O)CNC(=O)c2ccccc2)nc1C		CHEMBL3235179	=	IC50	nM	7450.0	CHEMBL2828	Homo sapiens	IC50	uM	7.45
	14577865	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOC(=O)c1sc(NC(=O)CNC(=O)c2ccc(N3CCOCC3)cc2)nc1C		CHEMBL3233034	=	IC50	nM	9310.0	CHEMBL2828	Homo sapiens	IC50	uM	9.31
	14577866	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(COCc1ccccc1)Nc1nc2ccccc2s1		CHEMBL3235180	=	IC50	nM	4370.0	CHEMBL2828	Homo sapiens	IC50	uM	4.37
	14577867	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOC(=O)c1sc(NC(=O)CNC(=O)CC(c2ccccc2)c2ccccc2)nc1C		CHEMBL3235181	=	IC50	nM	3790.0	CHEMBL2828	Homo sapiens	IC50	uM	3.79
	14577868	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccccc1)NCC(=O)Nc1nc2ccccc2s1		CHEMBL3235182	=	IC50	nM	6330.0	CHEMBL2828	Homo sapiens	IC50	uM	6.33
	14577869	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccccc2s1		CHEMBL3235183	=	IC50	nM	850.0	CHEMBL2828	Homo sapiens	IC50	uM	0.85
	14577870	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOC(=O)c1sc(NC(=O)CNC(=O)Cc2ccccc2)nc1C		CHEMBL3235184	=	IC50	nM	10110.0	CHEMBL2828	Homo sapiens	IC50	uM	10.11
	14577871	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CS(=O)(=O)c1ccc2nc(NC(=O)Cc3cccs3)sc2c1		CHEMBL3235185	=	IC50	nM	2690.0	CHEMBL2828	Homo sapiens	IC50	uM	2.69
	14577872	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(CNC(=O)C(c1ccccc1)c1ccccc1)Nc1nc2ccccc2s1		CHEMBL3235186	=	IC50	nM	1930.0	CHEMBL2828	Homo sapiens	IC50	uM	1.93
	14577873	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOC(=O)c1sc(NC(=O)COCc2ccccc2)nc1C		CHEMBL3235187	=	IC50	nM	7380.0	CHEMBL2828	Homo sapiens	IC50	uM	7.38
	14577874	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CC(=O)c1sc(NC(=O)Cc2cccc(Cl)c2)nc1C		CHEMBL3235188	=	IC50	nM	1120.0	CHEMBL2828	Homo sapiens	IC50	uM	1.12
	14577875	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccc(Cl)cc1)Nc1nc2ccccc2o1		CHEMBL3235193	=	IC50	nM	4110.0	CHEMBL2828	Homo sapiens	IC50	uM	4.11
	14577876	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Nc1nc2ccccc2s1)C(c1ccccc1)c1ccccc1		CHEMBL3235198	=	IC50	nM	1960.0	CHEMBL2828	Homo sapiens	IC50	uM	1.96
	14577877	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)C(c3ccccc3)c3ccccc3)sc2c1		CHEMBL3235531	=	IC50	nM	2820.0	CHEMBL2828	Homo sapiens	IC50	uM	2.82
	14577878	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(CCc1cccc(Cl)c1)Nc1nc2ccccc2s1		CHEMBL3235532	=	IC50	nM	3580.0	CHEMBL2828	Homo sapiens	IC50	uM	3.58
	14577879	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(CC(c1ccccc1)c1ccccc1)Nc1nc2ccccc2s1		CHEMBL3235533	=	IC50	nM	2500.0	CHEMBL2828	Homo sapiens	IC50	uM	2.5
	14577880	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc(NC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc1		CHEMBL3235534	=	IC50	nM	5500.0	CHEMBL2828	Homo sapiens	IC50	uM	5.5
	14577881	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	Cc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235535	=	IC50	nM	83.0	CHEMBL2828	Homo sapiens	IC50	uM	0.083
	14577882	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538	=	IC50	nM	23.0	CHEMBL2828	Homo sapiens	IC50	uM	0.023
	14577883	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235539	=	IC50	nM	530.0	CHEMBL2828	Homo sapiens	IC50	uM	0.53
	14577884	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235540	=	IC50	nM	540.0	CHEMBL2828	Homo sapiens	IC50	uM	0.54
	14577885	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235541	=	IC50	nM	1210.0	CHEMBL2828	Homo sapiens	IC50	uM	1.21
	14577886	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542	=	IC50	nM	68.0	CHEMBL2828	Homo sapiens	IC50	uM	0.068
	14577887	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3ccccc3Cl)sc2c1		CHEMBL3235543	=	IC50	nM	9710.0	CHEMBL2828	Homo sapiens	IC50	uM	9.71
	14577888	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3ccccc3Cl)sc2c1		CHEMBL3235544	=	IC50	nM	17430.0	CHEMBL2828	Homo sapiens	IC50	uM	17.43
	14577889	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccc(Cl)cc1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235545	=	IC50	nM	65.0	CHEMBL2828	Homo sapiens	IC50	uM	0.065
	14577890	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3ccc(Cl)cc3)sc2c1		CHEMBL3235546	=	IC50	nM	750.0	CHEMBL2828	Homo sapiens	IC50	uM	0.75
	14577891	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3ccc(Cl)cc3)sc2c1		CHEMBL3235547	=	IC50	nM	1110.0	CHEMBL2828	Homo sapiens	IC50	uM	1.11
	14577892	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(Br)cc2s1		CHEMBL3235548	=	IC50	nM	260.0	CHEMBL2828	Homo sapiens	IC50	uM	0.26
	14577893	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(Cl)cc2s1		CHEMBL3235549	=	IC50	nM	320.0	CHEMBL2828	Homo sapiens	IC50	uM	0.32
	14577894	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(F)cc2s1		CHEMBL3235550	=	IC50	nM	1170.0	CHEMBL2828	Homo sapiens	IC50	uM	1.17
	14577895	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(C)cc2s1		CHEMBL3235551	=	IC50	nM	290.0	CHEMBL2828	Homo sapiens	IC50	uM	0.29
	14577896	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235552	=	IC50	nM	10.0	CHEMBL2828	Homo sapiens	IC50	uM	0.01
	14577897	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3ccccc3OC)sc2c1		CHEMBL3235553	=	IC50	nM	2220.0	CHEMBL2828	Homo sapiens	IC50	uM	2.22
	14577898	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccccc1CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235554	=	IC50	nM	620.0	CHEMBL2828	Homo sapiens	IC50	uM	0.62
	14577899	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3ccccc3OC)sc2c1		CHEMBL3235555	=	IC50	nM	5760.0	CHEMBL2828	Homo sapiens	IC50	uM	5.76
	14577900	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1cccc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)c1		CHEMBL3235556	=	IC50	nM	42.0	CHEMBL2828	Homo sapiens	IC50	uM	0.042
	14577901	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1cccc(CC(=O)Nc2nc3ccc(OC)cc3s2)c1		CHEMBL3235557	=	IC50	nM	420.0	CHEMBL2828	Homo sapiens	IC50	uM	0.42
	14577902	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3cccc(OC)c3)sc2c1		CHEMBL3235558	=	IC50	nM	990.0	CHEMBL2828	Homo sapiens	IC50	uM	0.99
	14577903	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235559	=	IC50	nM	87.0	CHEMBL2828	Homo sapiens	IC50	uM	0.087
	14577904	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc1		CHEMBL3235560	=	IC50	nM	33.0	CHEMBL2828	Homo sapiens	IC50	uM	0.033
	14577905	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc(CC(=O)Nc2nc3ccc(OC)cc3s2)cc1		CHEMBL3235561	=	IC50	nM	570.0	CHEMBL2828	Homo sapiens	IC50	uM	0.57
	14577906	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3ccc(OC)cc3)sc2c1		CHEMBL3235562	=	IC50	nM	1090.0	CHEMBL2828	Homo sapiens	IC50	uM	1.09
	14577907	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccccc1)Nc1nc2ccccc2s1		CHEMBL1405979	=	IC50	nM	330.0	CHEMBL2828	Homo sapiens	IC50	uM	0.33
	14577908	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccccc1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235563	=	IC50	nM	47.0	CHEMBL2828	Homo sapiens	IC50	uM	0.047
	14577909	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccc(Cl)c(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235564	=	IC50	nM	56.0	CHEMBL2828	Homo sapiens	IC50	uM	0.056
	14577910	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3ccc(Cl)c(Cl)c3)sc2c1		CHEMBL3235565	=	IC50	nM	1240.0	CHEMBL2828	Homo sapiens	IC50	uM	1.24
	14577911	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3ccc(Cl)c(Cl)c3)sc2c1		CHEMBL3235566	=	IC50	nM	3430.0	CHEMBL2828	Homo sapiens	IC50	uM	3.43
	14577912	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(Cc1ccc(Cl)c(Cl)c1)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235567	=	IC50	nM	590.0	CHEMBL2828	Homo sapiens	IC50	uM	0.59
	14577913	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc(OC)c(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)c1		CHEMBL3235568	=	IC50	nM	190.0	CHEMBL2828	Homo sapiens	IC50	uM	0.19
	14577914	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1cc(CC(=O)Nc2nc3ccc(OC(F)(F)F)cc3s2)cc(OC)c1OC		CHEMBL3235569	=	IC50	nM	79.0	CHEMBL2828	Homo sapiens	IC50	uM	0.079
	14577915	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1ccc2nc(NC(=O)Cc3cc(OC)c(OC)c(OC)c3)sc2c1		CHEMBL3235570	=	IC50	nM	1120.0	CHEMBL2828	Homo sapiens	IC50	uM	1.12
	14577916	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CCOc1ccc2nc(NC(=O)Cc3cc(OC)c(OC)c(OC)c3)sc2c1		CHEMBL3235571	=	IC50	nM	1430.0	CHEMBL2828	Homo sapiens	IC50	uM	1.43
	14577917	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1cc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc(OC)c1OC		CHEMBL3235572	=	IC50	nM	15.0	CHEMBL2828	Homo sapiens	IC50	uM	0.015
	14577918	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	O=C(CC1CCCCC1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235573	=	IC50	nM	430.0	CHEMBL2828	Homo sapiens	IC50	uM	0.43
	14577919	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	CC(C)(C)CC(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235574	=	IC50	nM	460.0	CHEMBL2828	Homo sapiens	IC50	uM	0.46
	14577920	CHEMBL3239314	Inhibition of human recombinant CK-1delta using casein as substrate after 60 mins by Kinase-Glo assay	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	uM	1.0
	14577921	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOC(=O)c1sc(NC(=O)COCc2ccccc2)nc1C		CHEMBL3235187	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577922	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CC(=O)c1sc(NC(=O)Cc2cccc(Cl)c2)nc1C		CHEMBL3235188	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577923	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Cn1c(NC(=O)Cc2cccc(Cl)c2)nc2ccccc21		CHEMBL3235189	=	Inhibition	%	27.0	CHEMBL2828	Homo sapiens	INH	%	27.0
	14577924	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Cn1c(NC(=O)Cc2ccc(Cl)cc2)nc2ccccc21		CHEMBL3235190	=	Inhibition	%	31.0	CHEMBL2828	Homo sapiens	INH	%	31.0
	14577925	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(Cl)c1)Nc1nncs1		CHEMBL3235191	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577926	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(Cl)c1)Nc1ncccn1		CHEMBL3235192	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577927	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)cc1)Nc1ncccn1		CHEMBL1736728	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577928	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)cc1)Nc1nc2ccccc2o1		CHEMBL3235193	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577929	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccccc2o1		CHEMBL3235194	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	14577930	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)cc1)Oc1nc2ccccc2s1		CHEMBL3235195	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577931	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1C(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235196	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	14577932	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CCNc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235197	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	14577933	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Nc1nc2ccccc2s1)C(c1ccccc1)c1ccccc1		CHEMBL3235198	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577934	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)C(c3ccccc3)c3ccccc3)sc2c1		CHEMBL3235531	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577935	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(CCc1cccc(Cl)c1)Nc1nc2ccccc2s1		CHEMBL3235532	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577936	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(CC(c1ccccc1)c1ccccc1)Nc1nc2ccccc2s1		CHEMBL3235533	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577937	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(NC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc1		CHEMBL3235534	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577938	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Cc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235535	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577939	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	Cc1cccc2sc(NC(=O)Cc3cccc(Cl)c3)nc12		CHEMBL3235536	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577940	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(Cl)c1)Nc1nc2c(Cl)cccc2s1		CHEMBL3235537	=	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	14577941	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577942	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235539	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577943	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235540	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577944	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3cccc(Cl)c3)sc2c1		CHEMBL3235541	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577945	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577946	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3ccccc3Cl)sc2c1		CHEMBL3235543	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577947	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3ccccc3Cl)sc2c1		CHEMBL3235544	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577948	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)cc1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235545	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577949	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3ccc(Cl)cc3)sc2c1		CHEMBL3235546	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577950	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3ccc(Cl)cc3)sc2c1		CHEMBL3235547	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577951	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(Br)cc2s1		CHEMBL3235548	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577952	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(Cl)cc2s1		CHEMBL3235549	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577953	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(F)cc2s1		CHEMBL3235550	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577954	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(C)cc2s1		CHEMBL3235551	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577955	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235552	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577956	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3ccccc3OC)sc2c1		CHEMBL3235553	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577957	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccccc1CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235554	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577958	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3ccccc3OC)sc2c1		CHEMBL3235555	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577959	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1cccc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)c1		CHEMBL3235556	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577960	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1cccc(CC(=O)Nc2nc3ccc(OC)cc3s2)c1		CHEMBL3235557	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577961	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3cccc(OC)c3)sc2c1		CHEMBL3235558	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577962	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235559	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577963	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc1		CHEMBL3235560	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577964	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(CC(=O)Nc2nc3ccc(OC)cc3s2)cc1		CHEMBL3235561	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577965	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3ccc(OC)cc3)sc2c1		CHEMBL3235562	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577966	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccccc1)Nc1nc2ccccc2s1		CHEMBL1405979	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577967	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccccc1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235563	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577968	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)c(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235564	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577969	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3ccc(Cl)c(Cl)c3)sc2c1		CHEMBL3235565	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577970	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3ccc(Cl)c(Cl)c3)sc2c1		CHEMBL3235566	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577971	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	O=C(Cc1ccc(Cl)c(Cl)c1)Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL3235567	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577972	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc(OC)c(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)c1		CHEMBL3235568	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577973	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1cc(CC(=O)Nc2nc3ccc(OC(F)(F)F)cc3s2)cc(OC)c1OC		CHEMBL3235569	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577974	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1ccc2nc(NC(=O)Cc3cc(OC)c(OC)c(OC)c3)sc2c1		CHEMBL3235570	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577975	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	CCOc1ccc2nc(NC(=O)Cc3cc(OC)c(OC)c(OC)c3)sc2c1		CHEMBL3235571	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
	14577976	CHEMBL3239315	Inhibition of human recombinant CK-1delta using casein as substrate at 10 uM after 60 mins by Kinase-Glo assay relative to control	B	COc1cc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)cc(OC)c1OC		CHEMBL3235572	>	Inhibition	%	60.0	CHEMBL2828	Homo sapiens	INH	%	60.0
Active	14577977	CHEMBL3239316	Competitive inhibition of human recombinant CK-1delta using casein as substrate at 0.25 to 0.5 uM by Lineweaver-Burk plot analysis in presence of ATP	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14577978	CHEMBL3239317	Competitive inhibition of human recombinant CK-1delta using casein as substrate at 0.025 to 0.05 uM by Lineweaver-Burk plot analysis in presence of ATP	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14577979	CHEMBL3239317	Competitive inhibition of human recombinant CK-1delta using casein as substrate at 0.025 to 0.05 uM by Lineweaver-Burk plot analysis in presence of ATP	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14577980	CHEMBL3239317	Competitive inhibition of human recombinant CK-1delta using casein as substrate at 0.025 to 0.05 uM by Lineweaver-Burk plot analysis in presence of ATP	B	COc1ccccc1CC(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235552		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14578001	CHEMBL3239328	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at >= 2.5 uM after 1.5 hrs by immunoblotting analysis	B	O=C(Cc1ccccc1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235563		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14578002	CHEMBL3239329	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at 5 uM after 1.5 hrs by immunoblotting analysis	B	COc1cccc(CC(=O)Nc2nc3ccc(C(F)(F)F)cc3s2)c1		CHEMBL3235556		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	14580807	CHEMBL3239330	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at 10 uM after 1.5 hrs by immunoblotting analysis relative to control	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235559	=	FC		2.0	CHEMBL2828	Homo sapiens	FC		2.0
Active	14580808	CHEMBL3239331	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at >= 1.25 uM after 1.5 hrs by immunoblotting analysis	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14580809	CHEMBL3239332	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at 80 uM after 1.5 hrs by immunoblotting analysis	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	14580810	CHEMBL3239332	Inhibition of CK-1delta in HEK293 cells assessed as inhibition of ethacrynic acid-induced TDP-43 phosphorylation at Ser409/410 at 80 uM after 1.5 hrs by immunoblotting analysis	B	COc1ccccc1CC(=O)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235552		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	14582464	CHEMBL3240424	Inhibition of human CK1delta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	95.5	CHEMBL2828	Homo sapiens	Activity	%	95.5
	14663155	CHEMBL3268059	Inhibition of CK1delta (unknown origin) by TR-FRET assay	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	IC50	nM	84.0	CHEMBL2828	Homo sapiens	IC50	uM	0.084
	14663156	CHEMBL3268059	Inhibition of CK1delta (unknown origin) by TR-FRET assay	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	IC50	nM	104.0	CHEMBL2828	Homo sapiens	IC50	uM	0.104
	14663250	CHEMBL3270858	Inhibition of CSNK1D (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	90.0	CHEMBL2828	Homo sapiens	INH	%	90.0
	14663251	CHEMBL3270858	Inhibition of CSNK1D (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	0.7	CHEMBL2828	Homo sapiens	INH	%	0.7
	14663252	CHEMBL3270858	Inhibition of CSNK1D (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	0.6	CHEMBL2828	Homo sapiens	INH	%	0.6
	14741685	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2ccc(NC(=N)N)cc2)cc1		CHEMBL3290430	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741686	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)N)c2)cc1		CHEMBL3290431	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741687	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(C(=O)c2cccc(NC(=N)N)c2)cc1		CHEMBL3290432	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741688	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)N)c2)cc1		CHEMBL3290433	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741689	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Nc2cccc(NC(=N)N)c2)cc1		CHEMBL3290434	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741690	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.c1cc(NC2=NCCN2)cc(Oc2ccc(NC3=NCCN3)cc2)c1		CHEMBL3290435	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741691	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.O=C(c1ccc(NC2=NCCN2)cc1)c1cccc(NC2=NCCN2)c1		CHEMBL3290436	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741692	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.c1cc(Cc2ccc(NC3=NCCN3)cc2)cc(NC2=NCCN2)c1		CHEMBL3290437	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741693	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Oc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290438	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741694	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(C(=O)c2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290687	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741695	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Cc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290688	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741696	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Nc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290689	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741697	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)Nc3ccccc3)c2)cc1		CHEMBL3290690	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741698	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)Nc3ccccc3)c2)cc1		CHEMBL3290691	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741699	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Oc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290692	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741700	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(C(=O)c2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290693	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741701	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Cc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290694	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741702	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1cccc(Nc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290695	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741703	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1		CHEMBL3290696	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741704	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1		CHEMBL3290697	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741705	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	CC(=O)Nc1cccc(Oc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1.Cl		CHEMBL3290698	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	14741706	CHEMBL3292670	Inhibition of human recombinant casein kinase-1 delta using casein as substrate after 60 mins by kinase-glo luminescence assay	B	CC(=O)Nc1cccc(Nc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1.Cl		CHEMBL3290699	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15018564	CHEMBL3361878	Inhibition of CK1 delta (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	1.4	CHEMBL2828	Homo sapiens	INH	%	1.4
	15040661	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	IC50	nM	188.0	CHEMBL2828	Homo sapiens	IC50	uM	0.188
	15040662	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2c[nH]nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120960	=	IC50	nM	202.0	CHEMBL2828	Homo sapiens	IC50	uM	0.202
	15040663	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3ccc(C(=O)O)cc3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120995	=	IC50	nM	1600.0	CHEMBL2828	Homo sapiens	IC50	uM	1.6
	15040664	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2cn(-c3cccc(C(=O)O)c3)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120983	=	IC50	nM	89.0	CHEMBL2828	Homo sapiens	IC50	uM	0.089
	15040665	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCO)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120963	=	IC50	nM	240.0	CHEMBL2828	Homo sapiens	IC50	uM	0.24
	15040666	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2cn([C@H]3[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]3O)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3314270	=	IC50	nM	439.0	CHEMBL2828	Homo sapiens	IC50	uM	0.439
	15040667	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cl.Cn1c(-c2cn([C@H]3CCNC[C@@H]3F)nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL3120986	=	IC50	nM	437.0	CHEMBL2828	Homo sapiens	IC50	uM	0.437
	15040668	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)n2C)nn1)OCC		CHEMBL3120969	=	IC50	nM	3100.0	CHEMBL2828	Homo sapiens	IC50	uM	3.1
	15040669	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	Cn1c(-c2cn(CCP(=O)([O-])[O-])nn2)nc(-c2ccc(F)cc2)c1-c1ccncc1.[Na+].[Na+]		CHEMBL3120985	=	IC50	nM	225.0	CHEMBL2828	Homo sapiens	IC50	uM	0.225
	15040670	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1)c1ccccc1		CHEMBL3120970	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15040671	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(N)ccn23)n1		CHEMBL3314271	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15040672	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	C#Cc1ccn2c(-c3ccnc(SC)n3)c(-c3ccc(F)cc3)nc2n1		CHEMBL3314272	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15040673	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CC(=O)[O-])nn4)ccn23)n1.[Na+]		CHEMBL3314273	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15040674	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccn3c(-c4ccnc(SC)n4)c(-c4ccc(F)cc4)nc3n2)nn1)OCC		CHEMBL3314274	=	IC50	nM	21400.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	2.14
	15040675	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CSc1nccc(-c2c(-c3ccc(F)cc3)nc3nc(-c4cn(CCP(=O)([O-])[O-])nn4)ccn23)n1.[Na+].[Na+]		CHEMBL3314275	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	15040676	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1		CHEMBL3314276	=	IC50	nM	19900.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.99
	15040677	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCO)nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314277	=	IC50	nM	17900.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.79
	15040678	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CCOC(=O)Cn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1		CHEMBL3314278	=	IC50	nM	24500.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	2.45
	15040679	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CCOP(=O)(CCn1cc(-c2ccc(-c3nc(-c4ccc(F)cc4)c(-c4cc[nH]c(=O)c4)[nH]3)cc2)nn1)OCC		CHEMBL3314279	=	IC50	nM	44300.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	4.43
	15040680	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4cn(CCP(=O)([O-])[O-])nn4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[Na+].[Na+]		CHEMBL3314280	=	IC50	nM	10800.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.08
	15040681	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314281	=	IC50	nM	19700.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.97
	15040682	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=C([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)cc1.[Na+]		CHEMBL3313935	=	IC50	nM	24800.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	2.48
	15040683	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=C([O-])c1cc(-c2nc(-c3ccc(F)cc3)c(-c3cc[nH]c(=O)c3)[nH]2)ccc1O.[Na+]		CHEMBL3314282	=	IC50	nM	21200.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	2.12
	15040684	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(C3CCNCC3)nc2-c2ccc(F)cc2)cc[nH]1		CHEMBL3314283	=	IC50	nM	12000.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.2
	15040685	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	O=c1cc(-c2[nH]c(-c3ccc(-c4nnn[n-]4)cc3)nc2-c2ccc(F)cc2)cc[nH]1.[K+]		CHEMBL3314284	=	IC50	nM	12100.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	1.21
	15040686	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	CSc1nccc(-c2[nH]c(-c3ccc(O)cc3)nc2-c2ccc(F)cc2)n1		CHEMBL3314285	=	IC50	nM	5960.0	CHEMBL2828	Homo sapiens	IC50	10'-6M	5.96
	15040687	CHEMBL3363472	Inhibition of CK1-delta (unknown origin) by radiometric assay	B	C#Cc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc(SC)n3)[nH]2)cc1		CHEMBL3314286	=	IC50	nM	66300.0	CHEMBL2828	Homo sapiens	IC50	10'-5M	6.63
	15053969	CHEMBL3369596	Inhibition of CSNK1D (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
Not Active	15062601	CHEMBL3367925	Inhibition of human CK1delta by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	15072434	CHEMBL3388059	Inhibition of CK1delta (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
	15104927	CHEMBL3386801	Inhibition of CSNK1D (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	0.35	CHEMBL2828	Homo sapiens	Activity	%	0.35
	15104928	CHEMBL3386801	Inhibition of CSNK1D (unknown origin) assessed as residual enzyme activity at 10 uM	B	O=C(Nc1nc2cc3c(cc2[nH]1)OC(F)(F)O3)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337845	=	Activity	%	5.8	CHEMBL2828	Homo sapiens	Activity	%	5.8
	15116487	CHEMBL3376475	Inhibition of CSNK1D (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	30000.0	CHEMBL2828	Homo sapiens	IC50	uM	30.0
	15141948	CHEMBL3396744	Inhibition of CK1delta (unknown origin) by KINOMEScan assay	B	O/N=C1/c2ccccc2-c2nc3ccccc3nc21		CHEMBL3393601	=	Kd	nM	380.0	CHEMBL2828	Homo sapiens	Kd	uM	0.38
	15141949	CHEMBL3396744	Inhibition of CK1delta (unknown origin) by KINOMEScan assay	B	O=C(O/N=C1/c2ccccc2-c2nc3ccccc3nc21)c1ccco1		CHEMBL3393602	=	Kd	nM	560.0	CHEMBL2828	Homo sapiens	Kd	uM	0.56
	15141950	CHEMBL3396744	Inhibition of CK1delta (unknown origin) by KINOMEScan assay	B	COc1ccc(C(=O)O/N=C2/c3ccccc3-c3nc4ccccc4nc32)cc1OC		CHEMBL3393603	=	Kd	nM	5700.0	CHEMBL2828	Homo sapiens	Kd	uM	5.7
	15192451	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	15192452	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	6.0	CHEMBL2828	Homo sapiens	INH	%	6.0
	15192453	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	56.0	CHEMBL2828	Homo sapiens	INH	%	56.0
	15192454	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	15192455	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	15192456	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	21.0	CHEMBL2828	Homo sapiens	INH	%	21.0
	15192457	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	15.0	CHEMBL2828	Homo sapiens	INH	%	15.0
	15192458	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	34.0	CHEMBL2828	Homo sapiens	INH	%	34.0
	15192459	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	23.0	CHEMBL2828	Homo sapiens	INH	%	23.0
	15192460	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	15192461	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	1.0	CHEMBL2828	Homo sapiens	INH	%	1.0
	15192462	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	15192463	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	15192464	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	15192465	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	15192466	CHEMBL3413729	Inhibition of CK1D (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	15236112	CHEMBL3424695	Inhibition of human Casein kinase 1 delta assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N		CHEMBL1835439	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	15236126	CHEMBL3424695	Inhibition of human Casein kinase 1 delta assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)O		CHEMBL3422705	=	Activity	%	90.0	CHEMBL2828	Homo sapiens	Activity	%	90.0
	15236160	CHEMBL3424695	Inhibition of human Casein kinase 1 delta assessed as residual activity at 10 uM relative to control	B	CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC(C)C		CHEMBL3422697	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	15236184	CHEMBL3424695	Inhibition of human Casein kinase 1 delta assessed as residual activity at 10 uM relative to control	B	CCCCCCCCC[C@@H](O)[C@@H](N)Cc1ccccc1		CHEMBL3422700	=	Activity	%	93.0	CHEMBL2828	Homo sapiens	Activity	%	93.0
	15251835	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	43.0	CHEMBL2828	Homo sapiens	Activity	%	43.0
	15251962	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	67.0	CHEMBL2828	Homo sapiens	Activity	%	67.0
	15252064	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	72.0	CHEMBL2828	Homo sapiens	Activity	%	72.0
	15252709	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	86.0	CHEMBL2828	Homo sapiens	Activity	%	86.0
	15252811	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
	15252913	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	15253587	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	93.0	CHEMBL2828	Homo sapiens	Activity	%	93.0
	15253689	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	105.0	CHEMBL2828	Homo sapiens	Activity	%	105.0
	15253791	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	15254457	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	97.0	CHEMBL2828	Homo sapiens	Activity	%	97.0
	15254559	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	68.0	CHEMBL2828	Homo sapiens	Activity	%	68.0
	15255249	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	46.0	CHEMBL2828	Homo sapiens	Activity	%	46.0
	15255352	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	84.0	CHEMBL2828	Homo sapiens	Activity	%	84.0
	15255454	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	84.0	CHEMBL2828	Homo sapiens	Activity	%	84.0
	15256186	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	83.0	CHEMBL2828	Homo sapiens	Activity	%	83.0
	15256288	CHEMBL3428246	Inhibition of CK1delta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	67.0	CHEMBL2828	Homo sapiens	Activity	%	67.0
	15649113	CHEMBL3595098	Inhibition of CK1delta (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	nM	1000.0
	15686189	CHEMBL3606980	Inhibition of CK1delta (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL2828	Homo sapiens	INH	%	80.0
	15755869	CHEMBL3630646	Inhibition of CSNK1D (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	30.0	CHEMBL2828	Homo sapiens	Activity	%	30.0
	15756058	CHEMBL3632313	Inhibition of CK1delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	20.5	CHEMBL2828	Homo sapiens	INH	%	20.5
	15757038	CHEMBL3632313	Inhibition of CK1delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	13.49	CHEMBL2828	Homo sapiens	INH	%	13.49
	15758664	CHEMBL3632313	Inhibition of CK1delta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	77.81	CHEMBL2828	Homo sapiens	INH	%	77.81
318297	16314356	CHEMBL3707874	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1[nH]nc2c1[C@H](c1ccccc1)C1=C(CC(C)(C)CC1=O)N2		CHEMBL3673983	=	IC50	nM	21400.0	CHEMBL2828	Homo sapiens	IC50	nM	21400.0
	16376443	CHEMBL3734467	Inhibition of recombinant human CK1delta using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	-5.0	CHEMBL2828	Homo sapiens	INH	%	-5.0
	16398582	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	16398583	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	16398584	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	33.0	CHEMBL2828	Homo sapiens	INH	%	33.0
	16398585	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	34.0	CHEMBL2828	Homo sapiens	INH	%	34.0
	16398586	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	16398587	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	16398588	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	43.0	CHEMBL2828	Homo sapiens	INH	%	43.0
	16398589	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	44.0	CHEMBL2828	Homo sapiens	INH	%	44.0
	16398590	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	16398591	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	33.0	CHEMBL2828	Homo sapiens	INH	%	33.0
	16398592	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	16398593	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	2.0	CHEMBL2828	Homo sapiens	INH	%	2.0
	16398594	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	33.0	CHEMBL2828	Homo sapiens	INH	%	33.0
	16398595	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	53.0	CHEMBL2828	Homo sapiens	INH	%	53.0
	16398596	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	16398597	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	44.0	CHEMBL2828	Homo sapiens	INH	%	44.0
	16398598	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	24.0	CHEMBL2828	Homo sapiens	INH	%	24.0
	16398599	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	32.0	CHEMBL2828	Homo sapiens	INH	%	32.0
	16398600	CHEMBL3744320	Inhibition of CK1d (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	22.0	CHEMBL2828	Homo sapiens	INH	%	22.0
	16413426	CHEMBL3743718	Inhibition of CK1delta (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	16425336	CHEMBL3751256	Inhibition of CK1 delta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	4.7	CHEMBL2828	Homo sapiens	INH	%	4.7
	16431781	CHEMBL3748673	Inhibition of human CK1delta using [KRRRAL[pS]VASLPGL] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	16450788	CHEMBL3762306	Inhibition of CK1delta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	13.1	CHEMBL2828	Homo sapiens	INH	%	13.1
	16474683	CHEMBL3767169	Inhibition of CK1delta (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	16485714	CHEMBL3771442	Inhibition of human recombinant CSNK1D assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	16495365	CHEMBL3778172	Inhibition of N-terminal His6-tagged recombinant human CK1delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
Not Active	16497477	CHEMBL3776618	Inhibition of human CK1delta (1 to 415 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	16506527	CHEMBL3776522	Inhibition of full length recombinant human GST-tagged CSNK1D expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	16506528	CHEMBL3776523	Inhibition of full length recombinant human GST-tagged CSNK1D expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	11.0	CHEMBL2828	Homo sapiens	INH	%	11.0
	16507369	CHEMBL3777415	Inhibition of recombinant CK1delta (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	=	Activity	%	67.0	CHEMBL2828	Homo sapiens	Activity	%	67.0
	16508134	CHEMBL3778172	Inhibition of N-terminal His6-tagged recombinant human CK1delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	14.0	CHEMBL2828	Homo sapiens	Activity	%	14.0
	16509111	CHEMBL3778172	Inhibition of N-terminal His6-tagged recombinant human CK1delta expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-10.0	CHEMBL2828	Homo sapiens	Activity	%	-10.0
Not Active	16514113	CHEMBL3782161	Inhibition of partial length human CSNK1D expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	16527334	CHEMBL3789918	Inhibition of human CK1delta at 10 uM	B	CC1(C)CCC(Nc2ncnc3c2nn2ccccc32)CC1		CHEMBL3787247	=	Inhibition	%	85.1	CHEMBL2828	Homo sapiens	INH	%	85.1
	16565473	CHEMBL3804489	Inhibition of N-terminal GST-tagged CK1delta (unknown origin) expressed in Escherichia coli preincubated for 5 mins using CK1tide as substrate measured after 20 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	nM	1000.0
	16578384	CHEMBL3802256	Inhibition of full length wild type human CSNK1D expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	83.0	CHEMBL2828	Homo sapiens	Activity	%	83.0
	16580648	CHEMBL3802871	Inhibition of N-terminal GST-tagged CK1delta (unknown origin) expressed in Escherichia coli preincubated for 5 mins using CK1tide as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	83.0	CHEMBL2828	Homo sapiens	INH	%	83.0
	16580649	CHEMBL3802871	Inhibition of N-terminal GST-tagged CK1delta (unknown origin) expressed in Escherichia coli preincubated for 5 mins using CK1tide as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	-2.0	CHEMBL2828	Homo sapiens	INH	%	-2.0
	16594901	CHEMBL3812238	Inhibition of full length human CSNK1D expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	30.0	CHEMBL2828	Homo sapiens	Activity	%	30.0
	16596833	CHEMBL3812476	Inhibition of full-length human CSNK1D expressed in bacterial system assessed as remaining enzyme activity at 1 uM by KINOMEscan assay	B	Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21		CHEMBL3809691	<	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
	16611888	CHEMBL3816736	Inhibition of human CK1 delta (1 to 415 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-72.0	CHEMBL2828	Homo sapiens	Activity	%	-72.0
	16611889	CHEMBL3816736	Inhibition of human CK1 delta (1 to 415 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-67.0	CHEMBL2828	Homo sapiens	Activity	%	-67.0
	16611890	CHEMBL3816736	Inhibition of human CK1 delta (1 to 415 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-26.0	CHEMBL2828	Homo sapiens	Activity	%	-26.0
	16611891	CHEMBL3816736	Inhibition of human CK1 delta (1 to 415 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-74.0	CHEMBL2828	Homo sapiens	Activity	%	-74.0
	16614427	CHEMBL3817293	Inhibition of human CK1delta at 1 uM using [KRRRAL[pS]VASLPGL] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	16654127	CHEMBL3829287	Inhibition of human CK1delta (1 to 415 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	78.0	CHEMBL2828	Homo sapiens	Activity	%	78.0
	16844115	CHEMBL3877174	Inhibition of human CK1delta using casein as substrate in presence of [gamma-32P]-ATP	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1		CHEMBL489156	=	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	uM	1.0
	16844197	CHEMBL3877220	Inhibition of human full length CK1delta1 (2 to 415 residues) using PLSRTLpSVASLPGL as substrate after 2 hrs by kinase-glo assay	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	32.0	CHEMBL2828	Homo sapiens	IC50	nM	32.0
	16844198	CHEMBL3877220	Inhibition of human full length CK1delta1 (2 to 415 residues) using PLSRTLpSVASLPGL as substrate after 2 hrs by kinase-glo assay	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	IC50	nM	32.0	CHEMBL2828	Homo sapiens	IC50	nM	32.0
366073	17741114	CHEMBL3887986	"In Vitro ATP-33P Casein Assay: ""U""-bottomed Falcon plates are prepared by placing 5 uL of solutions of the compounds according to the invention at concentrations of 10, 1, 0.1, 0.01 or 0.001 uM in different wells. The solutions of the compounds according to the invention at these various concentrations are prepared by diluting in a test buffer (Tris 50 mM pH 7.5, MgCl2 10 M, DTT 2 mM and EGTA 1 mM) a stock solution in DMSO at a concentration of 10 mM. Next, 5 uL of dephosphorylated casein are added to a final concentration of 0.2 ug/uL, 20 uL of CK1 epsilon to a final concentration of 3 ng/uL, and 20 uL of ATP-33P to a final concentration of 0.02 uCi/uL mixed with cold ATP (10 uM final approximately 2x106 CPM per well). The final total test volume per well is equal to 50 uL. The ""U""-bottomed Falcon test plate mentioned above is vortexed, and then incubated at room temperature for 2 hours. After 2 hours the reaction is stopped by adding an ice-cold solution of 65 uL of cold ATP (2 mM) prepared in test buffer. 100 uL of the reaction mixture are then transferred from the ""U""-bottomed Falcon plate into Millipore MAPH filter plates, preimpregnated with 25 uL of ice-cold 100% TCA. The Millipore MAPH filter plates are agitated gently and are left to stand at room temperature for at least 30 minutes to precipitate the proteins. After 30 minutes, the filter plates are sequentially washed and filtered with 2x150 uL of 20% TCA, 2x150 uL of 10% TCA and 2x150 uL of 5% TCA (6 washes in total per plate/900 uL per well). The plates are left to dry overnight at room temperature. Next, 40 uL of Microscint-20 Packard scintillation liquid are added per well and the plates are closed in a leaktight manner. The radiation emitted by each well is then measured for 2 minutes in a TopCount NXT Packard scintillation counter, in which the values of CPM/well are measured."	B	CC(C)(C)NC(=O)N1CCn2c(c(C(N)=O)c(-c3ccccc3)c2C2CC2)C1		CHEMBL3950647	=	IC50	nM	31.0	CHEMBL2828	Homo sapiens	IC50	nM	31.0
412011	17776726	CHEMBL3888655	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
444253	17803961	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3940237	=	IC50	nM	5.2	CHEMBL2828	Homo sapiens	IC50	nM	5.2
444254	17803962	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(Cl)nc5ccccc45)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3899562	=	IC50	nM	1.3	CHEMBL2828	Homo sapiens	IC50	nM	1.3
444255	17803963	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(F)nc(F)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3949881	=	IC50	nM	1.1	CHEMBL2828	Homo sapiens	IC50	nM	1.1
444256	17803964	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3986343	=	IC50	nM	3.7	CHEMBL2828	Homo sapiens	IC50	nM	3.7
444257	17803965	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3954265	=	IC50	nM	1.2	CHEMBL2828	Homo sapiens	IC50	nM	1.2
444258	17803966	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccccn2)sc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3951515	=	IC50	nM	4.3	CHEMBL2828	Homo sapiens	IC50	nM	4.3
444259	17803967	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccccc2)sc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3980426	=	IC50	nM	8.3	CHEMBL2828	Homo sapiens	IC50	nM	8.3
444260	17803968	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4csc(-c5ccncc5)n4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3966079	=	IC50	nM	5.4	CHEMBL2828	Homo sapiens	IC50	nM	5.4
444261	17803969	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4csc(-c5ccccc5)n4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3891165	=	IC50	nM	7.7	CHEMBL2828	Homo sapiens	IC50	nM	7.7
444262	17803970	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4csc(-c5ccc(Cl)cc5)n4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3967195	=	IC50	nM	24.6	CHEMBL2828	Homo sapiens	IC50	nM	24.6
444263	17803971	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nocc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3895913	=	IC50	nM	7.3	CHEMBL2828	Homo sapiens	IC50	nM	7.3
444264	17803972	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4csc(Br)n4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3972492	=	IC50	nM	2.6	CHEMBL2828	Homo sapiens	IC50	nM	2.6
444265	17803973	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cscn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3975556	=	IC50	nM	4.6	CHEMBL2828	Homo sapiens	IC50	nM	4.6
444266	17803974	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccc(-c5cccnc5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3940555	=	IC50	nM	1.7	CHEMBL2828	Homo sapiens	IC50	nM	1.7
444267	17803975	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccc(-c5ccncc5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3896955	=	IC50	nM	1.7	CHEMBL2828	Homo sapiens	IC50	nM	1.7
444268	17803976	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cncc(-c5ccccc5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3963973	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444269	17803977	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cncc(-c5ccc(C#N)cc5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3923163	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444270	17803978	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccc(N5CCOCC5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3949364	=	IC50	nM	1.0	CHEMBL2828	Homo sapiens	IC50	nM	1.0
444271	17803979	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3929204	=	IC50	nM	4.3	CHEMBL2828	Homo sapiens	IC50	nM	4.3
444272	17803980	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cnccn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3937466	=	IC50	nM	9.5	CHEMBL2828	Homo sapiens	IC50	nM	9.5
444273	17803981	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccno4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3909525	=	IC50	nM	3.7	CHEMBL2828	Homo sapiens	IC50	nM	3.7
444274	17803982	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccc(F)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3946336	=	IC50	nM	2.6	CHEMBL2828	Homo sapiens	IC50	nM	2.6
444275	17803983	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(Cl)cc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3972305	=	IC50	nM	6.3	CHEMBL2828	Homo sapiens	IC50	nM	6.3
444276	17803984	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccnnc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3959875	=	IC50	nM	7.4	CHEMBL2828	Homo sapiens	IC50	nM	7.4
444277	17803985	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN(C)Cc1cccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)c1		CHEMBL3975103	=	IC50	nM	3.8	CHEMBL2828	Homo sapiens	IC50	nM	3.8
444278	17803986	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN(C)Cc1ccccc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3969521	=	IC50	nM	7.8	CHEMBL2828	Homo sapiens	IC50	nM	7.8
444279	17803987	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cncs4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3892824	=	IC50	nM	3.1	CHEMBL2828	Homo sapiens	IC50	nM	3.1
444280	17803988	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ncccn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3937324	=	IC50	nM	16.0	CHEMBL2828	Homo sapiens	IC50	nM	16.0
444281	17803989	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(CN5CCCC5)cc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3941685	=	IC50	nM	5.8	CHEMBL2828	Homo sapiens	IC50	nM	5.8
444282	17803990	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CCN(CC)Cc1ccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)cc1		CHEMBL3930043	=	IC50	nM	3.9	CHEMBL2828	Homo sapiens	IC50	nM	3.9
444283	17803991	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(C(C)(C)C)ncn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3936977	=	IC50	nM	10.1	CHEMBL2828	Homo sapiens	IC50	nM	10.1
444284	17803992	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(-c5ccc(F)cc5)ncn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3899986	=	IC50	nM	30.4	CHEMBL2828	Homo sapiens	IC50	nM	30.4
444285	17803993	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1c[nH]nc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3927972	=	IC50	nM	3.6	CHEMBL2828	Homo sapiens	IC50	nM	3.6
444286	17803994	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccncc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3981324	=	IC50	nM	2.8	CHEMBL2828	Homo sapiens	IC50	nM	2.8
444287	17803995	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ncccc4Cl)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3914746	=	IC50	nM	7.3	CHEMBL2828	Homo sapiens	IC50	nM	7.3
444288	17803996	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4nccs4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3921992	=	IC50	nM	30.5	CHEMBL2828	Homo sapiens	IC50	nM	30.5
444289	17803997	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccncn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3897438	=	IC50	nM	10.7	CHEMBL2828	Homo sapiens	IC50	nM	10.7
444290	17803998	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)nc(OC)n1		CHEMBL3913000	=	IC50	nM	10.2	CHEMBL2828	Homo sapiens	IC50	nM	10.2
444291	17803999	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CCOCC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3982877	=	IC50	nM	5.4	CHEMBL2828	Homo sapiens	IC50	nM	5.4
444292	17804000	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(CO)cc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3900216	=	IC50	nM	4.0	CHEMBL2828	Homo sapiens	IC50	nM	4.0
444293	17804001	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(Br)cc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3974872	=	IC50	nM	2.3	CHEMBL2828	Homo sapiens	IC50	nM	2.3
444294	17804002	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(F)cc(F)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3943891	=	IC50	nM	4.8	CHEMBL2828	Homo sapiens	IC50	nM	4.8
444295	17804003	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1ccc(F)c(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)c1		CHEMBL3969708	=	IC50	nM	5.6	CHEMBL2828	Homo sapiens	IC50	nM	5.6
444296	17804004	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cc(F)cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)c1		CHEMBL3935757	=	IC50	nM	1.9	CHEMBL2828	Homo sapiens	IC50	nM	1.9
444297	17804005	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cncc(Cl)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3905181	=	IC50	nM	4.1	CHEMBL2828	Homo sapiens	IC50	nM	4.1
444298	17804006	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(Cl)ccc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3896785	=	IC50	nM	5.2	CHEMBL2828	Homo sapiens	IC50	nM	5.2
444299	17804007	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(C#N)c(F)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3902451	=	IC50	nM	5.7	CHEMBL2828	Homo sapiens	IC50	nM	5.7
444300	17804008	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)ccn1		CHEMBL3978386	=	IC50	nM	6.1	CHEMBL2828	Homo sapiens	IC50	nM	6.1
444301	17804009	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccnc(C(C)(C)C)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3923511	=	IC50	nM	20.4	CHEMBL2828	Homo sapiens	IC50	nM	20.4
444302	17804010	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(F)ccc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3986616	=	IC50	nM	6.3	CHEMBL2828	Homo sapiens	IC50	nM	6.3
444303	17804011	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)ccn1		CHEMBL3916882	=	IC50	nM	7.6	CHEMBL2828	Homo sapiens	IC50	nM	7.6
444304	17804012	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(C#N)nc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3960227	=	IC50	nM	5.8	CHEMBL2828	Homo sapiens	IC50	nM	5.8
444305	17804013	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3925884	=	IC50	nM	4.5	CHEMBL2828	Homo sapiens	IC50	nM	4.5
444306	17804014	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(C#N)ccc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3910402	=	IC50	nM	4.1	CHEMBL2828	Homo sapiens	IC50	nM	4.1
444307	17804015	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(F)c(C#N)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3938335	=	IC50	nM	14.4	CHEMBL2828	Homo sapiens	IC50	nM	14.4
444308	17804016	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(F)cc(C#N)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3963299	=	IC50	nM	8.9	CHEMBL2828	Homo sapiens	IC50	nM	8.9
444309	17804017	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(OC(F)F)cc4F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3913183	=	IC50	nM	6.9	CHEMBL2828	Homo sapiens	IC50	nM	6.9
444310	17804018	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)c1F		CHEMBL3963771	=	IC50	nM	7.8	CHEMBL2828	Homo sapiens	IC50	nM	7.8
444311	17804019	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cnn(C)c4Cl)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3932365	=	IC50	nM	5.5	CHEMBL2828	Homo sapiens	IC50	nM	5.5
444312	17804020	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1c(F)cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)cc1F		CHEMBL3940974	=	IC50	nM	5.7	CHEMBL2828	Homo sapiens	IC50	nM	5.7
444313	17804021	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(F)cc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3912546	=	IC50	nM	7.2	CHEMBL2828	Homo sapiens	IC50	nM	7.2
444314	17804022	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cnccc4C(F)(F)F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3984487	=	IC50	nM	8.0	CHEMBL2828	Homo sapiens	IC50	nM	8.0
444315	17804023	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1ccncc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3962919	=	IC50	nM	7.1	CHEMBL2828	Homo sapiens	IC50	nM	7.1
444316	17804024	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccc(C(F)(F)F)n4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3928838	=	IC50	nM	24.7	CHEMBL2828	Homo sapiens	IC50	nM	24.7
444317	17804025	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN(C)c1ccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)cn1		CHEMBL3953061	=	IC50	nM	2.8	CHEMBL2828	Homo sapiens	IC50	nM	2.8
444318	17804026	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)n1		CHEMBL3946925	=	IC50	nM	14.2	CHEMBL2828	Homo sapiens	IC50	nM	14.2
444319	17804027	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(OCC(F)(F)F)nc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3919122	=	IC50	nM	4.4	CHEMBL2828	Homo sapiens	IC50	nM	4.4
444320	17804028	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3907142	=	IC50	nM	2.3	CHEMBL2828	Homo sapiens	IC50	nM	2.3
444321	17804029	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cncc(O)c4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3959158	=	IC50	nM	2.0	CHEMBL2828	Homo sapiens	IC50	nM	2.0
444322	17804030	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(-n5cccn5)nc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3932627	=	IC50	nM	3.8	CHEMBL2828	Homo sapiens	IC50	nM	3.8
444323	17804031	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(CCN5CCCC5)nc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3964687	=	IC50	nM	10.0	CHEMBL2828	Homo sapiens	IC50	nM	10.0
444324	17804032	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1ccncc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3941604	=	IC50	nM	2.6	CHEMBL2828	Homo sapiens	IC50	nM	2.6
444325	17804033	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccc(C(F)(F)F)cn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3910210	=	IC50	nM	34.6	CHEMBL2828	Homo sapiens	IC50	nM	34.6
444326	17804034	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1ccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)c(OC)n1		CHEMBL3913546	=	IC50	nM	41.0	CHEMBL2828	Homo sapiens	IC50	nM	41.0
444327	17804035	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CCc1ccc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)nc1		CHEMBL3983364	=	IC50	nM	11.9	CHEMBL2828	Homo sapiens	IC50	nM	11.9
444328	17804036	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1ncccc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3889710	=	IC50	nM	10.6	CHEMBL2828	Homo sapiens	IC50	nM	10.6
444329	17804037	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1ncccc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3982144	=	IC50	nM	3.3	CHEMBL2828	Homo sapiens	IC50	nM	3.3
444330	17804038	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3958671	=	IC50	nM	5.4	CHEMBL2828	Homo sapiens	IC50	nM	5.4
444331	17804039	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ncc(-c5ccccn5)s4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3893155	=	IC50	nM	3.3	CHEMBL2828	Homo sapiens	IC50	nM	3.3
444332	17804040	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cnc(C(F)(F)F)nc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3969763	=	IC50	nM	1.9	CHEMBL2828	Homo sapiens	IC50	nM	1.9
444333	17804041	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1ncc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)cn1		CHEMBL3898566	=	IC50	nM	435.0	CHEMBL2828	Homo sapiens	IC50	nM	435.0
444334	17804042	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3981164	=	IC50	nM	7.0	CHEMBL2828	Homo sapiens	IC50	nM	7.0
444335	17804043	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CCCC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3907589	=	IC50	nM	5.6	CHEMBL2828	Homo sapiens	IC50	nM	5.6
444336	17804044	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CCCCC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3889723	=	IC50	nM	5.1	CHEMBL2828	Homo sapiens	IC50	nM	5.1
444337	17804045	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CCCCCC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3917728	=	IC50	nM	4.2	CHEMBL2828	Homo sapiens	IC50	nM	4.2
444338	17804046	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CCC4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3939255	=	IC50	nM	7.1	CHEMBL2828	Homo sapiens	IC50	nM	7.1
444339	17804047	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN1CCC(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)CC1		CHEMBL3914705	=	IC50	nM	23.9	CHEMBL2828	Homo sapiens	IC50	nM	23.9
444340	17804048	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C4CC5CC46CC56)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3930261	=	IC50	nM	7.4	CHEMBL2828	Homo sapiens	IC50	nM	7.4
444341	17804049	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C45CCCC(CCC4)C5)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3902286	=	IC50	nM	5.5	CHEMBL2828	Homo sapiens	IC50	nM	5.5
444342	17804050	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C45CC6CC(CC(C6)C4)C5)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3924829	=	IC50	nM	4.1	CHEMBL2828	Homo sapiens	IC50	nM	4.1
444343	17804051	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)C45CC6CC(C)(CC(C)(C6)C4)C5)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3893301	=	IC50	nM	8.3	CHEMBL2828	Homo sapiens	IC50	nM	8.3
444344	17804052	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(C(F)(F)F)ccc1C(=O)Nc1cn2nc(-c3cn(C)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3915828	=	IC50	nM	6.5	CHEMBL2828	Homo sapiens	IC50	nM	6.5
444345	17804053	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3985580	=	IC50	nM	11.8	CHEMBL2828	Homo sapiens	IC50	nM	11.8
444346	17804054	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cccnc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3903330	=	IC50	nM	6.4	CHEMBL2828	Homo sapiens	IC50	nM	6.4
444347	17804055	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(C(=O)Nc2cn3nc(-c4cn(C)nc4-c4ccc(F)cc4)ccc3n2)cn1		CHEMBL3977481	=	IC50	nM	2.6	CHEMBL2828	Homo sapiens	IC50	nM	2.6
444348	17804056	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)CC(F)(F)F)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3921458	=	IC50	nM	10.3	CHEMBL2828	Homo sapiens	IC50	nM	10.3
444349	17804057	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4cc(O)ncn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3941721	=	IC50	nM	9.4	CHEMBL2828	Homo sapiens	IC50	nM	9.4
444350	17804058	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)C1CC1		CHEMBL3987095	=	IC50	nM	28.1	CHEMBL2828	Homo sapiens	IC50	nM	28.1
444351	17804059	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1ccncc1		CHEMBL3967723	=	IC50	nM	3.0	CHEMBL2828	Homo sapiens	IC50	nM	3.0
444352	17804060	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1csc(-c2ccncc2)n1		CHEMBL3976870	=	IC50	nM	8.5	CHEMBL2828	Homo sapiens	IC50	nM	8.5
444353	17804061	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1ccnc(F)c1		CHEMBL3960818	=	IC50	nM	3.2	CHEMBL2828	Homo sapiens	IC50	nM	3.2
444354	17804062	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1cc(F)nc(F)c1		CHEMBL3924423	=	IC50	nM	4.8	CHEMBL2828	Homo sapiens	IC50	nM	4.8
444355	17804063	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1ccncc1F		CHEMBL3952116	=	IC50	nM	3.5	CHEMBL2828	Homo sapiens	IC50	nM	3.5
444356	17804064	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1ccc(C(F)(F)F)nc1		CHEMBL3907683	=	IC50	nM	3.1	CHEMBL2828	Homo sapiens	IC50	nM	3.1
444357	17804065	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	O=C(Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1)c1cccc(-c2cccnc2)c1		CHEMBL3895186	=	IC50	nM	2.0	CHEMBL2828	Homo sapiens	IC50	nM	2.0
444358	17804066	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3900211	=	IC50	nM	2.5	CHEMBL2828	Homo sapiens	IC50	nM	2.5
444359	17804067	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccccn2)sc1C(=O)Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3951534	=	IC50	nM	5.5	CHEMBL2828	Homo sapiens	IC50	nM	5.5
444360	17804068	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3936537	=	IC50	nM	6.2	CHEMBL2828	Homo sapiens	IC50	nM	6.2
444361	17804069	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nocc1C(=O)Nc1cn2nc(-c3cn(C4CC4)nc3-c3ccc(F)cc3)ccc2n1		CHEMBL3919335	=	IC50	nM	6.0	CHEMBL2828	Homo sapiens	IC50	nM	6.0
444362	17804070	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCNCC1		CHEMBL3913933	=	IC50	nM	0.6	CHEMBL2828	Homo sapiens	IC50	nM	0.6
444363	17804071	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CCC(F)(F)F)CC1		CHEMBL3955665	=	IC50	nM	3.3	CHEMBL2828	Homo sapiens	IC50	nM	3.3
444364	17804072	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(Cc2ccon2)CC1		CHEMBL3926825	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444365	17804073	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN1CCN(c2c(-c3ccc4nc(NC(=O)c5ccnc(F)c5)cn4n3)c(-c3ccc(F)cc3)nn2C)CC1		CHEMBL3903967	=	IC50	nM	0.7	CHEMBL2828	Homo sapiens	IC50	nM	0.7
444366	17804074	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CCO)CC1		CHEMBL3961316	=	IC50	nM	0.1	CHEMBL2828	Homo sapiens	IC50	nM	0.1
444367	17804075	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COc1cc(C(=O)Nc2cn3nc(-c4c(-c5ccc(F)cc5)nn(C)c4N4CCNCC4)ccc3n2)ccn1		CHEMBL3933835	=	IC50	nM	0.8	CHEMBL2828	Homo sapiens	IC50	nM	0.8
444368	17804076	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CCCF)CC1		CHEMBL3936532	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444369	17804077	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COCCN1CCN(c2c(-c3ccc4nc(NC(=O)c5ccnc(F)c5)cn4n3)c(-c3ccc(F)cc3)nn2C)CC1		CHEMBL3909456	=	IC50	nM	0.73	CHEMBL2828	Homo sapiens	IC50	nM	0.73
444370	17804078	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL3909877	=	IC50	nM	1.2	CHEMBL2828	Homo sapiens	IC50	nM	1.2
444371	17804079	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(C(=O)C2CC2)CC1		CHEMBL3934241	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444372	17804080	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(C(=O)CN)CC1		CHEMBL3962177	=	IC50	nM	0.1	CHEMBL2828	Homo sapiens	IC50	nM	0.1
444373	17804081	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CC(N)=O)CC1		CHEMBL3939027	=	IC50	nM	0.2	CHEMBL2828	Homo sapiens	IC50	nM	0.2
444374	17804082	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CCC#N)CC1		CHEMBL3953610	=	IC50	nM	0.6	CHEMBL2828	Homo sapiens	IC50	nM	0.6
444375	17804083	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(CCS(C)(=O)=O)CC1		CHEMBL3970214	=	IC50	nM	2.9	CHEMBL2828	Homo sapiens	IC50	nM	2.9
444376	17804084	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL4107936	=	IC50	nM	1.0	CHEMBL2828	Homo sapiens	IC50	nM	1.0
444377	17804085	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCN(C[C@H](O)C(F)(F)F)CC1		CHEMBL3889600	=	IC50	nM	1.5	CHEMBL2828	Homo sapiens	IC50	nM	1.5
444378	17804086	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1N1CCNCC1		CHEMBL3889846	=	IC50	nM	0.9	CHEMBL2828	Homo sapiens	IC50	nM	0.9
444379	17804087	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1N1CCN(CCC(F)(F)F)CC1		CHEMBL3965134	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444380	17804088	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1N1CCN(Cc2ccon2)CC1		CHEMBL3935382	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444381	17804089	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL3950183	=	IC50	nM	0.6	CHEMBL2828	Homo sapiens	IC50	nM	0.6
444382	17804090	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1N1CCN(C(=O)c2ccon2)CC1		CHEMBL3932369	=	IC50	nM	1.0	CHEMBL2828	Homo sapiens	IC50	nM	1.0
444383	17804091	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCNCC1		CHEMBL3907925	=	IC50	nM	0.8	CHEMBL2828	Homo sapiens	IC50	nM	0.8
444384	17804092	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCN(CCC(F)(F)F)CC1		CHEMBL3895315	=	IC50	nM	1.6	CHEMBL2828	Homo sapiens	IC50	nM	1.6
444385	17804093	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCN(Cc2ccon2)CC1		CHEMBL3951296	=	IC50	nM	0.8	CHEMBL2828	Homo sapiens	IC50	nM	0.8
444386	17804094	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCN(C(=O)c2ccon2)CC1		CHEMBL3893406	=	IC50	nM	1.0	CHEMBL2828	Homo sapiens	IC50	nM	1.0
444387	17804095	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL3922374	=	IC50	nM	1.6	CHEMBL2828	Homo sapiens	IC50	nM	1.6
444388	17804096	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1N1CCN(CCCF)CC1		CHEMBL3905231	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444389	17804097	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N)c4)cn3n2)c1N1CCNCC1		CHEMBL3936095	=	IC50	nM	2.5	CHEMBL2828	Homo sapiens	IC50	nM	2.5
444390	17804098	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N)c4)cn3n2)c1N1CCN(CCC(F)(F)F)CC1		CHEMBL3909481	=	IC50	nM	2.5	CHEMBL2828	Homo sapiens	IC50	nM	2.5
444391	17804099	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N)c4)cn3n2)c1N1CCN(Cc2ccon2)CC1		CHEMBL3971152	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444392	17804100	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCOCC1		CHEMBL3952882	=	IC50	nM	2.0	CHEMBL2828	Homo sapiens	IC50	nM	2.0
444393	17804101	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCOCC1		CHEMBL3952882	=	IC50	nM	0.74	CHEMBL2828	Homo sapiens	IC50	nM	0.74
444394	17804102	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4cc(F)nc(F)c4)cn3n2)c1N1CCOCC1		CHEMBL3909742	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444395	17804103	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3N3CCOCC3)ccc2n1		CHEMBL3893281	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444396	17804104	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3N3CCOCC3)ccc2n1		CHEMBL3947948	=	IC50	nM	0.7	CHEMBL2828	Homo sapiens	IC50	nM	0.7
444397	17804105	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1N1CCNCC1		CHEMBL3913933	=	IC50	nM	2.1	CHEMBL2828	Homo sapiens	IC50	nM	2.1
444398	17804106	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(CCC(F)(F)F)CC1		CHEMBL3939036	=	IC50	nM	0.7	CHEMBL2828	Homo sapiens	IC50	nM	0.7
444399	17804107	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(Cc2ccon2)CC1		CHEMBL3902265	=	IC50	nM	1.1	CHEMBL2828	Homo sapiens	IC50	nM	1.1
444400	17804108	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL3895318	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444401	17804109	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	COCC(=O)N1CCC(c2c(-c3ccc4nc(NC(=O)c5ccnc(F)c5)cn4n3)c(-c3ccc(F)cc3)nn2C)CC1		CHEMBL3943491	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444402	17804110	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(C(=O)c2ccon2)CC1		CHEMBL3915816	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444403	17804111	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(C(=O)c2cncs2)CC1		CHEMBL3978116	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444404	17804112	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(CCCF)CC1		CHEMBL3931942	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444405	17804113	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(CCC#N)CC1		CHEMBL3942825	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444406	17804114	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(CC(N)=O)CC1		CHEMBL3922511	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444407	17804115	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL4108038	=	IC50	nM	0.2	CHEMBL2828	Homo sapiens	IC50	nM	0.2
444408	17804116	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCN(C[C@H](O)C(F)(F)F)CC1		CHEMBL3894506	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444409	17804117	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1C1CCNCC1		CHEMBL3902838	=	IC50	nM	1.5	CHEMBL2828	Homo sapiens	IC50	nM	1.5
444410	17804118	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1C1CCN(CCC(F)(F)F)CC1		CHEMBL3939825	=	IC50	nM	1.7	CHEMBL2828	Homo sapiens	IC50	nM	1.7
444411	17804119	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1C1CCN(CCCF)CC1		CHEMBL3915283	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444412	17804120	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1C1CCN(CC(N)=O)CC1		CHEMBL3944464	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444413	17804121	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCNCC1		CHEMBL3916526	=	IC50	nM	0.9	CHEMBL2828	Homo sapiens	IC50	nM	0.9
444414	17804122	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	CN1CCC(c2c(-c3ccc4nc(NC(=O)c5ccncc5)cn4n3)c(-c3ccc(F)cc3)nn2C)CC1		CHEMBL3925387	=	IC50	nM	2.7	CHEMBL2828	Homo sapiens	IC50	nM	2.7
444415	17804123	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(C2CC2)CC1		CHEMBL3922012	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444416	17804124	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(C2CCOCC2)CC1		CHEMBL3923060	=	IC50	nM	2.4	CHEMBL2828	Homo sapiens	IC50	nM	2.4
444417	17804125	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(CCO)CC1		CHEMBL3895083	=	IC50	nM	1.3	CHEMBL2828	Homo sapiens	IC50	nM	1.3
444418	17804126	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(Cc2ccon2)CC1		CHEMBL3981677	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444419	17804127	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(Cc2cc[nH]n2)CC1		CHEMBL3903876	=	IC50	nM	2.6	CHEMBL2828	Homo sapiens	IC50	nM	2.6
444420	17804128	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(Cc2cscn2)CC1		CHEMBL3970297	=	IC50	nM	3.6	CHEMBL2828	Homo sapiens	IC50	nM	3.6
444421	17804129	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(Cc2cocn2)CC1		CHEMBL3899096	=	IC50	nM	4.5	CHEMBL2828	Homo sapiens	IC50	nM	4.5
444422	17804130	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCN(Cc2nccs2)CC1		CHEMBL3890290	=	IC50	nM	1.5	CHEMBL2828	Homo sapiens	IC50	nM	1.5
444423	17804131	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCNCC3)ccc2n1		CHEMBL3893731	=	IC50	nM	2.5	CHEMBL2828	Homo sapiens	IC50	nM	2.5
444424	17804132	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(C)CC3)ccc2n1		CHEMBL3982756	=	IC50	nM	3.0	CHEMBL2828	Homo sapiens	IC50	nM	3.0
444425	17804133	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(Cc4ccon4)CC3)ccc2n1		CHEMBL3912884	=	IC50	nM	1.0	CHEMBL2828	Homo sapiens	IC50	nM	1.0
444426	17804134	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(CCC(F)(F)F)CC3)ccc2n1		CHEMBL3974768	=	IC50	nM	0.7	CHEMBL2828	Homo sapiens	IC50	nM	0.7
444427	17804135	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(CC(N)=O)CC3)ccc2n1		CHEMBL3900391	=	IC50	nM	0.2	CHEMBL2828	Homo sapiens	IC50	nM	0.2
444428	17804136	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCNCC3)ccc2n1		CHEMBL3957543	=	IC50	nM	1.4	CHEMBL2828	Homo sapiens	IC50	nM	1.4
444429	17804137	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(C)CC3)ccc2n1		CHEMBL3933511	=	IC50	nM	2.1	CHEMBL2828	Homo sapiens	IC50	nM	2.1
444430	17804138	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(CCC(F)(F)F)CC3)ccc2n1		CHEMBL3981157	=	IC50	nM	1.1	CHEMBL2828	Homo sapiens	IC50	nM	1.1
444431	17804139	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(Cc4ccon4)CC3)ccc2n1		CHEMBL3910319	=	IC50	nM	1.7	CHEMBL2828	Homo sapiens	IC50	nM	1.7
444432	17804140	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(CCC#N)CC3)ccc2n1		CHEMBL3947732	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444433	17804141	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCN(CC(N)=O)CC3)ccc2n1		CHEMBL3981952	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444434	17804142	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(Nc4ncccn4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3894100	=	IC50	nM	16.0	CHEMBL2828	Homo sapiens	IC50	nM	16.0
444435	17804143	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)Nc4ccccc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3977152	=	IC50	nM	14.6	CHEMBL2828	Homo sapiens	IC50	nM	14.6
444436	17804144	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)OCc4ccccc4)cn3n2)c(-c2ccc(F)cc2)n1		CHEMBL3965423	=	IC50	nM	51.5	CHEMBL2828	Homo sapiens	IC50	nM	51.5
444437	17804145	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(Nc4ncccn4)c(Br)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3925264	=	IC50	nM	871.0	CHEMBL2828	Homo sapiens	IC50	nM	871.0
444438	17804146	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4)c(Br)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3944359	=	IC50	nM	38.8	CHEMBL2828	Homo sapiens	IC50	nM	38.8
444439	17804147	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4)c(C#N)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3904017	=	IC50	nM	4.2	CHEMBL2828	Homo sapiens	IC50	nM	4.2
444440	17804148	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4)c(Cl)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3949680	=	IC50	nM	24.5	CHEMBL2828	Homo sapiens	IC50	nM	24.5
444441	17804149	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccccc4)c(F)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3981818	=	IC50	nM	5.6	CHEMBL2828	Homo sapiens	IC50	nM	5.6
444442	17804150	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccncc4)c(Br)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3958331	=	IC50	nM	17.0	CHEMBL2828	Homo sapiens	IC50	nM	17.0
444443	17804151	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1cc(-c2ccc3nc(NC(=O)c4ccncc4)c(-c4ccncc4)n3n2)c(-c2ccc(F)cc2)n1		CHEMBL3987018	=	IC50	nM	97.0	CHEMBL2828	Homo sapiens	IC50	nM	97.0
444444	17804152	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1c(NC(=O)c2ccccc2)nc2ccc(-c3cn(C)nc3-c3ccc(F)cc3)nn12		CHEMBL3901909	=	IC50	nM	54.0	CHEMBL2828	Homo sapiens	IC50	nM	54.0
444445	17804153	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1C1CCOCC1		CHEMBL3926405	=	IC50	nM	0.2	CHEMBL2828	Homo sapiens	IC50	nM	0.2
444446	17804154	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1C1CCOCC1		CHEMBL3910924	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444447	17804155	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1C1CCOCC1		CHEMBL3938867	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444448	17804156	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4cccc(-c5cccnc5)c4)cn3n2)c1C1CCOCC1		CHEMBL3932533	=	IC50	nM	0.2	CHEMBL2828	Homo sapiens	IC50	nM	0.2
444449	17804157	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2ccncc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCOCC3)ccc2n1		CHEMBL3906580	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444450	17804158	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cc1nc(-c2cccnc2)sc1C(=O)Nc1cn2nc(-c3c(-c4ccc(F)cc4)nn(C)c3C3CCOCC3)ccc2n1		CHEMBL3986585	=	IC50	nM	0.3	CHEMBL2828	Homo sapiens	IC50	nM	0.3
444451	17804159	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(F)c4)cn3n2)c1-c1ccncc1		CHEMBL3916656	=	IC50	nM	0.5	CHEMBL2828	Homo sapiens	IC50	nM	0.5
444452	17804160	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccnc(N5CCOCC5)c4)cn3n2)c1-c1ccncc1		CHEMBL3921603	=	IC50	nM	0.9	CHEMBL2828	Homo sapiens	IC50	nM	0.9
444453	17804161	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4ccncc4)cn3n2)c1-c1ccncc1		CHEMBL3948521	=	IC50	nM	0.4	CHEMBL2828	Homo sapiens	IC50	nM	0.4
444454	17804162	CHEMBL3889262	Kinase Assay: The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme, substrates (fluoresceinated peptide FL-AHA-KRRRAL-PSER-VASLPGL-OH and ATP) and test compounds in assay buffer (20 mM HEPES pH 7.4, 30 mM MgCl2, 0.015% Brij35 and 4 mM DTT). The reaction was incubated at room temperature for 22 hours and terminated by adding 45 ul of 35 mM EDTA to each sample. The reaction mixture was analyzed on the Caliper LABCHIP3000 (Caliper, Hopkinton, Mass.) by electrophoretic separation of the unphosphorylated substrate and phosphorylated product Inhibition data were calculated by comparison of the no enzyme control reactions for 100% inhibition and vehicle-only reactions for 0% inhibition. The final concentration of reagents in the assay were 200 pM CK1 or CK1, 50 uM ATP, 1.5 uM FL-AHA-KRRRAL-PSER-VASLPGL-OH, and 1.6% DMSO. Dose response curves were generated to determine the concentration required to inhibit 50% of the kinase activity (IC50). Compounds were dissolved at 10 mM in dimethylsulfoxide (DMSO) and evaluated at eleven concentrations. IC50 values were derived by non-linear regression analysis.	B	Cn1nc(-c2ccc(F)cc2)c(-c2ccc3nc(NC(=O)c4cccc(-c5cccnc5)c4)cn3n2)c1-c1ccncc1		CHEMBL3976515	=	IC50	nM	0.9	CHEMBL2828	Homo sapiens	IC50	nM	0.9
Inactive	17893572	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893573	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893574	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893575	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893576	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893577	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893578	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893579	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893580	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	869.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	869.0
Inactive	17893581	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893582	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893583	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893584	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	344.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	344.0
Inactive	17893585	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893586	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893587	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893588	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893589	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893590	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893591	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893592	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893593	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893594	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893595	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893596	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893597	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893598	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17893599	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3436.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	3436.0
Inactive	17893600	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893601	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893602	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	16150.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	16150.0
Inactive	17893603	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893604	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893605	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893606	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893607	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893608	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893609	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893610	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893611	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893612	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893613	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893614	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893615	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893616	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893617	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893618	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893619	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893620	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893621	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893622	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893623	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893624	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893625	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893626	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893627	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893628	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	1223.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	1223.0
Inactive	17893629	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893630	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893631	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893632	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893633	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893634	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893635	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893636	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893637	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893638	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893639	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893640	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	152.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	152.0
Inactive	17893641	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893642	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893643	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893644	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893645	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893646	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893647	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	188.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	188.0
Inactive	17893648	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893649	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893650	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893651	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893652	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893653	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893654	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	21528.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	21528.0
Inactive	17893655	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893656	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893657	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893658	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893659	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893660	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893661	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893662	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893663	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893664	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893665	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	287.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	287.0
Inactive	17893666	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893667	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893668	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893669	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893670	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893671	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893672	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893673	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893674	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893675	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893676	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893677	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893678	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893679	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893680	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893681	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893682	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893683	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	18396.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	18396.0
Inactive	17893684	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893685	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893686	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893687	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893688	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893689	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893690	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893691	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893692	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893693	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893694	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893695	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893696	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893697	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893698	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893699	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893700	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	3819.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	3819.0
Inactive	17893701	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893702	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893703	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893704	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893705	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893706	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893707	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893708	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893709	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893710	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893711	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893712	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893713	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893714	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	2381.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	2381.0
Inactive	17893715	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893716	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893717	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893718	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893719	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893720	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893721	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893722	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893723	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893724	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893725	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893726	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893727	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893728	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893729	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893730	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893731	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893732	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893733	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893734	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893735	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893736	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893737	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893738	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893739	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893740	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893741	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893742	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893743	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893744	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893745	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893746	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893747	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893748	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893749	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893750	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893751	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893752	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893753	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	236.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	236.0
Inactive	17893754	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893755	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893756	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893757	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893758	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893759	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893760	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893761	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893762	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893763	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893764	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893765	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893766	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893767	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893768	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893769	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893770	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893771	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893772	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893773	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893774	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893775	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893776	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	3879.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	3879.0
Inactive	17893777	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Active	17893778	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	=	Kd	nM	4821.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	4821.0
Active	17893779	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	1169.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	1169.0
Inactive	17893780	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893781	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893782	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893783	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893784	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893785	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893786	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893787	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893788	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893789	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893790	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893791	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893792	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893793	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893794	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893795	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893796	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893797	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893798	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893799	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893800	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893801	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893802	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893803	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893804	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893805	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893806	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893807	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893808	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893809	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893810	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893811	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893812	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893813	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893814	CHEMBL3991675	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2828	Homo sapiens	Kd apparent	nM	30000.0
	17964888	CHEMBL3994997	Inhibition of full length human CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	46.0	CHEMBL2828	Homo sapiens	Activity	%	46.0
	18007222	CHEMBL4003430	Inhibition of CK1 delta (unknown origin) assessed as residual activity at 1 uM relative to control	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4[nH]c(SC)nc4C)ccn3)cc2)c1		CHEMBL4082278	=	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
	18007236	CHEMBL4003444	Inhibition of CK1 delta (unknown origin) assessed as residual activity at 0.5 uM	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(Nc3cc(-c4c(-c5ccc(F)cc5)nc(SC)n4C)ccn3)cc2)c1		CHEMBL4077018	=	Activity	%	30.0	CHEMBL2828	Homo sapiens	Activity	%	30.0
	18021234	CHEMBL4005947	Inhibition of recombinant human N-terminal GST-tagged CK1 delta (1 to 294 amino acid residues) expressed in Escherichia coli assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	18021235	CHEMBL4005947	Inhibition of recombinant human N-terminal GST-tagged CK1 delta (1 to 294 amino acid residues) expressed in Escherichia coli assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	18114418	CHEMBL4025076	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	99.0	CHEMBL2828	Homo sapiens	Activity	%	99.0
	18134482	CHEMBL4029523	Inhibition of CK1delta (unknown origin) at 1 uM using CK1tide as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	=	Inhibition	%	28.0	CHEMBL2828	Homo sapiens	INH	%	28.0
	18134509	CHEMBL4029523	Inhibition of CK1delta (unknown origin) at 1 uM using CK1tide as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469	=	Inhibition	%	94.0	CHEMBL2828	Homo sapiens	INH	%	94.0
	18138929	CHEMBL4030440	Inhibition of CK1delta (unknown origin) at 10 uM relative to control	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1		CHEMBL1773422	=	Inhibition	%	94.0	CHEMBL2828	Homo sapiens	INH	%	94.0
	18138947	CHEMBL4030459	Inhibition of CK1delta (unknown origin) at 3 uM relative to control	B	Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1		CHEMBL4075428	=	Inhibition	%	88.0	CHEMBL2828	Homo sapiens	INH	%	88.0
	18153113	CHEMBL4034302	Inhibition of CK1d Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1	Outside typical range	CHEMBL4084955	=	Inhibition	%	-11.0	CHEMBL2828	Homo sapiens	INH	%	-11.0
	18185971	CHEMBL4040605	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL2828	Homo sapiens	INH	%	80.0
	18203600	CHEMBL4043887	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	96.0	CHEMBL2828	Homo sapiens	Activity	%	96.0
	18212141	CHEMBL4046159	Inhibition of CK1delta (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL2828	Homo sapiens	INH	%	20.0
	18232167	CHEMBL4050339	Inhibition of human CK1delta assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	18243289	CHEMBL4052511	Inhibition of CK1 delta (unknown origin) assessed as residual activity at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method relative to control	B	C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1		CHEMBL4071827	=	Activity	%	47.0	CHEMBL2828	Homo sapiens	Activity	%	47.0
	18253699	CHEMBL4055134	Inhibition of wild-type human full length CK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	98.0	CHEMBL2828	Homo sapiens	Activity	%	98.0
	18253700	CHEMBL4055134	Inhibition of wild-type human full length CK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	18265761	CHEMBL4057211	Inhibition of CK1-delta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	18265968	CHEMBL4057418	Inhibition of CK1-delta (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.7	CHEMBL2828	Homo sapiens	INH	%	6.7
	18266191	CHEMBL4057641	Inhibition of CK1-delta (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	10.7	CHEMBL2828	Homo sapiens	INH	%	10.7
	18282022	CHEMBL4119977	Inhibition of CK1delta (unknown origin) at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	10.0	CHEMBL2828	Homo sapiens	INH	%	10.0
	18282341	CHEMBL4119977	Inhibition of CK1delta (unknown origin) at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-0.3	CHEMBL2828	Homo sapiens	INH	%	-0.3
	18282670	CHEMBL4120255	Inhibition of CK1-delta (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	18282886	CHEMBL4120471	Inhibition of CK1-delta (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	0.0	CHEMBL2828	Homo sapiens	INH	%	0.0
	18283100	CHEMBL4120685	Inhibition of CK1-delta (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.7	CHEMBL2828	Homo sapiens	INH	%	4.7
	18407896	CHEMBL4151452	Inhibition of human CSNK1D expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	17.0	CHEMBL2828	Homo sapiens	Activity	%	17.0
	18407937	CHEMBL4151452	Inhibition of human CSNK1D expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	8.0	CHEMBL2828	Homo sapiens	Activity	%	8.0
	18407982	CHEMBL4151452	Inhibition of human CSNK1D expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	13.0	CHEMBL2828	Homo sapiens	Activity	%	13.0
Not Active	18409154	CHEMBL4151681	Inhibition of human recombinant CK1delta at 10 uM incubated for 60 mins by Kinase-Glo assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Not Active	18409155	CHEMBL4151681	Inhibition of human recombinant CK1delta at 10 uM incubated for 60 mins by Kinase-Glo assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	18440142	CHEMBL4156966	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
	18443305	CHEMBL4157944	Inhibition of human CK1delta assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	107.0	CHEMBL2828	Homo sapiens	Activity	%	107.0
	18449903	CHEMBL4178139	Inhibition of human CK1delta (1 to 415 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	97.0	CHEMBL2828	Homo sapiens	Activity	%	97.0
	18462163	CHEMBL4180850	Inhibition of recombinant human full length GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	106.0	CHEMBL2828	Homo sapiens	Activity	%	106.0
	18463737	CHEMBL4181153	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	7.0	CHEMBL2828	Homo sapiens	INH	%	7.0
	18484582	CHEMBL4185745	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
	18485039	CHEMBL4185745	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	86.0	CHEMBL2828	Homo sapiens	Activity	%	86.0
	18489092	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cn1cnc2c(NCc3nc4c(F)c(F)ccc4[nH]3)nc(N3CCOCC3)nc21		CHEMBL4203083	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	18489093	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CCn1cnc2c(NCc3nc4c(F)c(F)ccc4[nH]3)nc(N3CCOCC3)nc21		CHEMBL4207173	=	IC50	nM	4010.0	CHEMBL2828	Homo sapiens	IC50	nM	4010.0
	18489094	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4211454	=	IC50	nM	44.0	CHEMBL2828	Homo sapiens	IC50	nM	44.0
	18489095	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cc1		CHEMBL4213060	=	IC50	nM	535.0	CHEMBL2828	Homo sapiens	IC50	nM	535.0
	18489096	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cc1F		CHEMBL4216824	=	IC50	nM	4520.0	CHEMBL2828	Homo sapiens	IC50	nM	4520.0
	18489097	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1F		CHEMBL4203375	=	IC50	nM	48.0	CHEMBL2828	Homo sapiens	IC50	nM	48.0
	18489098	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	IC50	nM	53.0	CHEMBL2828	Homo sapiens	IC50	nM	53.0
	18489099	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc(F)c(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4214571	=	IC50	nM	10.0	CHEMBL2828	Homo sapiens	IC50	nM	10.0
	18489100	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c(F)c1		CHEMBL4208642	=	IC50	nM	525.0	CHEMBL2828	Homo sapiens	IC50	nM	525.0
	18489101	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cc1ccccc1-n1cnc2c(NCc3nc4c(F)c(F)ccc4[nH]3)nc(N3CCOCC3)nc21		CHEMBL4217142	=	IC50	nM	110.0	CHEMBL2828	Homo sapiens	IC50	nM	110.0
	18489102	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3ccccc3C(F)(F)F)nc2c1F		CHEMBL4206998	=	IC50	nM	230.0	CHEMBL2828	Homo sapiens	IC50	nM	230.0
	18489103	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4ccsc4)c3n2)CC1		CHEMBL4203268	=	IC50	nM	47.0	CHEMBL2828	Homo sapiens	IC50	nM	47.0
	18489104	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3ccsc3)nc2c1F		CHEMBL4206247	=	IC50	nM	54.0	CHEMBL2828	Homo sapiens	IC50	nM	54.0
	18489105	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccnc4)c3n2)CC1		CHEMBL4209759	=	IC50	nM	700.0	CHEMBL2828	Homo sapiens	IC50	nM	700.0
	18489106	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccnc3)nc2c1F		CHEMBL4209644	=	IC50	nM	335.0	CHEMBL2828	Homo sapiens	IC50	nM	335.0
	18489107	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4ccccn4)c3n2)CC1		CHEMBL4214158	=	IC50	nM	260.0	CHEMBL2828	Homo sapiens	IC50	nM	260.0
	18489108	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3ccccn3)nc2c1F		CHEMBL4202470	=	IC50	nM	440.0	CHEMBL2828	Homo sapiens	IC50	nM	440.0
	18489109	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4ccncc4)c3n2)CC1		CHEMBL4218574	=	IC50	nM	175.0	CHEMBL2828	Homo sapiens	IC50	nM	175.0
	18489110	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3ccncc3)nc2c1F		CHEMBL4206835	=	IC50	nM	260.0	CHEMBL2828	Homo sapiens	IC50	nM	260.0
	18489111	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4ccnc(F)c4)c3n2)CC1		CHEMBL4215429	=	IC50	nM	295.0	CHEMBL2828	Homo sapiens	IC50	nM	295.0
	18489112	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)ccn1		CHEMBL4218717	=	IC50	nM	145.0	CHEMBL2828	Homo sapiens	IC50	nM	145.0
	18489113	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4ccc(Cl)nc4)c3n2)CC1		CHEMBL4202462	=	IC50	nM	1120.0	CHEMBL2828	Homo sapiens	IC50	nM	1120.0
	18489114	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3ccc(Cl)nc3)nc2c1F		CHEMBL4215325	>	IC50	nM	9900.0	CHEMBL2828	Homo sapiens	IC50	nM	9900.0
	18489115	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCN(C)CC4)nc32)ccn1		CHEMBL4211128	=	IC50	nM	295.0	CHEMBL2828	Homo sapiens	IC50	nM	295.0
	18489116	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)ccn1		CHEMBL4210537	=	IC50	nM	1195.0	CHEMBL2828	Homo sapiens	IC50	nM	1195.0
	18489117	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4ccccc4[nH]3)c3ncn(-c4cccnc4)c3n2)CC1		CHEMBL4218233	=	IC50	nM	1565.0	CHEMBL2828	Homo sapiens	IC50	nM	1565.0
	18489118	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	c1cncc(-n2cnc3c(NCc4nc5ccccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4209180	=	IC50	nM	1155.0	CHEMBL2828	Homo sapiens	IC50	nM	1155.0
	18489119	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	c1cncc(-n2cnc3c(NCc4nc5ccccc5[nH]4)nc(N4CCNCC4)nc32)c1		CHEMBL4216210	=	IC50	nM	825.0	CHEMBL2828	Homo sapiens	IC50	nM	825.0
	18489120	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4cc(Cl)ccc4[nH]3)c3ncn(-c4cccnc4)c3n2)CC1		CHEMBL4203354	=	IC50	nM	335.0	CHEMBL2828	Homo sapiens	IC50	nM	335.0
	18489121	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Clc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccnc3)nc2c1		CHEMBL4205223	=	IC50	nM	520.0	CHEMBL2828	Homo sapiens	IC50	nM	520.0
	18489122	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Clc1ccc2[nH]c(CNc3nc(N4CCNCC4)nc4c3ncn4-c3cccnc3)nc2c1		CHEMBL4205502	=	IC50	nM	430.0	CHEMBL2828	Homo sapiens	IC50	nM	430.0
	18489123	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4cc(Cl)c(Cl)cc4[nH]3)c3ncn(-c4cccnc4)c3n2)CC1		CHEMBL4211678	=	IC50	nM	100.0	CHEMBL2828	Homo sapiens	IC50	nM	100.0
	18489124	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Clc1cc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccnc3)[nH]c2cc1Cl		CHEMBL4218827	=	IC50	nM	50.0	CHEMBL2828	Homo sapiens	IC50	nM	50.0
	18489125	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Clc1cc2nc(CNc3nc(N4CCNCC4)nc4c3ncn4-c3cccnc3)[nH]c2cc1Cl		CHEMBL4209206	=	IC50	nM	80.0	CHEMBL2828	Homo sapiens	IC50	nM	80.0
	18489126	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	COc1ccc2nc(CNc3nc(N4CCN(C)CC4)nc4c3ncn4-c3cccnc3)[nH]c2c1		CHEMBL4216393	=	IC50	nM	610.0	CHEMBL2828	Homo sapiens	IC50	nM	610.0
	18489127	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	COc1ccc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccnc3)[nH]c2c1		CHEMBL4213254	=	IC50	nM	520.0	CHEMBL2828	Homo sapiens	IC50	nM	520.0
	18489128	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	COc1ccc2nc(CNc3nc(N4CCNCC4)nc4c3ncn4-c3cccnc3)[nH]c2c1		CHEMBL4213833	=	IC50	nM	625.0	CHEMBL2828	Homo sapiens	IC50	nM	625.0
	18489129	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2nc(NCc3nc4cc(F)c(F)cc4[nH]3)c3ncn(-c4cccnc4)c3n2)CC1		CHEMBL4216088	=	IC50	nM	200.0	CHEMBL2828	Homo sapiens	IC50	nM	200.0
	18489130	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccnc3)[nH]c2cc1F		CHEMBL4205151	=	IC50	nM	175.0	CHEMBL2828	Homo sapiens	IC50	nM	175.0
	18489131	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5ccccc5o4)nc(N4CCOCC4)nc32)c1		CHEMBL4215691	=	IC50	nM	42.0	CHEMBL2828	Homo sapiens	IC50	nM	42.0
	18489132	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5ccccc5s4)nc(N4CCOCC4)nc32)c1		CHEMBL4211301	=	IC50	nM	9.0	CHEMBL2828	Homo sapiens	IC50	nM	9.0
	18489133	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc(-c5ccccc5)c[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4210412	=	IC50	nM	215.0	CHEMBL2828	Homo sapiens	IC50	nM	215.0
	18489134	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc(-c5ccccc5)co4)nc(N4CCOCC4)nc32)c1		CHEMBL4206164	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	18489135	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc(-c5ccccc5)cs4)nc(N4CCOCC4)nc32)c1		CHEMBL4206610	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	nM	10000.0
	18489136	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2ccc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccc(F)c3)cc2)CC1		CHEMBL4203539	=	IC50	nM	245.0	CHEMBL2828	Homo sapiens	IC50	nM	245.0
	18489137	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCN(c2ccc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cccc(F)c3)nc2)CC1		CHEMBL4211222	=	IC50	nM	50.0	CHEMBL2828	Homo sapiens	IC50	nM	50.0
	18489138	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4ncc[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4215749	=	IC50	nM	180.0	CHEMBL2828	Homo sapiens	IC50	nM	180.0
	18489139	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4ccccn4)nc(N4CCOCC4)nc32)c1		CHEMBL4217233	=	IC50	nM	85.0	CHEMBL2828	Homo sapiens	IC50	nM	85.0
	18489140	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4cccnc4)nc(N4CCOCC4)nc32)c1		CHEMBL4212255	=	IC50	nM	98.0	CHEMBL2828	Homo sapiens	IC50	nM	98.0
	18489141	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cc1ccc(CNc2nc(N3CCOCC3)nc3c2ncn3-c2cccc(F)c2)nc1		CHEMBL4212710	=	IC50	nM	80.0	CHEMBL2828	Homo sapiens	IC50	nM	80.0
	18489142	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Cc1cccc(CNc2nc(N3CCOCC3)nc3c2ncn3-c2cccc(F)c2)n1		CHEMBL4205929	=	IC50	nM	37.0	CHEMBL2828	Homo sapiens	IC50	nM	37.0
	18489143	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4ccccc4F)nc(N4CCOCC4)nc32)c1		CHEMBL4208025	=	IC50	nM	89.0	CHEMBL2828	Homo sapiens	IC50	nM	89.0
	18489144	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Nc1nc(NCc2nc3c(F)c(F)ccc3[nH]2)c2ncn(-c3cccc(F)c3)c2n1		CHEMBL4211791	=	IC50	nM	55.0	CHEMBL2828	Homo sapiens	IC50	nM	55.0
	18489145	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	OCCNc1nc(NCc2nc3c(F)c(F)ccc3[nH]2)c2ncn(-c3cccc(F)c3)c2n1		CHEMBL4215056	=	IC50	nM	76.0	CHEMBL2828	Homo sapiens	IC50	nM	76.0
	18489146	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCSCC4)nc32)c1		CHEMBL4203904	=	IC50	nM	185.0	CHEMBL2828	Homo sapiens	IC50	nM	185.0
	18489147	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	O=S1(=O)CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4212734	=	IC50	nM	175.0	CHEMBL2828	Homo sapiens	IC50	nM	175.0
	18489148	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	COC1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4204292	=	IC50	nM	230.0	CHEMBL2828	Homo sapiens	IC50	nM	230.0
	18489149	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	OCC1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4209917	=	IC50	nM	69.0	CHEMBL2828	Homo sapiens	IC50	nM	69.0
	18489150	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(NCC4CCOCC4)nc32)c1		CHEMBL4213205	=	IC50	nM	320.0	CHEMBL2828	Homo sapiens	IC50	nM	320.0
	18489151	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(NCCN4CCOCC4)nc32)c1		CHEMBL4212477	=	IC50	nM	830.0	CHEMBL2828	Homo sapiens	IC50	nM	830.0
	18489152	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	Fc1cccc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(NCCCN4CCOCC4)nc32)c1		CHEMBL4210748	=	IC50	nM	915.0	CHEMBL2828	Homo sapiens	IC50	nM	915.0
	18489153	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CCCCNc1nc(NCc2nc3c(F)c(F)ccc3[nH]2)c2ncn(-c3cccc(F)c3)c2n1		CHEMBL4218947	=	IC50	nM	1030.0	CHEMBL2828	Homo sapiens	IC50	nM	1030.0
	18489154	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN(C)C1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4207220	=	IC50	nM	1180.0	CHEMBL2828	Homo sapiens	IC50	nM	1180.0
	18489155	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CN1CCC(Nc2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4205719	=	IC50	nM	160.0	CHEMBL2828	Homo sapiens	IC50	nM	160.0
	18489156	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	O=C1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4217426	=	IC50	nM	150.0	CHEMBL2828	Homo sapiens	IC50	nM	150.0
	18489157	CHEMBL4187194	Inhibition of recombinant human full length N-terminal GST-tagged CK1delta expressed in baculovirus in Sf9 insect cells using ULight-Topo-IIa(Thr1342) peptide as substrate after 10 mins by TR-FRET assay	B	CNC1CCN(c2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncn(-c4cccc(F)c4)c3n2)CC1		CHEMBL4210085	=	IC50	nM	620.0	CHEMBL2828	Homo sapiens	IC50	nM	620.0
	18489502	CHEMBL4187243	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	5.2	CHEMBL2828	Homo sapiens	Activity	%	5.2
	18500765	CHEMBL4189216	Inhibition of human recombinant CK1delta assessed as residual activity at 1 uM after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccccc3)SCC4)sc2c1		CHEMBL1257064	=	Activity	%	55.0	CHEMBL2828	Homo sapiens	Activity	%	55.0
	18500769	CHEMBL4189229	Inhibition of CK1delta in human PANC1 cells assessed as residual activity at 2.33 uM using GST-tagged p53 (1 to 64 residues) as substrate after 48 hrs in presence of [gamma-32P]-ATP by Cherenkov counting method	B	Cc1ccc2nc(NC(=O)CSc3nc4c(c(=O)n3-c3ccccc3)SCC4)sc2c1		CHEMBL1257064	=	Activity	%	66.0	CHEMBL2828	Homo sapiens	Activity	%	66.0
	18500812	CHEMBL4189230	Inhibition of CK1delta isolated from human PANC1 cells at 5 uM using GST-tagged p53 (1 to 64 residues) as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccccc32)c(OC)c1		CHEMBL489156	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	18500813	CHEMBL4189231	Inhibition of CK1delta isolated from human PANC1 cells at 125 uM using GST-tagged p53 (1 to 64 residues) as substrate after 30 mins in presence of [gamma-32P]-ATP by Cherenkov counting method	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	18500818	CHEMBL4189245	Inhibition of human CK1delta transcription variant 1 using GST-tagged mouse p53 (1 to 64 residues) as substrate in presence of radiolabelled-ATP by Cherenkov counting method	B	O=C(Nc1nc2ccc(C(F)(F)F)cc2[nH]1)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337854	=	IC50	nM	22.0	CHEMBL2828	Homo sapiens	IC50	uM	0.022
	18500819	CHEMBL4189246	Inhibition of human CK1delta transcription variant 2 using GST-tagged mouse p53 (1 to 64 residues) as substrate in presence of radiolabelled-ATP by Cherenkov counting method	B	O=C(Nc1nc2ccc(C(F)(F)F)cc2[nH]1)c1csc(NC(=O)c2ccccc2OC(F)(F)F)n1		CHEMBL3337854	=	IC50	nM	42.0	CHEMBL2828	Homo sapiens	IC50	uM	0.042
Active	18500838	CHEMBL4189234	Inhibition of human recombinant CK1delta at 1 uM after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	COc1ccc(Cn2c(SCC(=O)Nc3nc4ccc(C(F)(F)F)cc4s3)nc3c(c2=O)SCC3)cc1		CHEMBL4204681		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	18500841	CHEMBL4189237	Inhibition of CK1delta in HEK293T cells assessed as stimulation of Wnt/beta-catenin signaling after 22 hrs in presence of Wnt3A-conditioned medium by Super-top flash reporter gene assay	B	COc1ccc(Cn2c(SCC(=O)Nc3nc4ccc(C(F)(F)F)cc4s3)nc3c(c2=O)SCC3)cc1		CHEMBL4204681	=	EC50	nM	1470.0	CHEMBL2828	Homo sapiens	EC50	uM	1.47
	18500842	CHEMBL4189198	Inhibition of CK1delta in HEK293T cells assessed as stimulation of Wnt/beta-catenin signaling at 5 uM after 22 hrs in presence of Wnt3A-conditioned medium by Super-top flash reporter gene assay relative to control	B	COc1ccc(Cn2c(SCC(=O)Nc3nc4ccc(C(F)(F)F)cc4s3)nc3c(c2=O)SCC3)cc1		CHEMBL4204681	=	Emax	%	225.0	CHEMBL2828	Homo sapiens	Emax	%	225.0
	18507845	CHEMBL4190917	Inhibition of recombinant human CK1delta (1 to 294 residues) at 1 uM using KRRRALS(p)VASLPGL as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	66.0	CHEMBL2828	Homo sapiens	INH	%	66.0
	18578791	CHEMBL4222456	Inhibition of CSNK1D (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	>	IC50	nM	500.0	CHEMBL2828	Homo sapiens	IC50	nM	500.0
	18578792	CHEMBL4222456	Inhibition of CSNK1D (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	>	IC50	nM	500.0	CHEMBL2828	Homo sapiens	IC50	nM	500.0
	18578793	CHEMBL4222456	Inhibition of CSNK1D (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	>	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	uM	1.0
	18655590	CHEMBL4230645	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL2828	Homo sapiens	Activity	%	95.0
	18663778	CHEMBL4232882	Inhibition of full length human CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	90.0	CHEMBL2828	Homo sapiens	Activity	%	90.0
	18663995	CHEMBL4232979	Binding affinity to full length human CSNK1D (M1 to K409 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2828	Homo sapiens	Kd	uM	5.0
	18697699	CHEMBL4254372	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	86.0	CHEMBL2828	Homo sapiens	Activity	%	86.0
	18708945	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	45.0	CHEMBL2828	Homo sapiens	INH	%	45.0
	18708960	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	72.0	CHEMBL2828	Homo sapiens	INH	%	72.0
	18709003	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	40.0	CHEMBL2828	Homo sapiens	INH	%	40.0
	18709035	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	38.0	CHEMBL2828	Homo sapiens	INH	%	38.0
	18709064	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	37.0	CHEMBL2828	Homo sapiens	INH	%	37.0
	18709093	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	79.0	CHEMBL2828	Homo sapiens	INH	%	79.0
	18709122	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	63.0	CHEMBL2828	Homo sapiens	INH	%	63.0
	18709169	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	33.0	CHEMBL2828	Homo sapiens	INH	%	33.0
	18709199	CHEMBL4256691	Inhibition of CK1delta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	79.0	CHEMBL2828	Homo sapiens	INH	%	79.0
	18709228	CHEMBL4256665	Inhibition of CK1delta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	78.0	CHEMBL2828	Homo sapiens	INH	%	78.0
	18709270	CHEMBL4256691	Inhibition of CK1delta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	31.0	CHEMBL2828	Homo sapiens	INH	%	31.0
	18709303	CHEMBL4256691	Inhibition of CK1delta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	78.0	CHEMBL2828	Homo sapiens	INH	%	78.0
	18728160	CHEMBL4259481	Inhibition of full length recombinant human GST-tagged CK1delta expressed in baculovirus expression system at 5 uM relative to control	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3nc4ccc(O)cc4s3)cc2)CC1		CHEMBL4287375	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	18750326	CHEMBL4263637	Inhibition of recombinant human CK1delta expressed in Baculovirus expression system at 2 uM by Z'-LYTE assay	B	O=C(Cc1ccc(F)cc1)Nc1cncc(-c2cc(-c3cccnc3)cs2)c1		CHEMBL4290247	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
	18751669	CHEMBL4264234	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	66.0	CHEMBL2828	Homo sapiens	Activity	%	66.0
	18782822	CHEMBL4270688	Inhibition of CK1delta (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	34.0	CHEMBL2828	Homo sapiens	Activity	%	34.0
	18811056	CHEMBL4275973	Inhibition of CK1delta (unknown origin) at 1.25 uM in presence of 100 uM ATP relative to control	B	O=C(Nc1cncc(-c2cc(-c3cccnc3)cs2)c1)C1CC1		CHEMBL4283503	=	Inhibition	%	4.0	CHEMBL2828	Homo sapiens	INH	%	4.0
Not Active	18847329	CHEMBL4304891	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	18857903	CHEMBL4307749	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	18892846	CHEMBL4314812	Inhibition of recombinant human CK1delta (1 to 294 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	103.0	CHEMBL2828	Homo sapiens	Activity	%	103.0
	18935854	CHEMBL4326989	Inhibition of ligand binding to human full-length CK1delta (M1 to K409 residues) expressed in bacterial expression system at 10 uM measured after 1 hr by Kinomescan method relative to control	B	O=c1c2ccccc2nc2n1-c1ccccc1/C2=N\O		CHEMBL1098827	>	Inhibition	%	90.0	CHEMBL2828	Homo sapiens	INH	%	90.0
	18937823	CHEMBL4327644	Inhibition of human CK1D assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.92	CHEMBL2828	Homo sapiens	Activity	%	96.92
	18937824	CHEMBL4327644	Inhibition of human CK1D assessed as residual activity at 1 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.14	CHEMBL2828	Homo sapiens	Activity	%	96.14
	18938482	CHEMBL4328002	Inhibition of human CK1D assessed as residual activity at 100 uM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	<	Activity	%	65.0	CHEMBL2828	Homo sapiens	Activity	%	65.0
Not Determined	18938855	CHEMBL4328366	Inhibition of human CK1D using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL2828	Homo sapiens	IC50		
	18938856	CHEMBL4328366	Inhibition of human CK1D using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	IC50	nM	171.0	CHEMBL2828	Homo sapiens	IC50	10'-7M	1.71
	18958820	CHEMBL4333339	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	59.0	CHEMBL2828	Homo sapiens	Activity	%	59.0
	18964183	CHEMBL4335028	Inhibition of recombinant human CK1delta (1 to 294 residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL2828	Homo sapiens	Activity	%	101.0
	18964184	CHEMBL4335028	Inhibition of recombinant human CK1delta (1 to 294 residues) assessed as residual activity at 1 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	94.0	CHEMBL2828	Homo sapiens	Activity	%	94.0
	18971719	CHEMBL4336771	Inhibition of human CK1delta in presence of [gamma33P]-ATP	B	Nc1ncnc2c1c(COc1cccc(Cl)c1)nn2C1CCOCC1		CHEMBL2069623	=	IC50	nM	711.0	CHEMBL2828	Homo sapiens	IC50	uM	0.711
	18971720	CHEMBL4336771	Inhibition of human CK1delta in presence of [gamma33P]-ATP	B	CN1Cc2nccc(-c3cn(C)nc3-c3ccc(F)cc3)c2C1=O		CHEMBL4445830	=	IC50	nM	13.0	CHEMBL2828	Homo sapiens	IC50	uM	0.013
	18971722	CHEMBL4336771	Inhibition of human CK1delta in presence of [gamma33P]-ATP	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	13.0	CHEMBL2828	Homo sapiens	IC50	uM	0.013
	18971845	CHEMBL4336855	Inhibition of recombinant human CK1delta (1 to 294 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	23.0	CHEMBL2828	Homo sapiens	Activity	%	23.0
	18985992	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	CN(C)Cc1n[nH]c(-c2ccc3[nH]nc(-c4cccc(C(=O)Nc5ccc(F)cc5)c4)c3c2)n1		CHEMBL3990606	=	Inhibition	%	99.0	CHEMBL2828	Homo sapiens	INH	%	99.0
	18985993	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)NCc4cnc(C)nc4N)c3)c2c1		CHEMBL4520994	=	Inhibition	%	92.0	CHEMBL2828	Homo sapiens	INH	%	92.0
	18985994	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)NCc4cccc5ccccc45)c3)c2c1		CHEMBL4476186	=	Inhibition	%	80.0	CHEMBL2828	Homo sapiens	INH	%	80.0
	18985995	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	C[C@@H](NC(=O)c1ccc2[nH]nc(-c3cccc(NS(C)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL4519384	=	Inhibition	%	66.0	CHEMBL2828	Homo sapiens	INH	%	66.0
	18985996	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)Nc4cc(-c5ccccn5)n[nH]4)c3)c2c1		CHEMBL4593943	=	Inhibition	%	57.0	CHEMBL2828	Homo sapiens	INH	%	57.0
	18985997	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	Fc1ccc(-c2n[nH]c3ccc(-c4n[nH]c(CN5CCCC5)n4)cc23)cc1		CHEMBL3940534	=	Inhibition	%	53.0	CHEMBL2828	Homo sapiens	INH	%	53.0
	18985998	CHEMBL4340090	Inhibition of CSNK1D (unknown origin) at 1 uM using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay relative to untreated control	B	O=C1CCCN1Cc1nnc(-c2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)[nH]1		CHEMBL4565017	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	18985999	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	CN(C)Cc1n[nH]c(-c2ccc3[nH]nc(-c4cccc(C(=O)Nc5ccc(F)cc5)c4)c3c2)n1		CHEMBL3990606	=	IC50	nM	134.0	CHEMBL2828	Homo sapiens	IC50	nM	134.0
Not Determined	18986000	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)NCc4cnc(C)nc4N)c3)c2c1		CHEMBL4520994		IC50			CHEMBL2828	Homo sapiens	IC50		
	18986001	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)NCc4cccc5ccccc45)c3)c2c1		CHEMBL4476186	=	IC50	nM	354.0	CHEMBL2828	Homo sapiens	IC50	nM	354.0
	18986002	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	C[C@@H](NC(=O)c1ccc2[nH]nc(-c3cccc(NS(C)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL4519384	=	IC50	nM	1030.0	CHEMBL2828	Homo sapiens	IC50	nM	1030.0
Not Determined	18986003	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	CNC(=O)c1ccc2[nH]nc(-c3cccc(C(=O)Nc4cc(-c5ccccn5)n[nH]4)c3)c2c1		CHEMBL4593943		IC50			CHEMBL2828	Homo sapiens	IC50		
	18986004	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	Fc1ccc(-c2n[nH]c3ccc(-c4n[nH]c(CN5CCCC5)n4)cc23)cc1		CHEMBL3940534	=	IC50	nM	848.0	CHEMBL2828	Homo sapiens	IC50	nM	848.0
Not Determined	18986005	CHEMBL4340091	Inhibition of CSNK1D (unknown origin) using CSNK1D/Ser/Thr 11 peptide incubated for 1 hr by FRET based Z'-LYTE assay	B	O=C1CCCN1Cc1nnc(-c2ccc3[nH]nc(-c4ccc(F)cc4)c3c2)[nH]1		CHEMBL4565017		IC50			CHEMBL2828	Homo sapiens	IC50		
	19005795	CHEMBL4344396	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c3ccnc(C)c3n(CCCC(N)=O)c2c1		CHEMBL4474836	=	Activity	%	60.0	CHEMBL2828	Homo sapiens	Activity	%	60.0
	19005796	CHEMBL4344396	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	13.0	CHEMBL2828	Homo sapiens	Activity	%	13.0
	19005797	CHEMBL4344396	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	17.0	CHEMBL2828	Homo sapiens	Activity	%	17.0
	19032184	CHEMBL4349778	Inhibition of CK1-delta (unknown origin) at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
Not Active	19039836	CHEMBL4351806	Inhibition of recombinant human CK1delta (1 to 294 residues) at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
Active	19041061	CHEMBL4352322	Inhibition of human CK1D at 10 uM using KRRRAL[pS]VASLPGL as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	19059522	CHEMBL4357823	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2828	Homo sapiens	Activity	%	100.0
	19090093	CHEMBL4365667	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	59.0	CHEMBL2828	Homo sapiens	Activity	%	59.0
	19091875	CHEMBL4366349	Inhibition of human CK1D at 100 nM using KRRRAL[pS]VASLPGL as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	2.83	CHEMBL2828	Homo sapiens	INH	%	2.83
	19144707	CHEMBL4377723	Inhibition of recombinant human CK1delta (1 to 294 residues) at 1 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-2.0	CHEMBL2828	Homo sapiens	INH	%	-2.0
	19146897	CHEMBL4378895	Inhibition of recombinant human CK1delta (1 to 294 residues) at 10 uM using KRRRALS(p)VASLPGL as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	19147798	CHEMBL4379194	Inhibition of recombinant human CK1delta (1 to 294 residues) using KRRRALS(p)VAS as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	19159350	CHEMBL4382454	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	19176688	CHEMBL4386152	Inhibition of CK1delta (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226	=	Activity	%	11.0	CHEMBL2828	Homo sapiens	Activity	%	11.0
	19176690	CHEMBL4386154	Inhibition of CK1delta (unknown origin)	B	CC(C)c1n[nH]c2c(NCc3ccc(-c4ccccn4)cc3)nc(SCCN)nc12		CHEMBL4540226	=	IC50	nM	45.0	CHEMBL2828	Homo sapiens	IC50	uM	0.045
	19180993	CHEMBL4387204	Inhibition of recombinant full length human GST-tagged CK1delta expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	10.5	CHEMBL2828	Homo sapiens	INH	%	10.5
	19181219	CHEMBL4387204	Inhibition of recombinant full length human GST-tagged CK1delta expressed in baculovirus expression system at 0.1 uM using serine/threonine-11 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	5.0	CHEMBL2828	Homo sapiens	INH	%	5.0
	19191657	CHEMBL4389173	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2828	Homo sapiens	INH	%	100.0
	19191836	CHEMBL4389650	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2828	Homo sapiens	INH	%	100.0
	19199946	CHEMBL4391276	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	2.8	CHEMBL2828	Homo sapiens	Activity	%	2.8
	19230865	CHEMBL4397156	Inhibition of CK1delta (unknown origin) at 100 nM by [gamma-33P]ATP-based radiometric or Alphascreen assay relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	6.0	CHEMBL2828	Homo sapiens	INH	%	6.0
	19266371	CHEMBL4405321	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	19274901	CHEMBL4407582	Inhibition of recombinant human full-length GST-tagged CSNK1D expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 11 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	16.0	CHEMBL2828	Homo sapiens	INH	%	16.0
	19274902	CHEMBL4407582	Inhibition of recombinant human full-length GST-tagged CSNK1D expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 11 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	19274903	CHEMBL4407582	Inhibition of recombinant human full-length GST-tagged CSNK1D expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 11 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	3.0	CHEMBL2828	Homo sapiens	INH	%	3.0
	19368536	CHEMBL4424360	Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli at 5 uM using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21		CHEMBL4471178	>	Inhibition	%	30.0	CHEMBL2828	Homo sapiens	INH	%	30.0
Active	19368537	CHEMBL4424360	Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli at 5 uM using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C1CC1)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(NCCN(C)C)nc21		CHEMBL4462126		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	19368543	CHEMBL4424365	Inhibition of CK1delta (unknown origin) at 5 uM relative to control	B	CC(C1CC1)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(NCCN(C)C)nc21		CHEMBL4462126	>	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	19368558	CHEMBL4424380	Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C)n1cnc2c(NCc3cccc(C(F)(F)F)c3)ncnc21		CHEMBL4471178	=	IC50	nM	12000.0	CHEMBL2828	Homo sapiens	IC50	uM	12.0
	19368559	CHEMBL4424380	Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control	B	CC(C1CC1)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(NCCN(C)C)nc21		CHEMBL4462126	=	IC50	nM	3600.0	CHEMBL2828	Homo sapiens	IC50	uM	3.6
	19368560	CHEMBL4424380	Inhibition of recombinant N-terminal human GST-tagged CK1delta (1 to 294 residues) expressed in Escherichia coli using RKKKAEpSVASLTSQCSYSS peptide as substrate after 3 hrs by kinase-glo luminescent assay relative to control	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	19432882	CHEMBL4429540	Inhibition of CK1delta (unknown origin) at 1 uM	B	Cc1nccc(Nc2cc(NC3CCN(c4ccc(C#N)cc4)CC3)c(C(N)=O)cn2)n1		CHEMBL4463436	=	Inhibition	%	25.0	CHEMBL2828	Homo sapiens	INH	%	25.0
	20598028	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	=	Ki	nM	40.0	CHEMBL2828	Homo sapiens	Ki	uM	0.04
	20598029	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	=	IC50	nM	230.0	CHEMBL2828	Homo sapiens	IC50	uM	0.23
	20598030	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccccc3)nn2)CC1		CHEMBL4639555	=	IC50	nM	110.0	CHEMBL2828	Homo sapiens	IC50	uM	0.11
	20598031	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc(-c2nnc(N3CCNCC3)cc2-c2ccncc2)cc1		CHEMBL4639028	=	IC50	nM	50.0	CHEMBL2828	Homo sapiens	IC50	uM	0.05
	20598032	CHEMBL4602786	Inhibition of human CK1delta	B	CCN(CC)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4642101	=	IC50	nM	340.0	CHEMBL2828	Homo sapiens	IC50	uM	0.34
	20598033	CHEMBL4602786	Inhibition of human CK1delta	B	CCCN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4648747	=	IC50	nM	250.0	CHEMBL2828	Homo sapiens	IC50	uM	0.25
	20598034	CHEMBL4602786	Inhibition of human CK1delta	B	CN(C)c1cc(-c2ccncc2)c(-c2ccccc2)nn1		CHEMBL4645737	=	IC50	nM	710.0	CHEMBL2828	Homo sapiens	IC50	uM	0.71
	20598035	CHEMBL4602786	Inhibition of human CK1delta	B	CN(C)c1cc(-c2ccncc2)c(-c2cccc3ccccc23)nn1		CHEMBL4646628	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	20598036	CHEMBL4602786	Inhibition of human CK1delta	B	CN(C)c1cc(-c2ccncc2)c(-c2ccc3ccccc3c2)nn1		CHEMBL4648060	=	IC50	nM	6650.0	CHEMBL2828	Homo sapiens	IC50	uM	6.65
	20598037	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccccc4c3)nn2)CC1		CHEMBL4129018	=	IC50	nM	2610.0	CHEMBL2828	Homo sapiens	IC50	uM	2.61
	20598038	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cc(F)ccc4c3)nn2)CC1		CHEMBL4643993	=	IC50	nM	5210.0	CHEMBL2828	Homo sapiens	IC50	uM	5.21
	20598039	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4ccc(F)cc4c3)nn2)CC1		CHEMBL4640881	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	20598040	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4cccc(F)c4c3)nn2)CC1		CHEMBL4642456	>	IC50	nM	10000.0	CHEMBL2828	Homo sapiens	IC50	uM	10.0
	20598041	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4c(F)cccc4c3)nn2)CC1		CHEMBL4643060	=	IC50	nM	10020.0	CHEMBL2828	Homo sapiens	IC50	uM	10.02
	20598042	CHEMBL4602786	Inhibition of human CK1delta	B	CN1CCN(c2cc(-c3ccncc3)c(-c3ccc4[nH]ccc4c3)nn2)CC1		CHEMBL4635980	=	IC50	nM	320.0	CHEMBL2828	Homo sapiens	IC50	uM	0.32
	20598043	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc2cc(-c3nnc(N4CCNCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4647072	=	IC50	nM	2020.0	CHEMBL2828	Homo sapiens	IC50	uM	2.02
	20598044	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc2cc(-c3nnc(N4CCCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4635988	=	IC50	nM	9130.0	CHEMBL2828	Homo sapiens	IC50	uM	9.13
	20598045	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc2cc(-c3nnc(N4CCCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4639995	=	IC50	nM	3190.0	CHEMBL2828	Homo sapiens	IC50	uM	3.19
	20598046	CHEMBL4602786	Inhibition of human CK1delta	B	c1ccc2cc(-c3nnc(N4CCC4)cc3-c3ccncc3)ccc2c1		CHEMBL4643246	=	IC50	nM	5830.0	CHEMBL2828	Homo sapiens	IC50	uM	5.83
	20598047	CHEMBL4602786	Inhibition of human CK1delta	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	IC50	nM	1000.0	CHEMBL2828	Homo sapiens	IC50	uM	1.0
	20600495	CHEMBL4603447	Inhibition of recombinant human full-length GST-tagged CSNK1D expressed in baculovirus expression system using FRET-labeled Ser/Thr 11 peptide as substrate measured after 1 hr in presence of ATP by Z'-lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2828	Homo sapiens	IC50	uM	100.0
	20663894	CHEMBL4618904	Inhibition of full length recombinant human GST-tagged CSNK1D expressed in baculovirus expression system using casein as substrate incubated for 10 mins in presence of ATP by KinaseGlo luminescence assay	B	CCn1ccc2c3c(=O)cc(-c4cccc5ccccc45)[nH]c3ccc21		CHEMBL4173408	=	IC50	nM	15220.0	CHEMBL2828	Homo sapiens	IC50	uM	15.22
	20663895	CHEMBL4618904	Inhibition of full length recombinant human GST-tagged CSNK1D expressed in baculovirus expression system using casein as substrate incubated for 10 mins in presence of ATP by KinaseGlo luminescence assay	B	Oc1cc(-c2cccc(Br)c2)nc2ccc3[nH]ccc3c12		CHEMBL203847	=	IC50	nM	12950.0	CHEMBL2828	Homo sapiens	IC50	uM	12.95
	22392020	CHEMBL4667115	Inhibition of recombinant human GST-tagged full length CK1delta expressed in baculovirus expression system using Ser/Thr 11 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.0	CHEMBL2828	Homo sapiens	INH	%	1.0
	22423721	CHEMBL4674436	Inhibition of human CK1D using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	92.87	CHEMBL2828	Homo sapiens	Activity	%	92.87
	22423722	CHEMBL4674436	Inhibition of human CK1D using KRRRAL[pS]VASLPGL as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	90.09	CHEMBL2828	Homo sapiens	Activity	%	90.09
	22752717	CHEMBL4700181	Inhibition of human CK1d by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	40200.0	CHEMBL2828	Homo sapiens	IC50	uM	40.2
Not Determined	22752718	CHEMBL4700181	Inhibition of human CK1d by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL2828	Homo sapiens	IC50		
	22843445	CHEMBL4720442	Inhibition of human CK1D assessed as residual activity using KRRRAL[pS]VASLPGL as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	101.34	CHEMBL2828	Homo sapiens	Activity	%	101.34
	22844665	CHEMBL4721340	Inhibition of CK1D (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	80.24	CHEMBL2828	Homo sapiens	Activity	%	80.24
	22886584	CHEMBL4728287	Binding affinity to CSNK1D (unknown origin)	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	=	Kd	nM	100.0	CHEMBL2828	Homo sapiens	Kd	nM	100.0
Not Active	22889499	CHEMBL4729018	Inhibition of wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	22935030	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(C)nc12		CHEMBL4790041	=	IC50	nM	15170.0	CHEMBL2828	Homo sapiens	IC50	uM	15.17
	22935031	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(C3CCCC3)nc12		CHEMBL4747427	=	IC50	nM	12320.0	CHEMBL2828	Homo sapiens	IC50	uM	12.32
Not Determined	22935032	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cc4ccccc4[nH]3)nc12		CHEMBL4778286		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935033	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccccc3)nc12		CHEMBL4754212	=	IC50	nM	8670.0	CHEMBL2828	Homo sapiens	IC50	uM	8.67
Not Determined	22935034	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(F)cc3)nc12		CHEMBL4785880		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935035	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccncc3)nc12		CHEMBL4758812	=	IC50	nM	20190.0	CHEMBL2828	Homo sapiens	IC50	uM	20.19
Not Determined	22935036	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(OCc4ccccc4)cc3)nc12		CHEMBL4746578		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935037	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(OC)cc3)nc12		CHEMBL4746308		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935038	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(O)cc3)nc12		CHEMBL4747099		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935039	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(OC)c3)nc12		CHEMBL4747963	=	IC50	nM	25000.0	CHEMBL2828	Homo sapiens	IC50	uM	25.0
	22935040	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(F)c3)nc12		CHEMBL4800506	=	IC50	nM	15240.0	CHEMBL2828	Homo sapiens	IC50	uM	15.24
Not Determined	22935041	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc([N+](=O)[O-])c3)nc12		CHEMBL4761423		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935042	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(N)c3)nc12		CHEMBL4762847	=	IC50	nM	16590.0	CHEMBL2828	Homo sapiens	IC50	uM	16.59
	22935043	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4785118	=	IC50	nM	2060.0	CHEMBL2828	Homo sapiens	IC50	uM	2.06
	22935044	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(O)c(O)c3)nc12		CHEMBL4752279	=	IC50	nM	4750.0	CHEMBL2828	Homo sapiens	IC50	uM	4.75
Not Determined	22935045	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cc(OC)cc(OC)c3)nc12		CHEMBL4790796		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935046	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCOC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4752690	=	IC50	nM	480.0	CHEMBL2828	Homo sapiens	IC50	uM	0.48
	22935047	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1ncc(C(=O)O)c2nc(-c3cccc(O)c3)nn12		CHEMBL4789473	=	IC50	nM	26750.0	CHEMBL2828	Homo sapiens	IC50	uM	26.75
	22935048	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4776464	=	IC50	nM	320.0	CHEMBL2828	Homo sapiens	IC50	uM	0.32
	22935049	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4761245	=	IC50	nM	990.0	CHEMBL2828	Homo sapiens	IC50	uM	0.99
Not Determined	22935050	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CC(C)(C)OC(=O)NCCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4778241		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935051	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CC(C)(C)OC(=O)NCCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4743742	=	IC50	nM	5320.0	CHEMBL2828	Homo sapiens	IC50	uM	5.32
	22935052	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	NCCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12.O=C(O)C(F)(F)F		CHEMBL4744604	=	IC50	nM	1260.0	CHEMBL2828	Homo sapiens	IC50	uM	1.26
	22935053	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	NCCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12.O=C(O)C(F)(F)F		CHEMBL4793727	=	IC50	nM	210.0	CHEMBL2828	Homo sapiens	IC50	uM	0.21
Not Determined	22935054	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cccc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4795225		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935055	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4787742		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935056	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3cc(N(C)C)nc(N)n3n2)c1		CHEMBL4754160		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935057	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)cc2nc(-c3cccc(O)c3)nn12		CHEMBL4793501	=	IC50	nM	300.0	CHEMBL2828	Homo sapiens	IC50	uM	0.3
	22935058	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)cc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4795601	=	IC50	nM	740.0	CHEMBL2828	Homo sapiens	IC50	uM	0.74
Not Determined	22935059	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	CN(C)c1cc2nc(-c3cc(O)cc(O)c3)nn2c(N)n1		CHEMBL4778174		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935060	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccccc3)nn12		CHEMBL4741040		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935061	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1ccc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)cc1		CHEMBL4784014		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935062	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccc(O)cc3)nn12		CHEMBL4783769	=	IC50	nM	1320.0	CHEMBL2828	Homo sapiens	IC50	uM	1.32
Not Determined	22935063	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cccc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4744672		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935064	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cccc(-c2nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3n2)c1		CHEMBL4740102		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935065	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cccc(O)c3)nn12		CHEMBL4760165	=	IC50	nM	460.0	CHEMBL2828	Homo sapiens	IC50	uM	0.46
Not Determined	22935066	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Oc1cccc(-c2nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3n2)c1		CHEMBL4764918		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935067	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1ccc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)cc1OC		CHEMBL4758938	=	IC50	nM	5650.0	CHEMBL2828	Homo sapiens	IC50	uM	5.65
	22935068	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccc(O)c(O)c3)nn12		CHEMBL4783829	=	IC50	nM	910.0	CHEMBL2828	Homo sapiens	IC50	uM	0.91
Not Determined	22935069	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4791507		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935070	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccc(Cl)cc4)nc(N)n3n2)c1		CHEMBL4789767		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935071	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccc(F)cc4)nc(N)n3n2)c1		CHEMBL4755847		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935072	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3nc(NCc4cccc(C)c4)nc(N)n3n2)c1		CHEMBL4765035		IC50			CHEMBL2828	Homo sapiens	IC50		
Not Determined	22935073	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(OC)cc(-c2nc3cc(NC4CCCCC4)nc(N)n3n2)c1		CHEMBL4787530		IC50			CHEMBL2828	Homo sapiens	IC50		
	22935074	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	IC50	nM	180.0	CHEMBL2828	Homo sapiens	IC50	uM	0.18
	22935075	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccc(Cl)cc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4793180	=	IC50	nM	750.0	CHEMBL2828	Homo sapiens	IC50	uM	0.75
	22935076	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccc(F)cc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4784755	=	IC50	nM	470.0	CHEMBL2828	Homo sapiens	IC50	uM	0.47
	22935077	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Cc1cccc(CNc2nc(N)n3nc(-c4cc(O)cc(O)c4)nc3n2)c1		CHEMBL4745216	=	IC50	nM	530.0	CHEMBL2828	Homo sapiens	IC50	uM	0.53
	22935078	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NC2CCCCC2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4782184	=	IC50	nM	670.0	CHEMBL2828	Homo sapiens	IC50	uM	0.67
	22935079	CHEMBL4739354	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	COc1cc(O)cc(-c2nc3nc(NC4CCCCC4)nc(N)n3n2)c1		CHEMBL4743699	=	IC50	nM	3300.0	CHEMBL2828	Homo sapiens	IC50	uM	3.3
	22935080	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(C)nc12		CHEMBL4790041	=	Inhibition	%	66.6	CHEMBL2828	Homo sapiens	INH	%	66.6
	22935081	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(C3CCCC3)nc12		CHEMBL4747427	=	Inhibition	%	76.8	CHEMBL2828	Homo sapiens	INH	%	76.8
	22935082	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cc4ccccc4[nH]3)nc12		CHEMBL4778286	=	Inhibition	%	22.4	CHEMBL2828	Homo sapiens	INH	%	22.4
	22935083	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccccc3)nc12		CHEMBL4754212	=	Inhibition	%	62.2	CHEMBL2828	Homo sapiens	INH	%	62.2
	22935084	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(F)cc3)nc12		CHEMBL4785880	=	Inhibition	%	44.7	CHEMBL2828	Homo sapiens	INH	%	44.7
	22935085	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccncc3)nc12		CHEMBL4758812	=	Inhibition	%	59.7	CHEMBL2828	Homo sapiens	INH	%	59.7
	22935086	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(OCc4ccccc4)cc3)nc12		CHEMBL4746578	=	Inhibition	%	39.7	CHEMBL2828	Homo sapiens	INH	%	39.7
	22935087	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(OC)cc3)nc12		CHEMBL4746308	=	Inhibition	%	50.3	CHEMBL2828	Homo sapiens	INH	%	50.3
	22935088	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(O)cc3)nc12		CHEMBL4747099	=	Inhibition	%	39.3	CHEMBL2828	Homo sapiens	INH	%	39.3
	22935089	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(OC)c3)nc12		CHEMBL4747963	=	Inhibition	%	52.0	CHEMBL2828	Homo sapiens	INH	%	52.0
	22935090	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(F)c3)nc12		CHEMBL4800506	=	Inhibition	%	53.7	CHEMBL2828	Homo sapiens	INH	%	53.7
	22935091	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc([N+](=O)[O-])c3)nc12		CHEMBL4761423	=	Inhibition	%	21.6	CHEMBL2828	Homo sapiens	INH	%	21.6
	22935092	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(N)c3)nc12		CHEMBL4762847	=	Inhibition	%	66.8	CHEMBL2828	Homo sapiens	INH	%	66.8
	22935093	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4785118	=	Inhibition	%	88.9	CHEMBL2828	Homo sapiens	INH	%	88.9
	22935094	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3ccc(O)c(O)c3)nc12		CHEMBL4752279	=	Inhibition	%	98.0	CHEMBL2828	Homo sapiens	INH	%	98.0
	22935095	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cc(OC)cc(OC)c3)nc12		CHEMBL4790796	=	Inhibition	%	18.8	CHEMBL2828	Homo sapiens	INH	%	18.8
	22935096	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4752690	=	Inhibition	%	97.8	CHEMBL2828	Homo sapiens	INH	%	97.8
	22935097	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1ncc(C(=O)O)c2nc(-c3cccc(O)c3)nn12		CHEMBL4789473	=	Inhibition	%	75.8	CHEMBL2828	Homo sapiens	INH	%	75.8
	22935098	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4776464	=	Inhibition	%	90.4	CHEMBL2828	Homo sapiens	INH	%	90.4
	22935099	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4761245	=	Inhibition	%	86.1	CHEMBL2828	Homo sapiens	INH	%	86.1
	22935100	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CC(C)(C)OC(=O)NCCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12		CHEMBL4778241	=	Inhibition	%	16.8	CHEMBL2828	Homo sapiens	INH	%	16.8
	22935101	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CC(C)(C)OC(=O)NCCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12		CHEMBL4743742	=	Inhibition	%	84.2	CHEMBL2828	Homo sapiens	INH	%	84.2
	22935102	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	NCCNC(=O)c1cnc(N)n2nc(-c3cccc(O)c3)nc12.O=C(O)C(F)(F)F		CHEMBL4744604	=	Inhibition	%	93.0	CHEMBL2828	Homo sapiens	INH	%	93.0
	22935103	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	NCCNC(=O)c1cnc(N)n2nc(-c3cc(O)cc(O)c3)nc12.O=C(O)C(F)(F)F		CHEMBL4793727	=	Inhibition	%	93.6	CHEMBL2828	Homo sapiens	INH	%	93.6
	22935104	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccc(OC)c(OC)c2)n2nc(-c3ccccc3)nc12		CHEMBL4756773	=	Inhibition	%	35.7	CHEMBL2828	Homo sapiens	INH	%	35.7
	22935105	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccc(OC)c(OC)c2)n2nc(-c3ccc(F)cc3)nc12		CHEMBL4792643	=	Inhibition	%	11.3	CHEMBL2828	Homo sapiens	INH	%	11.3
	22935106	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccccc2)n2nc(-c3cccc(OC)c3)nc12		CHEMBL4781221	=	Inhibition	%	10.9	CHEMBL2828	Homo sapiens	INH	%	10.9
	22935107	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccc(-c3ccccc3)cc2)n2nc(-c3cccc(OC)c3)nc12		CHEMBL4741407	=	Inhibition	%	17.5	CHEMBL2828	Homo sapiens	INH	%	17.5
	22935108	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NC)n2nc(-c3cccc(O)c3)nc12		CHEMBL4786315	=	Inhibition	%	7.1	CHEMBL2828	Homo sapiens	INH	%	7.1
	22935109	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccccc2)n2nc(-c3cccc(O)c3)nc12		CHEMBL4751991	=	Inhibition	%	1.2	CHEMBL2828	Homo sapiens	INH	%	1.2
	22935110	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CCOC(=O)c1cnc(NCc2ccc(-c3ccccc3)cc2)n2nc(-c3cccc(O)c3)nc12		CHEMBL4781111	=	Inhibition	%	9.0	CHEMBL2828	Homo sapiens	INH	%	9.0
	22935111	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cccc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)c1	Outside typical range	CHEMBL4795225	=	Inhibition	%	-12.7	CHEMBL2828	Homo sapiens	INH	%	-12.7
	22935112	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4787742	=	Inhibition	%	19.4	CHEMBL2828	Homo sapiens	INH	%	19.4
	22935113	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3cc(N(C)C)nc(N)n3n2)c1		CHEMBL4754160	=	Inhibition	%	33.5	CHEMBL2828	Homo sapiens	INH	%	33.5
	22935114	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)cc2nc(-c3cccc(O)c3)nn12		CHEMBL4793501	=	Inhibition	%	75.2	CHEMBL2828	Homo sapiens	INH	%	75.2
	22935115	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)cc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4795601	=	Inhibition	%	80.2	CHEMBL2828	Homo sapiens	INH	%	80.2
	22935116	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	CN(C)c1cc2nc(-c3cc(O)cc(O)c3)nn2c(N)n1	Outside typical range	CHEMBL4778174	=	Inhibition	%	-22.1	CHEMBL2828	Homo sapiens	INH	%	-22.1
	22935117	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccccc3)nn12		CHEMBL4741040	=	Inhibition	%	39.7	CHEMBL2828	Homo sapiens	INH	%	39.7
	22935118	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1ccc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)cc1		CHEMBL4784014	=	Inhibition	%	15.6	CHEMBL2828	Homo sapiens	INH	%	15.6
	22935119	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccc(O)cc3)nn12		CHEMBL4783769	=	Inhibition	%	70.4	CHEMBL2828	Homo sapiens	INH	%	70.4
	22935120	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cccc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4744672	=	Inhibition	%	18.1	CHEMBL2828	Homo sapiens	INH	%	18.1
	22935121	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cccc(-c2nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3n2)c1	Outside typical range	CHEMBL4740102	=	Inhibition	%	-10.3	CHEMBL2828	Homo sapiens	INH	%	-10.3
	22935122	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cccc(O)c3)nn12		CHEMBL4760165	=	Inhibition	%	84.2	CHEMBL2828	Homo sapiens	INH	%	84.2
	22935123	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Oc1cccc(-c2nc3nc(NCc4ccccc4)nc(NCc4ccccc4)n3n2)c1		CHEMBL4764918	=	Inhibition	%	-8.5	CHEMBL2828	Homo sapiens	INH	%	-8.5
	22935124	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1ccc(-c2nc3cc(NCc4ccccc4)nc(N)n3n2)cc1OC		CHEMBL4758938	=	Inhibition	%	72.4	CHEMBL2828	Homo sapiens	INH	%	72.4
	22935125	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3ccc(O)c(O)c3)nn12		CHEMBL4783829	=	Inhibition	%	93.8	CHEMBL2828	Homo sapiens	INH	%	93.8
	22935126	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccccc4)nc(N)n3n2)c1		CHEMBL4791507	=	Inhibition	%	4.5	CHEMBL2828	Homo sapiens	INH	%	4.5
	22935127	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccc(Cl)cc4)nc(N)n3n2)c1		CHEMBL4789767	=	Inhibition	%	9.7	CHEMBL2828	Homo sapiens	INH	%	9.7
	22935128	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3nc(NCc4ccc(F)cc4)nc(N)n3n2)c1		CHEMBL4755847	=	Inhibition	%	10.5	CHEMBL2828	Homo sapiens	INH	%	10.5
	22935129	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3nc(NCc4cccc(C)c4)nc(N)n3n2)c1		CHEMBL4765035	=	Inhibition	%	13.9	CHEMBL2828	Homo sapiens	INH	%	13.9
	22935130	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(OC)cc(-c2nc3cc(NC4CCCCC4)nc(N)n3n2)c1		CHEMBL4787530	=	Inhibition	%	41.9	CHEMBL2828	Homo sapiens	INH	%	41.9
	22935131	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	Inhibition	%	85.3	CHEMBL2828	Homo sapiens	INH	%	85.3
	22935132	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccc(Cl)cc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4793180	=	Inhibition	%	95.8	CHEMBL2828	Homo sapiens	INH	%	95.8
	22935133	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NCc2ccc(F)cc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4784755	=	Inhibition	%	87.0	CHEMBL2828	Homo sapiens	INH	%	87.0
	22935134	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Cc1cccc(CNc2nc(N)n3nc(-c4cc(O)cc(O)c4)nc3n2)c1		CHEMBL4745216	=	Inhibition	%	79.7	CHEMBL2828	Homo sapiens	INH	%	79.7
	22935135	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Nc1nc(NC2CCCCC2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4782184	=	Inhibition	%	89.3	CHEMBL2828	Homo sapiens	INH	%	89.3
	22935136	CHEMBL4739355	Inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) at 40 uM using casein as substrate measured after 60 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	COc1cc(O)cc(-c2nc3nc(NC4CCCCC4)nc(N)n3n2)c1		CHEMBL4743699	=	Inhibition	%	68.6	CHEMBL2828	Homo sapiens	INH	%	68.6
	22935142	CHEMBL4739361	Binding affinity to wild-type human full length CSNK1D (M1 to K409 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	Activity	%	14.0	CHEMBL2828	Homo sapiens	Activity	%	14.0
	22935148	CHEMBL4739366	Inhibition of recombinant human full-length N-terminal GST-tagged CK1delta using casein as substrate measured after 10 mins in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954	=	IC50	nM	300.0	CHEMBL2828	Homo sapiens	IC50	uM	0.3
Active	22935149	CHEMBL4739367	ATP competitive inhibition of recombinant human N-terminal GST-tagged CK1delta (1 to 294 residues) in presence of varying level of ATP by Kinase-Glo reagent-based luminescence assay	B	Nc1nc(NCc2ccccc2)nc2nc(-c3cc(O)cc(O)c3)nn12		CHEMBL4742954		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	22935151	CHEMBL4739369	Inhibition of full-length human CK1delta expressed in Escherichia coli BL21-CodonPlus(DE3)-RIL competent cells using PLSRTLpSVASLPGL as substrate incubated for 3 hrs in presence of ATP by Kinase-Glo luminescence assay	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1		CHEMBL1951415	=	IC50	nM	14.0	CHEMBL2828	Homo sapiens	IC50	nM	14.0
	22935152	CHEMBL4739370	Inhibition of wild-type human CK1delta using PLSRTLpSVASLPGL as substrate incubated for 40 mins in presence of ATP by Kinase-Glo luminescence assay	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCN(Cc3ccon3)CC2)n1		CHEMBL4128865	=	IC50	nM	3.9	CHEMBL2828	Homo sapiens	IC50	nM	3.9
	22943988	CHEMBL4742508	Inhibition of CSNK1D (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	10.0	CHEMBL2828	Homo sapiens	Activity	%	10.0
	22949072	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	22949073	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	88.0	CHEMBL2828	Homo sapiens	Activity	%	88.0
	22949074	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	89.0	CHEMBL2828	Homo sapiens	Activity	%	89.0
	22949075	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	92.0	CHEMBL2828	Homo sapiens	Activity	%	92.0
	22949076	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	22949077	CHEMBL4765739	Inhibition of human CK1-delta assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	88.0	CHEMBL2828	Homo sapiens	Activity	%	88.0
	22949078	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	91.0	CHEMBL2828	Homo sapiens	Activity	%	91.0
	22949079	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	22949080	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	86.0	CHEMBL2828	Homo sapiens	Activity	%	86.0
	22949081	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	79.0	CHEMBL2828	Homo sapiens	Activity	%	79.0
	22949082	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	84.0	CHEMBL2828	Homo sapiens	Activity	%	84.0
	22949083	CHEMBL4765740	Inhibition of human CK1-delta assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	82.0	CHEMBL2828	Homo sapiens	Activity	%	82.0
	22952795	CHEMBL4766732	Inhibition of recombinant human CK1delta (1 to 294 residues) assessed as residual activity at 10 uM using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	2.0	CHEMBL2828	Homo sapiens	Activity	%	2.0
	22953063	CHEMBL4767000	Inhibition of recombinant human CK1delta (1 to 294 residues) using KRRRALS(p)VASLPGL as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	509.0	CHEMBL2828	Homo sapiens	IC50	uM	0.509
	22977485	CHEMBL4772123	Inhibition of CK1delta (unknown origin)	B	Nc1nc2c([nH]1)c1c(c3[nH]c(N)nc32)[C@H](CNC(=O)c2[nH]cc(Br)c2Br)[C@H]1CNC(=O)c1[nH]cc(Br)c1Br		CHEMBL4780812	=	IC50	nM	680.0	CHEMBL2828	Homo sapiens	IC50	uM	0.68
	23120310	CHEMBL4804366	Inhibition of CK1d in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	58900.0	CHEMBL2828	Homo sapiens	IC50	uM	58.9
	23120311	CHEMBL4804366	Inhibition of CK1d in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	68200.0	CHEMBL2828	Homo sapiens	IC50	uM	68.2
	23120312	CHEMBL4804366	Inhibition of CK1d in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	IC50	nM	95000.0	CHEMBL2828	Homo sapiens	IC50	uM	95.0
Not Determined	23121352	CHEMBL4804548	Inhibition of CK1d in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542		Inhibition	%		CHEMBL2828	Homo sapiens	INH		
	23121353	CHEMBL4804548	Inhibition of CK1d in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	50.0	CHEMBL2828	Homo sapiens	INH	%	50.0
	23121354	CHEMBL4804548	Inhibition of CK1d in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL2828	Homo sapiens	INH	%	90.0
	23122508	CHEMBL4804859	Inhibition of human CSNK1D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	87.0	CHEMBL2828	Homo sapiens	Activity	%	87.0
	23123203	CHEMBL4805447	Inhibition of human CSNK1D assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL2828	Homo sapiens	Activity	%	98.0
	23123688	CHEMBL4805932	Inhibition of DNA-tagged human CSNK1D assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	83.0	CHEMBL2828	Homo sapiens	Activity	%	83.0
	23124021	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4852083	=	IC50	nM	8600.0	CHEMBL2828	Homo sapiens	IC50	nM	8600.0
	23124022	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	IC50	nM	2935.0	CHEMBL2828	Homo sapiens	IC50	nM	2935.0
	23124023	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOC[C@H]4CO)nc32)cn1		CHEMBL4868638	=	IC50	nM	6065.0	CHEMBL2828	Homo sapiens	IC50	nM	6065.0
	23124024	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	COc1cc2nc(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cnn(C)c3)[nH]c2cc1Cl		CHEMBL4855324	=	IC50	nM	4.0	CHEMBL2828	Homo sapiens	IC50	nM	4.0
	23124025	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cc1cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)no1		CHEMBL4847754	=	IC50	nM	4745.0	CHEMBL2828	Homo sapiens	IC50	nM	4745.0
	23124026	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(F)c(F)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4856716	>	IC50	nM	9900.0	CHEMBL2828	Homo sapiens	IC50	nM	9900.0
	23124027	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cscn3)nc2c1F		CHEMBL4868958	=	IC50	nM	870.0	CHEMBL2828	Homo sapiens	IC50	nM	870.0
	23124028	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOC[C@@H]4CO)nc32)cn1		CHEMBL4849960	=	IC50	nM	333.0	CHEMBL2828	Homo sapiens	IC50	nM	333.0
	23124029	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3cncs3)nc2c1F		CHEMBL4849684	=	IC50	nM	419.0	CHEMBL2828	Homo sapiens	IC50	nM	419.0
	23124030	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	Fc1ccc2[nH]c(CNc3nc(N4CCOCC4)nc4c3ncn4-c3nccs3)nc2c1F		CHEMBL4856935	=	IC50	nM	400.0	CHEMBL2828	Homo sapiens	IC50	nM	400.0
	23124031	CHEMBL4806265	Inhibition of casein kinase 1delta (unknown origin)	B	FC(F)n1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4867928	=	IC50	nM	1257.0	CHEMBL2828	Homo sapiens	IC50	nM	1257.0
	23124496	CHEMBL4806464	Inhibition of human CSNK1D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	20.0	CHEMBL2828	Homo sapiens	Activity	%	20.0
	23124497	CHEMBL4806464	Inhibition of human CSNK1D assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	22.0	CHEMBL2828	Homo sapiens	Activity	%	22.0
	23125247	CHEMBL4806842	Inhibition of human CSNK1D at 2000 nM by KINOMEscan assay	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	>	Inhibition	%	65.0	CHEMBL2828	Homo sapiens	INH	%	65.0
	23125258	CHEMBL4806850	Inhibition of human CSNK1E by DiscoverX assay	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Kd	nM	280.0	CHEMBL2828	Homo sapiens	Kd	nM	280.0
	23127954	CHEMBL4807793	Inhibition of CK1-delta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2828	Homo sapiens	Activity	%	75.0
	23127955	CHEMBL4807793	Inhibition of CK1-delta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2828	Homo sapiens	Activity	%	75.0
	23127956	CHEMBL4807793	Inhibition of CK1-delta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2828	Homo sapiens	Activity	%	75.0
Not Active	23317343	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	81.0	CHEMBL2828	Homo sapiens	% Control	%	81.0
Not Active	23317811	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	92.0	CHEMBL2828	Homo sapiens	% Control	%	92.0
Not Active	23318481	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23318961	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	94.0	CHEMBL2828	Homo sapiens	% Control	%	94.0
Not Active	23319600	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23320073	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	98.9	CHEMBL2828	Homo sapiens	% Control	%	98.9
Not Active	23320751	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	95.0	CHEMBL2828	Homo sapiens	% Control	%	95.0
Not Active	23321219	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23321849	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	80.0	CHEMBL2828	Homo sapiens	% Control	%	80.0
Not Active	23322317	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	83.0	CHEMBL2828	Homo sapiens	% Control	%	83.0
Not Active	23323006	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23323474	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	92.0	CHEMBL2828	Homo sapiens	% Control	%	92.0
Not Active	23323977	CHEMBL4880596	CK1delta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	3.0	CHEMBL2828	Homo sapiens	% inhibition	%	3.0
Not Active	23324328	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23324963	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23325431	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23326078	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL2828	Homo sapiens	% Control	%	93.0
Not Active	23326546	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	83.0	CHEMBL2828	Homo sapiens	% Control	%	83.0
Not Active	23327246	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	85.0	CHEMBL2828	Homo sapiens	% Control	%	85.0
Not Active	23327714	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	93.0	CHEMBL2828	Homo sapiens	% Control	%	93.0
Not Active	23328301	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	76.0	CHEMBL2828	Homo sapiens	% Control	%	76.0
Not Active	23328769	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	81.0	CHEMBL2828	Homo sapiens	% Control	%	81.0
Not Active	23329299	CHEMBL4881006	CK1delta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	116.0	CHEMBL2828	Homo sapiens	% residual kinase activity	%	116.0
Not Active	23329715	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23330183	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	83.0	CHEMBL2828	Homo sapiens	% Control	%	83.0
Not Active	23330939	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23331407	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23331994	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23332462	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23333178	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23333817	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	82.0	CHEMBL2828	Homo sapiens	% Control	%	82.0
Not Active	23334285	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	95.0	CHEMBL2828	Homo sapiens	% Control	%	95.0
Not Active	23334882	CHEMBL4881506	CK1delta (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	65.0	CHEMBL2828	Homo sapiens	% inhibition	%	65.0
Not Active	23335264	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23335732	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23336359	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23336827	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	97.0	CHEMBL2828	Homo sapiens	% Control	%	97.0
Not Active	23337555	CHEMBL4881926	CSNK1D Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL2828	Homo sapiens	% Ctrl	%	97.0
Not Active	23337908	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL2828	Homo sapiens	% Control	%	96.0
Not Active	23338376	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23338988	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	96.0	CHEMBL2828	Homo sapiens	% Control	%	96.0
Not Active	23339456	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23340093	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL2828	Homo sapiens	% Control	%	99.0
Not Active	23340561	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23341218	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23341686	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23342302	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL2828	Homo sapiens	% Control	%	96.0
Not Active	23342770	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23343400	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	81.0	CHEMBL2828	Homo sapiens	% Control	%	81.0
Not Active	23343868	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	84.0	CHEMBL2828	Homo sapiens	% Control	%	84.0
Not Active	23344506	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23345079	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23345547	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	81.0	CHEMBL2828	Homo sapiens	% Control	%	81.0
Not Active	23346124	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23346593	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	92.5	CHEMBL2828	Homo sapiens	% Control	%	92.5
Not Active	23347201	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	84.7	CHEMBL2828	Homo sapiens	% Control	%	84.7
Not Active	23347684	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23348263	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23348731	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23349318	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	87.0	CHEMBL2828	Homo sapiens	% Control	%	87.0
Not Active	23349936	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23350404	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23351009	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23351477	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23352006	CHEMBL4882697	CSNK1D (CK1 delta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.9742	CHEMBL2828	Homo sapiens	% Inhibition	%	0.9742
Not Active	23352501	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	80.0	CHEMBL2828	Homo sapiens	% Control	%	80.0
Not Active	23352969	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	84.0	CHEMBL2828	Homo sapiens	% Control	%	84.0
Not Active	23353851	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23354319	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23355051	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	84.0	CHEMBL2828	Homo sapiens	% Control	%	84.0
Not Active	23355519	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	83.0	CHEMBL2828	Homo sapiens	% Control	%	83.0
Not Active	23356155	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23356623	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23357232	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	92.0	CHEMBL2828	Homo sapiens	% Control	%	92.0
Not Active	23357879	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23358347	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23358933	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23359531	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23359999	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23360584	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL2828	Homo sapiens	% Control	%	94.0
Not Active	23361052	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	98.0	CHEMBL2828	Homo sapiens	% Control	%	98.0
Not Active	23361625	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	95.0	CHEMBL2828	Homo sapiens	% Control	%	95.0
Not Active	23362161	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23362629	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	75.0	CHEMBL2828	Homo sapiens	% Control	%	75.0
Not Active	23363234	CHEMBL4883233	CSNK1D (CK1 delta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.31	CHEMBL2828	Homo sapiens	% inhibition	%	4.3096
Not Active	23363235	CHEMBL4883233	CSNK1D (CK1 delta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-2.916	CHEMBL2828	Homo sapiens	% inhibition	%	-2.9156
Not Active	23364271	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	93.0	CHEMBL2828	Homo sapiens	% Control	%	93.0
Not Active	23364739	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	80.0	CHEMBL2828	Homo sapiens	% Control	%	80.0
Not Active	23365478	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	95.0	CHEMBL2828	Homo sapiens	% Control	%	95.0
Not Active	23366021	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	92.0	CHEMBL2828	Homo sapiens	% Control	%	92.0
Not Active	23366611	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23367079	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23367513	CHEMBL4883866	CK1-delta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL2828	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23367957	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23368425	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	90.0	CHEMBL2828	Homo sapiens	% Control	%	90.0
Not Active	23369024	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	89.0	CHEMBL2828	Homo sapiens	% Control	%	89.0
Not Active	23369492	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	83.0	CHEMBL2828	Homo sapiens	% Control	%	83.0
Not Active	23370021	CHEMBL4884265	CK1delta(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	94.0	CHEMBL2828	Homo sapiens	% residual kinase activity	%	94.0
Not Active	23370460	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23370928	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	89.0	CHEMBL2828	Homo sapiens	% Control	%	89.0
Not Active	23371737	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	84.0	CHEMBL2828	Homo sapiens	% Control	%	84.0
Not Active	23372205	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	96.0	CHEMBL2828	Homo sapiens	% Control	%	96.0
	23372709	CHEMBL4884674	CK1delta(CS1DLGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2828	Homo sapiens	pIC50		6.0
	23373118	CHEMBL4884965	CK1delta(CS1DLGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2828	Homo sapiens	pIC50		6.0
	23373479	CHEMBL4885256	CK1delta(CS1DLGI1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2828	Homo sapiens	pIC50		6.0
Not Active	23374939	CHEMBL4885933	CK1_delta Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	1.5	CHEMBL2828	Homo sapiens	% Inhibition	%	1.5
Not Active	23375632	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	90.0	CHEMBL2828	Homo sapiens	% Control	%	90.0
Not Active	23376100	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23376677	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	81.0	CHEMBL2828	Homo sapiens	% Control	%	81.0
Not Active	23377147	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	74.0	CHEMBL2828	Homo sapiens	% Control	%	74.0
Not Active	23378005	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	99.0	CHEMBL2828	Homo sapiens	% Control	%	99.0
Not Active	23378473	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23379640	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	96.0	CHEMBL2828	Homo sapiens	% Control	%	96.0
Not Active	23380108	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	74.0	CHEMBL2828	Homo sapiens	% Control	%	74.0
Not Active	23380802	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23381450	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23381918	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23382397	CHEMBL4887117	CKLdelta Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	27.0	CHEMBL2828	Homo sapiens	% inhibition	%	27.0
Not Active	23382542	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	98.0	CHEMBL2828	Homo sapiens	% Control	%	98.0
Not Active	23383010	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
Not Active	23383748	CHEMBL4887392	CSNK1D Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	100.0	CHEMBL2828	Homo sapiens	% Ctrl	%	100.0
Not Active	23384223	CHEMBL4887818	CK1delta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	9.07	CHEMBL2828	Homo sapiens	% inhibition	%	9.07
Not Active	23384925	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL2828	Homo sapiens	% Control	%	88.0
Not Active	23385392	CHEMBL4879649	KinomeScan assay: inhibition of CSNK1D	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2828	Homo sapiens	% Control	%	100.0
